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Abstract
Central dopamine and oxytocin interactions during penile erection
Both dopamine and oxytocin have established roles in the central regulation of male sexual behaviour
in rats and are clearly pro-erectile when exogenously applied. Penile erection induced by dopamine or
oxytocin can be blocked by pre-treatment with an oxytocin and dopamine receptor antagonist,
respectively (Martino et al 2005; Melis et al, 1997). So it is believed that an interaction exists between
these two neural circuitries during the stimulation of penile erection. However, where such neural
crosstalk occurs and by what cellular mechanisms remains unknown. The medial preoptic nucleus
(MPN), supraoptic nucleus (SON) and paraventricular nucleus (PVN) of the hypothalamus are three
brain nuclei believed to have an important role in masculine sexual behaviour. To investigate a
dopamine-oxytocin link in the central regulation of erectile function, this study was comprised of
three parts to examine (1) the behavioural effects of dopamine agonists and antagonists on penile
erection-induced neuronal activation within the three key hypothalamic nuclei (2) the expression of
D2, D3 and D4 receptor expression by hypothalamic oxyocin neurons and (3) the effect of spinal
oxytocin receptor blockade on dopamine agonist -induced penile erection. The data show that whilst
D2 and D3 but not D4 receptor stimulation during pharmacological-induced penile erection appears to
involve in part the activation of parvocellular paraventricular oxytocin neurons, magnocellular
oxytocin cells in the hypothalamic nuclei remain unaffected. Conversely, blockade of central D4 but
not D2 or D3 dopamine receptors during physiologically-induced penile erection, attenuated the
activation of magnocellular supraoptic oxytocin cells and was without effect on paraventricular
oxytocin cells. Additionally, antagonism of central D3 receptors significantly decreased neuronal
activation in all three regions of interest after intromission, however, these neurons were not
oxytocinergic. Thus, dopaminergic stimulation (and/or the behavioural context) of penile erection
may involve differential activation of central oxytocin neurons. In addition, D2, D3 and D4 receptors
were expressed by oxytocin cells in the MPN, SON and PVN with D4 receptors predominantly
expressed on magnocellular oxytocin neurons. Finally, blockade of oxytocin action in the
lumbosacral cord (a potential release site for oxytocin), markedly impaired erectile function after
dopaminergic stimulation. Taken together, the data suggest that dopamine elicits penile erection via
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the stimulation of D2, D3 and/or D4 receptors (perhaps located on oxytocin neurons) by differential
activation of non-oxytocinergic and/or oxytocinergic pathways in specific hypothalamic nuclei.





Central control of penile erection




Male sexual behaviour is a well characterised and relatively highly conserved behaviour in most
mammals. Male sexual behaviour is a complex series of behavioural events that culminates in
ejaculation. It involves the integration of sensory, olfactory and social cues which subsequently
stimulate central and peripheral processes to elicit penile erection and co-ordinate skeletal and motor
output that facilitate copulation. Sexual behaviour is comprised of a motivational phase (sexual
arousal and mounting) and a consummatory phase (penile erection, intromissions and ejaculation).
The mating pattern consists of a brief number of mounts followed by a series of intromissions
(approximately 8-15) until ejaculation occurs. The rat enters a brief sexual refractory period
(approximately 6-10 min) before engaging in further sexual contact (Beyer et al, 1981; Paredes and
Agmo, 2004 for review). The brain loci involved, neurochemical correlates and the neural circuitry
underlying each sexual event (namely, sexual motivation, mounting, penile erection, ejaculation,
sexual reward and sexual satiety) have yet to be fully elucidated. However, much progress has been
made in recent times with the use of more highly refined lesioning, tract-tracing and
immunocytochemical techniques as well as the commercial availability of more pharmacological tools
with greater selectively, to identify specific brain nuclei and neural substrates that may mediate
components of masculine sexual behaviour.
1.2 Penile erection
Penile erection is one particular component of male sexual function that has received much attention
due to reports of erectile dysfunction in those patients suffering from a range of diseases including
diabetes, andrological and psychotic disorders (Basu and Ryder, 2004; Glander et al, 2007; Papatsoris
et al, 2006). Although psychogenic factors may have a contributory role in erectile dysfunction,
organic processes including vascular, hormonal and neurobiological are the main leading causes of the
pathophysiology of erectile dysfunction (Kaminetsky, 2008). Penile erection is a complex reflex
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response influenced by neural, steroidal, hormonal and vascular inputs (Giuliano and Rampin, 2000;
Heaton, 2000; Hull et al, 1999; Ralph, 2005); the neurochemical and anatomical properties of which
have yet to be fully established. Achievement of penile erection relies upon increased blood flow to
the penis (via arterial dilatation), engorgement of the penis with blood and penile rigidity (due to
relaxation of the corpus cavernosum and corpus spongiosum) and contraction of the perineal striated
muscles to enhance penile rigidity. Autonomic pathways originating in the spinal cord serve as the
main anti-erectile (sympathetic) and pro-erectile (parasympathetic) pathways controlling penile
erection. The intraspinal networks responsible for preventing and eliciting penile erection are the
thoracolumbar sympathetic and sacral parasympathetic nuclei, respectively, (Giuliano and Rampin,
2000 for review). Excitatory signals are transmitted to the penis via the cavernous nerve which
receives input from the pelvic nerve. Because of the close anatomical arrangement between spinal
networks and the penis and studies showing spinal cord injured rats and humans (thus removing all
supraspinal contributions) are capable of eliciting penile erection (Chapelle et al, 1980; Ishizuka et al,
2002; Vargas et al, 2004); the spinal cord is emerging as the key structure controlling penile erection
which integrates converging commands from peripheral and supraspinal influences.
From the spinal cord, sympathetic and parasympathetic fibres running in the cavernosal nerves
provide the neuronal efferents to the penis. The cavernosal nerves reside in the major pelvic ganglia,
which are in turn innervated by lumbosacral-derived pelvic nerves and thoracolumbar-derived
hypogastric nerves. Additionally, the sensory afferents of peripheral origin are relayed to the
lumbosacral spinal cord via the pudendal nerves and impinge on the dorsal penile nerve (Figure 1.1).
1.3 Intromission
The term intromission is used in rodent sexual behaviour studies and serves as a physiological marker
of penile erection. Intromission is often defined as in-copula penile erection and is a highly
stereotyped behaviour. In rats, achievement of intromission occurs when a male is placed with a
receptive female rat. Male rats initially display mounting behaviour (when the male positions himself
directly behind the female and place's his front paws on her back without displaying pelvic thrusting)
during which, the genital region receives somatosensory stimulation. Such genitosensory feedback
9
Figure 1.1: Neuroanatomy of penile erection





Neuronal pathways regulating penile erection. Sexually-associated stimulii reach the
penile erection centres in the brain, including the hypothalamus. Neural signals are
transmitted to the spinal cord where anti-erectile sympathetic fibres run in the hypogastric
nerve toward the pelvic ganglion. Likewise, pro-erectile parasympathetic pathways
present in the pelivc nerve also impinge on the pelvic ganglion. For both pathways, the
cavernous nerve serves as the final common pathway to the penis. Sensory information
from the penis is relayed to the spinal cord via the pudendal nerve.
(Adapted from Argiolas and Melis, 1995)
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accompanied by sexually-stimulating olfactory cues act to facilitate intromission in the male rat.
During intromission, in-copula stimulation of the prepuce seems to have a role in the activation of
copulatory thrusting patterns (Contreras and Agmo, 1993). Once the thrusting threshold has been
reached, the combined peripheral inputs from the penis, prepuce and perineal striated muscles to the
brain may result in the activation of as yet unknown central pathways culminating in penile
withdrawal and dismounting. Intromitting parameters such as latency and frequency are often
recorded during copulation and they can be regarded as indicators of penile erection associated with
sexual arousal and erectile efficiency, respectively.
1.4 Ejaculation
Ejaculation is essentially a physiological process and can be difficult to define behaviourally, even to
the trained observer. It is a spinal reflex and is comprised of two phases: seminal emission and
expulsion. Seminal emission involves secretion of seminal fluids into the urethra and contraction of
the vas deferens to propel the sperm through this vessel. Expulsion of semen requires closure of the
bladder neck and rhythmic contractions of the urethra and perineal striated muscles. Behavioural
characterisation of ejaculation is apparent when the male maintains the mounting position for a brief
period (1-2 sees) after the last series of intromissions; following this the female initiates a separation.
The male will then tend to groom his genital region afterwards and engage in a brief period (4-6 min)
of sexual inactivity. As seen with central control of penile erection, the spinal cord serves as the
primary central site controlling ejaculation via the spinal ejaculation generator (Mckenna, 1999)
which influences autonomic and somatic nuclei in the lumbosacral spinal cord (Allard et al, 2005).
This was implied after studies showing that removal of descending supraspinal influences after spinal
cord injury does not attenuate ejaculatory responses to peripheral stimulation in humans and rats
(Brackett, 1999; Griffith et al, 1973; McKenna et al, 1991; Pescatori et al, 1993). Thus, the spinal
cord appears to be the main central controller of the ejaculatory response. Sympathetic inputs
influencing ejaculation reside in the thoracolumbar segments of the spinal cord (Baron and Janig,
1991; Nadelhaft and McKenna, 1987). Conversely, those exerting parasympathetic control originate
in the sacral parasympathetic nucleus (SPN) of the lumbosacral spinal cord (Hancock and Peveta,
1979a, 1979b; Nadelhaft and Booth, 1984). During ejaculation, in addition to a coordinated
sympathetic and parasympathetic outflow from the spinal ejaculation generator, there is also
10
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convergent somatic output from the pudendal motorneurons innervating the perineal striated muscles
(Coolen et al, 2004 for review). Rhythmic activation of these motorneurons facilitates the expulsion
of semen and contributes to the heightened pleasurable sensations experienced during ejaculation
(Gerstenberg et al, 1990; Holmes et al, 1991; Holmes and Sachs, 1991). The neural substrates and
circuitries subserving ejaculation still remain poorly understood. However, recently there has been
some progress in the elucidation of these pathways as shown by Truitt and Coolen (2002) who
demonstrated that a specific set of lumbar spinothalamic cells located in the L3-L4 spinal cord region
are a component of the spinal ejaculation generator and are crucial for eliciting the ejaculatory
response (Coolen et al, 2004; Truitt and Coolen, 2002). In rats, the relaying of sensory information
during ejaculation is believed to be conveyed by the dorsal penile nerve and the pudendal nerve
(McKenna et al, 1991; Pescatori et al, 1993).
Thus, it can be seen that the consummatory elements of male sexual behaviour is comprised of three
phases; penile erection, intromission and ejaculation (often defined as copulatory behaviour). There is
abundant data on the central processes and neural correlates involved in the expression of penile
erection in particular and because this sexual component precedes intromission and ejaculation and
acts as a physiological stimulator for both, it is necessary to better understand neuroanatomically and
neurochemically those central pathways activated during erectile function. We know that the spinal
cord is the central mediator for penile erection; however, it is still unclear as to those supraspinal
influences that are able to modulate neurotransmission within the pro-erectile spinal networks.
1.5 Brain nuclei involved in the central control ofpenile erection.
The significant role of the brain in mediating penile erection was first shown by Benassi-Benelli and
colleagues (1979) who found that pharmacologically-induced penile erection (agonist given
systemically) could be inhibited by a centrally- but not a peripherally-acting antagonist. This finding
has since been confirmed in other studies (Ferrari and Claudi, 1991; Hsieh et al, 2003; Pehek et al,
1988) and has reinforced the notion that central brain mechanisms partly regulate erectile function.
Several brain structures have been implicated in the neural control of penile erection, with the
hypothalamic nuclei showing the most convincing evidence for a prominent role. However, it is
11
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important to add that there are several studies which show that central influences on penile erection
are not restricted to the hypothalamus but involve other subcortical structures (Summary diagram is
shown in Figure 1.2).
1.5.1. Hypothalamus
It is widely accepted that the hypothalamus serves as a major integration site, where central, sensory
and peripheral inputs converge to regulate various neuroendocrine-mediated behaviours. Specific
nuclei within the hypothalamus are believed to be important sites for regulating erectile function,
namely the medial preoptic area (MPOA), the paraventriclar nucleus (PVN) and to a lesser extent the
supraoptic nucleus (SON).
MPOA
The MPOA (containing the MPN) (Figure 1.3A) has proved to be an important integration site for the
expression of male sexual behaviour. This was demonstrated after lesioning studies of the MPOA
showed almost complete abolishment of male copulatory function in various species (Koyama et al,
1984; Liu et al, 1997; Lloyd and Dixson, 1988). With regard to the role of the MPOA during penile
erection, there have been several conflicting reports questioning the importance of the MPOA in
eliciting erectile events. Using intracavernous pressure (ICP) as an indicator of erectile function, there
have been several studies demonstrating that electrical stimulation of the MPOA produces powerful
transient increases in ICP (Giuliano et al, 1996; Giuliano et al, 1997; Sato and Christ, 2000).
Additionally, by altering endogenous neurotransmitter levels in the MPOA, non-contact and reflexive
erections can be augmented (Adachi et al, 2003). Immunocytochemical studies using Fos as a marker
of neuronal activation have indicated that upon exposure to oestrus female cues, non-contact
erections, copulation and ejaculation have all been shown separately to increase neuronal activation in
the MPOA of male rats (Bressler and Baum, 1996; Cooleen et al, 1996; Robertson et al, 1991;
Shimura et al, 1994; Struthers, 2001; Veening and Coolen, 1998). However, support for a role of the
MPOA in the central control of penile erection was diminished after lesioning studies showed that
damage to the MPOA and its fibres had no significant effects on non-contact erections but severely
disrupted copulatory behaviour (Liu et al, 1997). Pharmacological studies in involving microinjection
12





















Summary of those nuclei implicated in central control of penile erection. Both the MPOA
and PVN appear to be key players in initiating penile erection in various contexts. The SON
may have a role during in-copula penile erection. The MeA, BNST and NA are necessary
for the integration of sexual stimuli with sexual arousal processes. MPN=medial preoptic
nucleus; MeA=medial amygdala; SON=supraoptic nucleus; BNST=bed nucleus of stria
terminalis; PVN=paraventricular nucleus; NAc=nucleus accumbens.
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of dopaminergic ligands directly into the MPOA (primary site for mediating the dopaminergic effects
on copulation) (Hull et al, 1986; Pehek et al, 1988) have similarly shown conflicting reports. Injection
of the dopamine agonist, quinelorane into the MPOA (lpg) had a facilitatory role in erectile function
(Bazzett et al, 1991; Markowski et al, 1994). Conversely, in another study where quinelorane was
injected into the MPOA (2.5pg), erectile function was inhibited and yet seminal emission enhanced
(Bitran et al, 1989). However, pharmacological data should be interpreted with caution as the erectile
responses appear to depend on which MPOA receptors that are stimulated by the exogenously applied
pro-erectile drug and the dose administered (Hull et al, 1992; Markowski et al, 1994).
Thus, it seems that the MPOA is crucial for efficient copulatory behaviour in rats. Because removal
of MPOA influence on erectile pathways has only a minor impact on penile erection; its role in the
initiation of penile erection appears to be modulatory. It is very likely that MPOA involvement in
erectile function is indirect via MPOA projections to another important pro-erectile structure, the PVN
(Conrad and Pfaff, 1976).
PVN
The PVN (Figure 1.3B) is believed by some researchers to be critical for the initiation of penile
erection upon pharmacological stimulation or exposure to oestrous female cues (Argiolas and Mel is,
2004; Melis et al, 1998, 1999). The PVN proves to be a suitable candidate because it receives neural
inputs from almost all hypothalamic nuclei and its branching anatomical arrangement allows for
discrete action at multiple target sites in the CNS. The PVN is comprised of five subregions, namely,
the anterior, dorsal, medial, magnocellular and lateral subdivisions (Figure 4). Because specific
parvocellular neuronal groups have been implicated in mediating penile erection (Kita et al, 2006,
Witt and Insel, 1994), there has been some suggestion of a paraventricular subregion-specific
activation during erection. Parvocellular neurons located in the PVN have been shown to project to
the lumbosacral spinal cord and lie in close apposition to spinal pro-erectile networks (Tang et al,
1998; Veronneau-Longueville et al, 1999). Thus, such a defined neuroanatomical pathway could
serve as one potential route through which supraspinal commands are transmitted to the erectile
centres in the spinal cord. Electrical stimulation of the PVN and micro-injection of various
13
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pharmacological agents including those that mimic the actions of dopamine, oxytocin, nitric oxide,
excitatory amino acids into the PVN have all been shown to have profound facilitatory effects on
penile erection (Argiolas and Melis, 2005 for review; Chen et al, 1997; Melis et al, 1987). Neural
mapping studies using Fos as a marker of neuronal activation, have shown the PVN to be activated
during various aspects of masculine sexual behaviour (Caquineau et al, 2006; Kita et al, 2006; Pfaus
and Heeb, 1997; Witt et Insel, 1994). Additionally, experiments involving lesioning of either part or
all of the PVN show that there are significant deficits in penile erection (Paredes and Agmo, 2004)
which do not appear to be due to a direct effect on penile striated muscles as PVN-derived
parvocellular fibres innervating somatic outflow are very sparse (Tang et al, 1999). Chemical
destruction of the parvocellular PVN using the excitotoxin, NMDA, which leaves predominantly the
magnocellular region intact in the PVN shows there are significant deficits in erectile activity as
evidenced by an increase in the latency to achievement of penile erection and a marked decrease in the
frequency of erections (Liu et al, 1997). Moreover, such PVN lesions completely abolish the pro-
erectile effect of the nonselective dopamine agonist, apomorphine and oxytocin (Argiolas et al, 1987).
These results suggest that the parvocellular PVN neurons (namely, anterior, dorsal and medial fibres
known to project to the spinal cord) (Wagner and Clemens, 1991) may have an intermediary role in
the excitation phase of penile erection and are perhaps crucial during sexual arousal and the initiation
of erection. In contrast, the magocellular subdivision of the PVN appears to have a role in the
consummatory elements of sexual behaviour (eg. intromission, pelvic thrusting, ejaculation)
(Caquineau et al, 2006; Pattij et al, 2005). Since the PVN receives diffuse innervation from some
hypothalamic and extra-hypothalamic structures that have been implicated in penile erection (Gray et
al 1989; Herman et al, 2005; Liposits, 1993; Larsen et al, 1994; Prewitt and Herman, 1998) and its
projections impinge on spinal pro-erectile centres (Veronneau-Longueville et al, 1999), it seems
logical to assume that the PVN may serve as the final common nucleus which supplies descending
excitatory fibres to the lumbosacral spinal cord. Thus, the PVN may have a more pivotal role in
triggering the expression of penile erection.
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Figure 1.3: Diagrammatic representation of rat brain on coronal view. Hypothalamic nuclei involved
in the central control of penile erection are the MPN (A), SON and PVN (B). 3v=third ventricle;
fx=fornix; AC=anterior commisure; MPOA=medial preoptic area; MPN=medial preoptic nucleus;
OX=optic chiasm; SON=supraoptic nucleus; PVN=paraventricular nucleus.
Bregma: -0.92mm
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Figure 1.4: Subdivisions comprising the PVN of the rat, represented in coronal view. Based on the
atlas of Paxinos and Watson, 1988. ap=anterior parvocellular; dp=dorsal parvocellular; mp=medial
parvocellular; lp=lateral parvocellular; pm=posterior magnocellular.
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SON
Relatively little is known regarding the role of the predominantly magnocellular SON (Figure 1.3B) in
central control of penile erection. Fos immunocytochemical studies have revealed that in-copula
penile erection (intromission) and ejaculation produced dense clusters of Fos expression in the SON
(Caquineau et al, 2006; Pattij et al, 2005; Phillips-Farfan and Fernandez-Guasti, 2007). Interestingly,
in males deemed sexually sluggish, there is very weak neuronal activation in the SON (Pattij et al,
2005). So, there appears to be emerging evidence to suggest that this nucleus may be activated during
the display of copulatory behaviour.
1.5.2 Medial amygdala (MeA)
The basolateral and corticomedial amygdala are believed to be involved in the processing of sexually
conditioned odours and have a role in sexual reward (Kippin et al 2003; Lehman and Winans, 1982).
However, it is the MeA that has shown to exert some control of the erectile process. The MeA is
typically known to be involved in social recognition and social interaction (Ferguson et al, 2001;
Ferguson et al, 2002 for review). In addition, there is some support for an established role of the MeA
in the mediation of male sexual behaviour (Harris and Sach, 1975; Kondo et al, 1992). Because it
receives major olfactory imputs, the MeA is regarded as an important integrative site for mediating
sexually-stimulating cues and the evocation of penile erection. Robinson and Mishkin (1968) initially
demonstrated that electrical stimulation of the MeA in primates had a powerful effect on penile
erection. More recently, it has been shown that male rats with damage to the MeA display
impairments in non contact erections but no obvious deficits in reflexive erections or copulation were
observed (Kondo et al, 1998; Kondo and Sachs, 2002). Thus, the MeA appears to be another
important central candidate that is part of a larger network regulating erectile function.
1.5.3 Bed nucleus ofthe stria terminalis (BNST)
The BNST is another brain region which has been implicated in the neural control of non-contact
erections. As seen with the PVN and MeA, destruction of the BNST has profound inihibitory effects
on the expression of penile erection in response to female oestrous cues, whilst producing no apparent
deficits in full copulatory function (Kondo et al, 1998; Liu et al, 1997). Reciprocal connections exist
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between the BNST and the MeA, MPOA and PVN (Canteras et al, 1995; Dong and Swanson, 2006;
Saphier and Feldman, 1986; Sawchenko and Swanson, 1983), thus the BNST seems to contribute in
part to the neural circuitry subserving penile erection.
1.5.4 Nucleus accumbens (NAc)
The nucleus accumbens (NAc) has been shown to have some influence on a diverse range of
behaviour including fear and social isolation (Fulford and Marsden, 1998; Lapiz et al, 2001 for
review; Schwienbacher et al, 2003). The NAc also has a key central role in the sexual reward circuit
as evidenced by an increase in NAc neuronal firing and intra-NAc monoaminergic neurotransmission
when pairing olfactory stimulation with sexually receptive oestrus females (Damsma et al, 1992; West
et al, 1992). However, its role in regulating masculine sexual behaviour is less well defined. The
NAc is known for its role in sexual motivation. Pharmacological agonists microinjected into the NAc
which act to mimic or enhance dopamine release, were shown to reduce the time to which male rats
displayed mounting and intromitting compared to control rats (Hull et al, 1986; Everitt et al, 1990;
Giuliano and Allard, 2001). Additionally, local infusion of the dopamine antagonist, haloperidol into
the NAc, decreased sexual motivational parameters (Pfaus and Phillips, 1991). The importance of the
NAc in mediating the comsummatory elements of sexual behaviour is less well defined. Neurotoxic
and electrolytic disruption of the NAc has shown that the fundamental aspects of male sexual
behaviour remain intact (Liu et al, 1998); however, when exposed to a receptive yet inaccessible
female, substantial deficits in the display of non-contact erections were observed (Kippin et al, 2004;
Liu et al, 1998). The NAc appears to have some role in responding to remote sexual cues and
integrating such stimuli with those processes controlling sexual arousal.
Thus, it can be seen that central control of penile erection involves a complex and hierarchical
neuronal network operating at the supraspinal level which subsequently influences the spinal erectile
network. However, neurochemical substrates and neuronal phenotypes that may modulate central
neurotransmission remain to be fully elucidated.
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1.6. Oxytocin
Oxytocin is a classical neuroendocrine hormone that can initiate a wide spectrum of peripheral and
central effects. It is a nonapeptide comprised of nine amino acids and it is very similar in structure to
the peptide hormone, arginine vasopressin (AVP), where it differs in only two of the nine amino acid
sequences.
1.6.1.1 Oxytocin synthesis and distirbution
Oxytocin is primarily synthesised in magnocellular neurosecretory cells in the SON and PVN, where
it is transported to the posterior pituitary and released into the blood. From here oxytocin has a vital
role in mediating parturition and the milk ejection reflex in rats (Insel et al, 1997b; Neumann, 2001a;
Russell et al, 2001; Russell et al, 2003 for review). Similarly, oxytocin is also generated in
parvocellular neurons in the PVN which project to extrahypothalamic regions within the CNS where
they have a role in mediating various autonomic functions (Badoer, 2001; Mack et al, 2002;
Petersson, 2002; Tang et al, 1998). Oxytocinergic fibres are not restricted to the SON and PVN but
also lie outwith these two nuclei where they are found to be expressed in various other brain nuclei
including the hippocampus, cortex, amygdala, olfactory bulbs, substantia nigra, brain stem and the
spinal cord (Gimpl and Fahrenholz, 2001 for review and references therein; Sawchenko and Swanson,
1985; Sofroniew and Weindl, 1978). With its diffuse projections, oxytocin is able to influence a range
of neuroendocrine-mediated functions governing social and affiliative behaviours such as maternal
and socio-sexual behaviour (Argiolas and Melis 1995; Insel et al., 1997a, b; Argiolas, 1999; Argiolas
and Melis 2004; Kendrick, 2000, 2004; Richard et al, 1991 for review).
1.6.1.2 Oxytocin release
As previously mentioned, magnocellular and parvocellular oxytocn release into systemic circulation
and the CNS occurs via projections to the posterior pituitary and extrahypothalamic brain regions,
respectively. Oxytocin release from axon terminals occurs in the classical manner where axonal
release is preceeded by an influx of calcium into axonal terminals in response to an invading action
potential. However, as first demonstrated by Moos and colleagues (1984), oxytocin can also be
released somatodendritically from magnocellular oxytocin neurons in the PVN and SON to regulate
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its own release. This finding was further substantiated in numerous in vivo studies using
microdialysis to quantitatively measure oxytocin release in the plasma and the brain of parturient and
lactating rats (Moos et al, 1989; Neumann et al, 1993a; Neumann et al, 1993b). Unlike axonal release
of oxytocin, dendritic release of oxytocin is triggered by release of calcium from intracellular stores
and is generally electrically-independent (Ludwig et al, 2002b; Ludwig and leng, 2006 for review).
Central (somatodendritic) and peripheral (axonal) oxytocin release from magnocellular cells can act
synergistically to influence behavioural consequences. During suckling, there is a concomitant release
of oxytocin into the bloodstream, SON and PVN which contributes to the milk ejection reflex (Moos
et al, 1989; Neumann et al, 1993b). This simultaneous release of oxytocin into the brain and
periphery was also observed in female (intruder) rats during an emotional stressor when a virgin
intruder is introduced to the homecage of and confronted with a lactating female rat (Bosch et al,
2004; Neumann et al, 2001b). Such synergy between the central and peripheral oxytocin systems
does not always exist and infact there can be an apparent disassociation between the two as seen
during another psychosocial stressor such as social defeat. Engelmann and colleagues (1999)
demonstrated that whilst intra-SON oxytocin release increased in response to social defeat, peripheral
oxytocin release remained unaffected. Thus, it can be seen that during certain neuroendocrine-
mediated behaviours, centrally-acting and peripherally-acting oxytocin may act in unison or
independently to exert their behaviourally-specific effects.
1.6.1.3 Oxytocin receptors
The encoded oxytocin receptor is a 389-amino acid polypeptide with seven transmembrane domains
and is thus part of the G protein-coupled receptor family. When oxytocin binds to its receptor it
initiates a cascade of intracellular events that culminate in a range of cellular responses including an
increase in neuronal firing, neurotransmitter release, smooth muscle contraction and protein
phosphorylation (Figure 1.5). In rats, peripheral expression of oxytocin receptors is concentrated in
the male and female reproductive tract and in myoepithelial cells in mammary tissue (Gimpl and
Fahrenholz, 2001; Zhang et al, 2005). Additionally, oxytocin receptors are also abundantly expressed
throughout the CNS and often exist in the same regions expressing oxytocin fibres. In addition to
their expression in the SON and PVN, oxytocin receptors are also found in the regions of the cortex,
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Figure 1.5 : Oxytocin intracellular signalling pathways
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Transduction pathways activated upon oxytocin receptor stimulation. Oxytocin receptors are G
protein-coupled receptors . Oxytocin binds to an oxytocin receptor coupled to GTP binding
proteins which in turn activate PLC. From there, PLC stimulates DAG which generates PKC and
results in the phosphorylation of target proteins. Additionally, PLC activates IP3 which triggers a
cascade of calcium dependent mechanisms which promote protein synthesis, neurotransmitter
release and smooth muscle contraction. OT=oxytocin; OTR=oxytocin receptor; GTP=guanine
triphosphate; PLC=phospholipase C; IP3=inositol triphosphate; DAG= diacylglycerol; Caj
intracellular calcium; PKC=protein kinase C; NO=nitric oxide.
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hippocampus, limbic system, basal ganglia, medial preoptic area, olfactory bulbs, amygdala and the
brain stem (Freund-Mercier et al, 1994; Gimpl and Fahrenholz, 2001; Yoshimura et al, 1993). There
is widespread distribution of oxytocin receptors in the thoracic and lumbosacral segments of the spinal
cord, with the dorsal horn, dorsal grey commisure, intermediolateral cell column all possessing
oxytocin receptors (Veronneau-Longueville et al, 1999). However, some brain areas show a distinct
mismatch between oxytocin fibre distribution and oxytocin receptor expression, such as seen in the
amygdala and olfactory bulbs where there is a significantly greater proportion of oxytocin receptors
compared to oxytocin fibres that innervate these nuclei (Ferguson et al, 2001; Huber et al, 2005;
Terenzi and Ingram, 2005). Such an anatomical mismatch gives rise to the possibility that centrally
released oxytocin can diffuse to distant sites within the brain to exert its effects. The oxytocinergic
system may also be involved in complex interactions with other neuromediator)' pathways which
regulate oxytocinergic and non-oxytocinergic neurotransmission in the brain. Such a finding was
recently seen in a study examining the occurrence of penile erection in conscious male rats where
local injection of oxytocin into the ventral tegmental area stimulated release of dopamine in the
nucleus accumbens and the PVN (Melis et al, 2007).
1.6.1.4 Oxytocin and behaviour
In the periphery, oxytocin is widely known to have a potent stimulatory effect on uterine muscle tone
and triggering the onset of labour (Fuchs et al, 1995; Kimura et al, 1992). In males, the testis and the
epididymis are peripheral targets of oxytocin where it aids in maintaining spermiation and sperm
motility (Gimpl and Fahrenholz, 2001 for review). In the brain, the actions of oxytocin have been
shown to be important in regulating socio-sexual behaviours. Oxytocin pathways subserving maternal
and social behaviour are believed to be important in governing familial and non-familial bonds
(Campbell, 2008 for review; Cushing and carter, 2000; Ferguson et al, 2000; Kendrick, 2000). In
monogamous prairie voles, centrally delivered oxytocin markedly increases the length of time spent in
social contact, implying that oxytocin facilitates pair bond formation within this strain of voles (Cho
et al, 1999). Finally, central oxytocin has also been shown to have anxiolytic properties whereby
oxytocin-treated mice engage in more risk-taking, explorative and investigative behaviours (Bale et al,
2001; McCarthy et al, 1996; Ring et al, 2006).
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1.6.2 Oxytocin and male sexual behaviour
The role of oxytocin in male sexual behaviour has been well documented (Argiolas and Melis, 2004).
It has long been known that oxytocin when injected either peripherally, centrally or intra-thecally, can
be an extremely potent inducer of penile erection (Argiolas et al, 1985; Argiolas et al, 1986; Martino
et al, 2005; Kita et al, 2006) and has a strong pro-copulatory effect in male rats (Arletti et al, 1985).
In humans, plasma oxytocin levels are significantly elevated during arousal, penile erection and
ejaculation (Uckert et al, 2003; Carmichael et al, 1987). Both rodent and human studies suggest that
oxytocin acts as an important mediator for appetitive and consummatory phases in male sexual
behaviour, serving as a facilitatory neuromodulator during sexual arousal and consummation. The
medial preoptic nucleus (MPN) of the MPOA, SON and PVN are three key hypothalamic nuclei
believed to partly influence male sexual behaviour via their oxytocinergic contributions. The PVN
and SON are the richest oxytocin-containing nuclei in the brain whereas the MPN of the MPOA
expresses a comparatively small oxytocinergic neuronal population. Pharmacological and
neuroanatomical studies have shown that specific facilitatory effects on sexual behaviour are partly
modulated via oxytocin action within these structures. Thus, these three nuclei are potential key
candidates for neural control of erectile function.
1.6.2.1 MPOA
Currently, all sexual behaviour studies implicating oxytocin action in the MPOA have been performed
on female rodents. To our knowledge, no such neuropeptide involvement in the MPOA has been
investigated in male rats. Central infusion of increasing doses of oxytocin dramatically increases
female soliciting behaviours, such as the lordortic response in ovariectomised, hormonally-primed
female rats and hamsters (Caldwell et al, 1989; Whitman and Albers, 1995; Schulze and Gorzalka,
1991). Likewise, oestrogen-primed females injected with an oxytocin receptor antagonist in the
MPOA show a reduction in the expression of lordosis postures (Caldwell et al, 1994). Furthermore,
immunocytochemical studies revealed that mounting by male rats increased oxytocin
immunoreactivity in the MPOA of female rats (Caldwell et al, 1989). So, in females the MPOA
appears to be a primary site for the facilitative effects of oxytocin to induce sexual receptivity. Thus,
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it is entirely possible that oxytocin populations residing in the MPOA may also be similarly effective
in eliciting sexual responses in male rats.
1.6.2.2 PVN
Considerably more is known regarding the role of oxytocin in the PVN during penile erection and this
has previously been extensively reviewed (Argiolas and Melis, 2004). Recruitment of oxytocin
neurons in the PVN during sexual behaviour has recently been substantiated after increased oxytocin
release in the PVN was correlated with mating behaviour in male rats (Wadherr and Neumann, 2007)
implicating paraventricular oxytocin involvement during copulation. It is widely accepted that
oxytocin can be released somatodendritically from magnocellular oxytocin neurons in the PVN (and
SON) (Ludwig, 1998), suggesting that local oxytocin release within this nucleus has an autoregulatory
effect. Furthermore, it has been demonstrated that somatodendritic release of oxytocin can increase
neuronal firing in magnocellular oxytocin neurons (Ludwig, 2002a, Richard et al, 1997). These
findings infer that oxytocin can in fact modulate its own activity via direct and/or indirect actions on
oxytocin neurons in the PVN (and SON) (Ludwig, 2002). Thus, it is quite possible that such
oxytocinergic activation via local oxytocin may underlie the neuroendocrine pathways facilitating
penile erection.
Electrolytic and neurotoxic destruction of the oxytocin rich PVN, which results in widespread loss of
central oxytocin levels (Hawthorn et al, 1985), abolishes the erectile response to oxytocin and other
pharmacological ligands (Argiolas et al; 1987; Liu et al, 1997). Additionally, blockade of central
oxytocin receptors after pre-treatment with an oxytocin receptor antagonist disrupts non-contact
erections (Melis et al, 1999) and penile erections evoked after intra-PVN delivery of oxytocin
(Argiolas, 1999 for review; Melis and Argiolas, 2003).
Immunocytochemical studies using combined Fos and oxytocin labelling as a marker of oxytocin
neuronal activation have provided additional neuronatomical support of an underlying oxytocinergic
pathway mediating penile erection and copulation. An increased Fos expression in oxytocin neurons
was observed in lateral parvocellular oxytocin neurons in the PVN during intromissions and
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ejaculations (Witt et al, 1994). Furthermore, Fos expression in oxytocin neurons increased with the
intensity of sexual stimuli (ranging from an oestrus odour to intromission and ejaculation) (Witt et al,
1994). Oxytocin-induced penile erection was shown to selectively activate paraventricular
parvocellular oxytocin neurons known to project to the spinal cord (Kita et al, 2006). Meanwhile,
paraventricular magnocellular oxytocin cells were also shown to be stimulated during intromission
(Caquineau et al, 2006).
Finally, electrical and tactile stimulation of the dorsal penile nerve, selectively excites oxytocin cells
in the PVN (Yanagimoto et al, 1996) implying that sensory afferents arising from the penis have a
role in peripheral feedback.
Thus, it seems that the PVN is a crucial brain area necessary for responding to the pro-erectile effects
of oxytocin.
It is not clear whether local oxytocin release (presumably via magnocellular oxytocin neurons) or
distant oxytocin release (via parvocellular oxytocin neuronal projections) function sequentially or in
concert to help coordinate the erectile response. Additionally, the complexity of oxytocin
involvement is enhanced by the presence of both a parvocellular and magnocellular neuronal
population, which some believe may differentially influence aspects of masculine sexual behaviour.
In all likelihood, it is very possible that dendritic release of oxytocin within the PVN activates both
oxytocin neuronal phenotypes which in turn cause central release of oxytocin at multiple sites. It is
this central wide presence of oxytocin that presumably initiates the rapid onset of penile rigidity and
facilitates the consummatory parameters that follow during mating behaviour, although this is highly
specualative.
1.6.2.3 SON
Very little is known regarding the role of the magnocellular oxytocin system in the SON during penile
erection. Similar to the PVN, magnocellular oxytocin neurons exist in the SON where they too
project to the posterior pituitary and are secreted into the blood to exert their peripheral hormonal
actions (Kiss and Mikkelson, 2005 for review). The potential role of magnocellular oxytocin cells in
the regulation of erectile function has been poorly evaluated; however, human studies have revealed
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that plasma oxytocin levels only show a marked increase after ejaculation and not during sexual
arousal (Murphy et al, 1987). In another study, where men were exposed to erotic stimuli, only a
marginal increase in plasma oxytocin levels was observed during the flaccid to semi-erect state of the
penis. However, no such changes in neuropeptide concentration occurred following that when penile
rigidity was achieved. Conversely, once the penis returned to the flaccid state, there was a steady
increase in systemic plasma oxytocin levels (Uckert et al, 2003). The sexually-specific increase in
systemic oxytocin levels after ejaculation has also been confirmed in animal models (Stoneham et al,
1985). These findings postulate that magnocellular oxytocin release into the systemic circulation is
not essentially involved in penile erection associated with sexual arousal but may have an underlying
functional role in signalling the end of a sexual encounter and the beginning of sexual satiety. It is
important to add that whilst magnocellular oxytocin cells have a clear peripheral role in mediating
various sexual responses that currently do not include the initiation of penile erection, a central pro-
erectile role (via local somatodendritic release) in the SON cannot be ruled out and merits further
investigation.
The effect of intra-SON injection of oxytocin or other pro-erectile drugs on penile erection is not
known. However, in support of the oxytocin release data, immunocytochemical studies have revealed
that supraoptic oxytocin cells become activated during intromission (Caquineau et al, 2006) and
ejaculation (Pattij et al, 2005) in rats. Thus, it seems that supraoptic oxytocin cells are stimulated
upon in-copula penile erection (after achievement of penile rigidity) and ejaculation. As with the
PVN, stimulation of the dorsal penile nerve excites oxytocin cells in the SON (Honda et al 1999)
suggesting they too may be highly responsive to peripheral sensory afferents originating in the penis.
1.7 Control ofoxytocin neurons during penile erection
It is apparent that central oxytocinergic neurons have an established role in mediating erectile
function; however, those neural circuits impinging on and modulating the activity of oxytocin neurons
during the expression of masculine sexual behaviour are poorly understood. Many central factors
such as the serotonin, melanocortin, glutamate and GABA systems are all believed to have a part in
neuromodulatory influence on oxytocinergic neurotransmission (Argiolas and Melis et al, 2004 for
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review; Caquineau et al, 2006; De Jong et al, 2007; Martin and Maclntyre, 2004; Melis et al, 2006;
Pederson and Boccia, 2006; Succu et al, 2006).
1.7.1 Noradrenlalin and oxytocin interactions
To our knowledge, there does not seem to be any published work showing a link between central
noradrenaline and oxytocin during penile erection. Noradrenaline is a neuromediator for the
sympathetic (anti-erectile) nervous system, so it seems unlikely that it would have a strong facilitatory
influence over penile erection Hippocampal noradrenergic neurotransmission is believed to play a
role in the negative feedback loop controlling penile erection (Chang et al, 2001) but a central role in
facilitating erectile function has not been established (Martinez-Pineiro et al, 1994). In hormonally-
primed female rats, oxytocin has been shown to stimulate noradrenaline release in the ventromedial
hypothalamus during lordosis (sexually-receptive behaviour) (Etgen and Karkanias, 1994; Vincent
and Etgen, 1993). However, such a link has yet to be investigated in male rats during masculine
sexual behaviour.
1.7.2 Serotonin and oxytocin interactions
There is emerging evidence for an interactive role between serotonin and oxytocin during ejaculation
which has previously been extensively reviewed (De Jong et al, 2006, 2007 for review). Additionally,
there has been some published data suggesting a link between these two neuromodulators during the
expression of penile erection. Stimulation of central serotonin receptors (particularly the 5HT-1C
subtype) elicits penile erection and this has been correlated with elevated plasma oxytocin levels
(Bagdy et al, 1992; Bagdy and Kalogeras, 1993). Neuroanatomical studies have also revealed that in
addition to oxytocin projections, there is a distinct serotonerigc innervation of the lumbosacral spinal
cord where serotonin fibres are believed to impinge on preganglionic fibres of the spinal pro-erectile
network (Tang et al. 1998). Contained within this spinal nucleus are oxytocin receptor binding sites
(Veronneau-Longueville et al, 1999) suggesting that the lumbosacral spinal cord may serve as another
central integration site for serotonin and oxytocin neurotransmission.
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The involvement of the oxytocin-rich PVN in mediating serotonin responses however, remains
debatable after conflicting findings. Destruction of the PVN did not significantly impair penile
erection or affect plasma oxytocin levels after central administration of 5HT-2C receptor agonists
(Bagdy and Makara, 1995). However, these findings conflict with other studies which showed 5HT-
2C agonists were able to enhance oxytocin concentrations in plasma (Bagdy and Makara, 1994;
Bagdy, 1996), although erectile events were not recorded in these studies. In these experiments, the
serotonin agonists were administered into the lateral ventricle, so perhaps they were acting at oxytocin
sites other than the PVN to produce the differential oxytocin responses observed in the above studies.
Taken together, the published data highlights a possible serotonin-oxytocin link during penile erection
and suggests that integration sites may exist not only in the brain but at the level of the lumbosacral
spinal cord, which is crucial for inducing erectile episodes.
1.7.3 Melanocortin and oxytocin interactions
Melanocortins such as melanotan-Il (MT-II) and alpha-melanocyte stimulating hormone (a-MSH) are
known to act on all subtypes of melanocortin receptors (Martin and Maclntyre, 2004) and have been
shown to be potent erectogenic agents in animals and humans (Bertolini and Gessa, 1981; Wessells et
al, 1998). Because melanocortin receptors are abundantly expressed in the MPN, SON and PVN (and
many other hypothalamic and extra-hypothalamic regions) (Adan and Gispen, 1997), it is possible that
melanocortins may be involved in the regulation of central oxytocin responses. Although it is
presumed that melanocortin and oxytocin interactions are likely to occur in hypothalamic nuclei to
mediate erectogenesis, this was shown not to be the case based in studies where the pro-erectile
effects of peripheral but not central administration of melanocortins were blocked after oxytocin
receptor blockade (Martin et al, 2002; Mizusawa et al, 2002). This suggests that melanocortins may
act indirectly on central oxytocin sites or via non-oxytocinergic targets. However, a more direct role
for melanocortin influence over central oxytocinergic transmission was suggested by
immunocytochemical studies where central delivery of a-MSH increased the activation of
magnocellular oxytocin neurons in the SON and PVN. Furthermore, central injection of a
melanocortin receptor antagonist (which selectively targets the melanocortin receptor 4, or MC4)
significantly attenuated the activation of magnocellular oxytocin neurons. Although this antagonist
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did not have a significant inhibitory effect on the expression of erectile function in this study, rats did
take longer to display penile erection indicating some impairment of erectile parameters (Caquineau et
al, 2006).
1.7.4 Glutamate and oxytocin interactions
The agonist, NMDA, mimics the effects of endogenous glutamate via action on NMDA receptors and
enhancing excitatory amino acid neurotransmission. When injected into the PVN, the pro-erectile
effects of NMDA (Argiolas, 1999; Melis et al, 1994; Melis and Argiolas, 2003) are believed to
involve the stimulation of hypothalamic oxytocin cells as glutamatergic fibres are known to lie in
close apposition with paraventricular oxytocin cells (van den Pol, 1991). The contributory role of
oxytocin during NMDA-mediated erection was also emphasised after central administration of an
oxytocin receptor antagonist blocked NMDA-induced penile erection (Melis et al, 1994). To add to
these findings, it has recently been demonstrated that during non-contact erection and copulation,
there is marked increase in glutamic acid concentrations within the PVN (Melis et al, 2004), an effect
which is believed to be modulated via endocannabinoids (Melis et al, 2006; Succu et al, 2006). Thus,
such increased activity levels of glutamate in the PVN specifically during the expression sexual
behaviour, make it highly likely that glutamate may exert some excitatory influence over oxytocin
neurons to regulate masculine sexual behaviour.
1.7.5 GABA and oxytocin interactions
In addition to the known excitatory neuromodulators, the inhibitory neurotransmitter, GABA has been
hypothesised as having an inhibitory role on the generation of penile erection via its GABAergic
inputs to hypothalamic oxytocin cells. GABAergic fibres innervate magnocellular oxytocin neurons
in the PVN (Jourdain et al, 1999) and almost 50% of all synapses impinging on magnocellular
neurons are GABAergic (Gies and Theodosis, 1994). A direct role for GABAergic modulation of
central oxytocinergic neurotransmission was established when GABA (applied in vitro to SON slices)
was shown to influence neuronal firing patterns in magnocellular oxytocin cells (Kombian et al, 1996;
Renaud and Bourque, 1991 for review). So, it can be seen that by altering GABAergic
neurotransmission, magnocellular oxytocin activity can subsequently be augmented, which in turn
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could impact on a range of oxytocin-mediated behaviours such as penile erection. Only relatively
recently has the interaction between GABA and oxytocin been looked in the context of penile
erection. Melis and Argiolas (2002) found that stimulation of GABA (subtype A) receptors in the
PVN was able to inhibit penile erection elicited by oxytocin. Additionally, they were able to reverse
this inhibitory effect on erectile function by administering a GABA (subtype A) receptor antagonist.
Thus, blocking GABA (subtype A) receptors in the PVN presumably disinhibits magnocellular (and
perhaps pavocellular) oxytocin cells. The removal of such inhibitory input would allow oxytocin
neurons to respond to excitatory input and so increase oxytocin release and facilitate penile erection.
At the moment this is purely hypothetical; however, taken together, the findings lightly touch on the
existence of a potential mechanistic pathway that may contribute to evoking penile erection.
1.7.6 Nitric oxide and oxytocin interactions
The peripheral role of nitric oxide (NO) during the expression of penile erection is well researched
(Andersson, 2000 for review; Giuliano et al, 1997; Rajfer et al, 1992). In addition, there appears to be
an emerging central role for NO in mediating penile erection via paraventricular oxytocin fibres.
Penile erection stimulated by intra-PVN injection of NO donors can be antagonised with pre-treatment
of an oxytocin receptor antagonist (Melis and Argiolas, 1995). Conversely, injection of inhibitors of
nitric oxide synthase (NOS) (the enzyme which generates NO) into the PVN blocks oxytocin-induced
penile erection (Argiolas and Melis, 1995; Melis and Argiolas, 1993; Melis et al, 1994). Additionally,
the marked increase in paraventricular N02 and N03 levels (indicators of NO activity) that occurs
concomitant to non-contact erections, was inhibited by an oxytocin receptor antagonist (Melis et al,
2000). Neuroanatomical studies investigating the central expression of penile NOS (PnNOS), a
variant of the regulatory protein, neuronal NOS (nNOS) have revealed PnNOS to be abundantly
expressed in central nuclei influencing erectile function. PnNOS is generally known to be a peripheral
facilitator of the penile framework (Gonzalez-Cadavid et al, 2000). However, it has also been shown
to be co-expessed with oxytocin neurons in the MPN, SON and PVN (Ferrini et al, 2003). Both
magocellular and parvocellular oxytocin cells were found to be colocalised with PnNOS (Ferrini et al,
2003). Such coexpression of PnNOS and oxytocin indicate that PnNOS may influence oxytocin
release into the neurohypophysis (via magnocellular oxytocin neurons) or locally (via somatodendritc
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release) to control neuroendocrine-mediated behaviours. Additionally, PnNOS may have a putative
role in activating the spinal pro-erectile network via descending parvocellular oxytocin projections.
Taken together, these findings implicate NO as an important neuromediator that appears to interact
with oxytocin at the supraspinal level (although spinal and peripheral links cannot be ruled out) during
male sexual behaviour.
Much of the current research investigating the neural inputs that can alter central oxytocinergic
neurotransmission in a penile erection context have focused on the monoamine, dopamine. Dopamine
is proving to be one particularly important neurotransmitter that may activate central oxytocin
pathways during sexual arousal and copulation (Argiolas and Melis, 2004; Martino et al, 2005; Melis
and Argiolas, 2003 for review). Pharmacological, immunocytochemical and release studies have
revealed dopamine to have a key facilitatory role in male sexual behaviour.
1.8 The role ofdopamine and male sexual behaviour
Dopamine is an immensely important central neurotransmitter that has widespread projections and
functions throughout the CNS. Dopamine synthesis is a two-step reaction and involves the creation of
L-dihydroxyphenylalanine (L-DOPA) from L-tyrosine via tyrosine hydroxylase. L-DOPA is then
converted to dopamine by DOPA decarboxylase. Dopamine is then enzymatically converted to 3,4-
dihydroxyphenyl acetic acid (DOPAC) and 3-methoxytyramine (3-MT) via the enzymes monoamine
oxidase (MAO) and catechol-O-methyl transferase (COMT), respectively. Finally, DOPA and 3-MT
are further degraded by COMT and MAO, respectively, to yield the inactive homovanillic acid (HVA)
(Figure 1.7).
1.8.1 Dopamine systems
Dopamine has a key role in a range of neurochemical and neurohormonal functions including
cognition, sexual behaviour, milk production, arousal, reward, co-ordination and motricity.
Dopaminergic neuronal cell bodies originating in the substantia nigra (SN), hypothalamus, ventral
tegmental area (VTA), arcuate nucleus and the zona incerta project to various brain structures and
comprise six main pathways summarised in table 1.1. Of all the central dopamine pathways, the
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Synthesis and breakdown of dopamine. The chemical composition of dopamine is illustrated
in A. Dopamine is synthesised from the conversion of L-tyrosine to L-DOPA by tyrosine
hydroxylase. L-DOPA then becomes dopamine via the actions of DOPA decarboxylase.
The breakdown of dopamine involves the actions of the two enzymes, MAO and COMT to
produce DOPAC and 3-MT respectively. DOPAC and 3-MT are then subsequnetly
degraded to the inactive HVA via COMT and MAO, respectively (B). L-DOPA: L-
dihyroxyphenylalanine, MAO: monoamine oxidase, COMT: catechol-O-methyl transferase,
DOPAC: 3,4-dihydroxyphenyl acetic acid, 3-MT: 3-methoxytyramine, HVA: homovanillic
acid.
Table 1.1: Dopaminergic systems
Dopamine systems Origin Projections Function
Nigrostriatal SN (A9) Striatum Motricity
Mesocortical VTA (A10) Cortex Emotionality





















Spinal cord Contraction of
penile striated
muscles
Central dopaminergic pathways. Within the CNS, three major dopamine pathways
exist; the nigrostriatal, mesocortical/mesolimbic and tuberoinfundibular systems which
influence motor function, mood, reward and neuropeptide release. There are two
additional minor dopamine pathways; the incertohypothalamic and diencephalospinal
systems which are believed to modulate elements of sexual behaviour. SN= substantia
nigra; VTA=ventral tegmental area; Nac=nucleus accumbens).
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incertohypothalamic dopaminergic system located in the zona incerta (All and A13 cell groups) and
the periventricular region (A14 cell group) (Bjorkland et al, 1975) is thought to be key for the display
of masculine sexual behaviour (Edwards and Isaccs, 1991; Maillard and Edwards, 1991). Dopamine
exerts its effect via the activation of dopamine receptors of which five (D1-D5) have been identified in
the central nervous system (CNS) so far. Each of these integrative dopaminergic systems contribute
widely to the regulation of male sexual behaviour ranging from sexual motivation to genital and
somatomotor response patterns that define copulation.
The tuberoinfundibular system is believed to have an indirect role on sexual behaviour by influencing
prolactin and gonadotrophin secretion which subsequently affects central release of sex steroids
including testosterone (Kruger et al, 2005; Paredes and Agmo, 2004 for review). Similarly, the
diencephalospinal dopamine pathway would appear to have a role in enhancing penile rigidity due to
the dopaminergic innervation of penile striated muscles (Holstege et al, 1996). However, there is
insufficient behavioural data to confirm an overall importance of these two dopamine circuits in
regulating sexual performance.
The nigrostriatal and mesolimbic dopamine pathways are reportedly important for controlling sexual
motivation (Hull et al, 1999 for review; Hull and Dominguez, 2006), as inferred by studies
demonstrating that these two systems are critical for sexual appetitive behaviour and have priming
properties to allow the animal to respond to incoming sexual stimuli more readily and to enhance
sensorimotor output (Dominguez and Hull, 2005; Jones and Robbins, 1992; Salamone, 1992).
However, a role for these two systems in facilitating consummatory parameters requires further
investigation.
Much interest has surrounded the role of the incertohypothalamic dopamine system (located in the
All A13 and A14 cell groups), primarily due to its projections to key brain structures (namely the
MPOA, PVN and SON) (Bjorkland et al, 1975) which are important for the expression of masculine
sexual behaviour. Lesioning of the zona incerta (which contains the dopamine cell bodies of the
incertohypothalamic system), had clear inhibitory effects on copulatory behaviour (including penile
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erection, intormission and ejaculation) but had no effect on parameters associated with sexual
motivation (Edwards and Isaacs, 1991; Maillard and Edwards, 1991). In addition, lesions of the
incertohypothalamic system in female rats markedly disrupts the preovulatory surges in LH and
prolactin (Sanghera et al, 1991) which suggests that in males, the same effect may also be observed
with regard to testosterone's effects on sexual responses. Also, selective ablation of the MPOA and
therefore its incertohypothalamic-derived dopamine inputs, results in a profound inhibitory effect on
copulatory function as evidenced by a substantial reduction in the expression of mounts, intromissions
and ejaculations (Arendash and Gorski, 1983; Paredes and Agmo, 2004 for review, Paredes, 2003).
Thus, the incertohypothalamic pathways may have direct (via dopaminergic projections to sexually
responsive brain nuclei) and indirect (via testosterone) roles in central control of consummatory
phases of masculine sexual behaviour where they may mediate the steroidal components associated
with the pro-sexual effects of dopamine.
In conclusion, it is very likely that all the major dopamine systems and in particular the nigrotriatal,
mesolimbic and incertohypothalamic pathways act in concert to prepare an animal for responding to
sexually exciting stimuli and to promote a range of behaviours that define a sexual encounter.
1.8. 2 Dopamine receptors
As previously mentioned, five dopamine receptors exist in the CNS and comprise D1 -like (D1 and
D5) and D2-like (D2, D3 and D4) receptor subgroups. The receptors can be divided into two separate
subgroups depending on the transduction system to which they are coupled to (1) Dl-like receptors
(D1 and D5) which positively activate adenylate cyclase and D2-like receptors (D2, D3 and D4)
which are negatively or not coupled to the enzyme. There is generally widespread expression of all
dopamine receptors in the brain with abundant levels of D1 and D2 receptors and moderate expression
of D3, D4 and D5 receptors (Ariano et al, 1989; Bitner et al, 2006; Defagot et al, 1997; Khan et al,
1998; Mansour et al 1990; Missale at al, 1998 for review). D1 and D2 receptors are found in the
striatum, cortex, hypothalamus, olfactory bulbs and substantia nigra (Levey et al, 1993; Khan 1998).
D3 receptor expression is more restricted, with the nucleus accumbens, olfactory tubercles and the
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Islands of Calleja showing moderate to high levels of the D3 receptor (Khan et al, 1998). In
comparison to D2 receptors, D4 receptor levels appear to be less abundant in subcortical structures.
The cortex, hippocampus and striatum have all been shown to possess D4 receptors (Defagot et al,
1997; Khan et al, 1998) (See figure 1.6 for brain maps of dopamine D2, D3 and D4 receptor
distribution). Finally, D5 receptor expression in the rat brain is comparatively scarce, however, D5
receptors have been shown to exist in the striatum, cortex, substantia nigra pars compacta and nucleus
accumbens (Khan et al, 2000). Since most published work has implicated a role of the D2-like (D2,
D3, D4) in mediating the pro-erectile effects of dopamine agonists, this thesis will concentrate on D2,
D3 and D4 receptors.
The erectogenic response to systemic and intra-MPOA administration of D1 agonists has been
reported before (D'Aquila et al, 2003; Markowski et al, 1994). Similarly, D5 receptors have been
implicated in sexual reward (Kudwa et al, 2005). However, it is the D2-like receptors that have the
most convincing role in the mediation of penile erection. Table 1.2 illustrates some dopamine D2-like
receptor ligands that are known to augment the expression of penile erection in rats. It is apparent that
stimulation of D2-like receptors has a profound facilitative effect on penile erection, particularly via
D4 receptors. Much attention has been drawn to the role of the D4 receptor during penile erection due
to the introduction of highly selective pharmacological tools. Unfortunately, such highly specific
dopamine receptor drugs have yet to be developed for the D2 and D3 receptors due to both these
receptors demonstrating a high degree of sequence homology. D2 and D3 receptor ligands that are
currently available either show the same or only marginal selectivity at D2 and D3 receptors. Thus,
results from behavioural studies employing D2 and D3 receptor ligands should be interpreted with
caution.
1.8.3 Dopamine and sexual behaviour
Female sexual behaviour
The role of dopamine in female sexual function is more ambiguous than in males. Some findings
have shown dopamine to participate in the activation of those pathways controlling sexual motivation
and sexual reward (Paredes and Agmo for review, 2004). However, its involvement in female sexual
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receptor expression (shaded regions). D2, D3 and D4 receptor expression are not exclusive to
these nuclei, however, these brain regions possess comparatively higher levels of each receptor.
NA=nucleus accumbens; lcj=islands of calleja; OT=olfactory tubercles.
Table 1.2: The effects of dopaminergic ligands on penile erection
Dopaminerqic liqands erectile response references
D2/D3R ligands
Quinelorane (agonist) facilitates penile erection,
high doses inhibit penile
erection
Bitran et al, 1989; Doherty
and Wisler, 1994; Eaton et
al, 1991; Pomerantz, 1991.
Quinipirole (agonist) facilitates penile erection Hsieh et al, 2004; Melis et
al, 1987; Zarrindast et al
,1982.
Lisuride (agonist) increases ICP rises Chen et al, 1999
L-741,626 (antagonist) decreases penile erection Millan etal, 2002
Sulpiride (antagonist) reduces penile erection;
blocks increases in ICP
Chen et al, 1999; Ferrari et
al, 1993; Zarrindast et al,
1992;
D3R ligands
7-OH-DPAT (agonist) no effect on ICP, facilitates
penile erection
Chen et al, 1999; Ferrari
and Giuliano,1995;
Nafadotride (antagonist) unknown, however inhibits
ejaculation
Clement et al, 2007; Kitrey
et al, 2007; Stafford and
Coote, 2006.
S33084 (antagonist) reduces penile erection Millan et al, 2000.
D4R ligands
PD168077 (agonist) facilitates penile erection Melis etal, 2005, 2006.
ABT-724 (agonist) facilitates penile erection Brioni et al, 2004.
PIP3EA (agonist) facilitates penile erection Enguehard-Gueiffier et al,
2006; Melis et al, 2006.
L-745,870 (antagonist) reduces penile erection Enguehard-Gueiffier et al,
2006; Melis et al, 2005,
2006; Succu et al, 2007.
A-381393 (antagonist) reduces penile erection Nakane et al, 2005.
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reflexes is less well defined. Early studies suggested that dopamine may infact have an inhibitory role
in females as inferred by studies utilising dopamine agonists such as quinelorane and analysing their
effect on lordosis (sexual reflex displayed by a receptive female rat in response to a mounting male
placing his front paws on the female's flanks). These authors found that stimulation of the
dopaminergic system reduced the expression and duration of lordosis (Eliasson and Meyerson, 1976;
Everitt et al, 1975). In contrast in another study, apomorphine and quinelorane were found to have a
facilitatory effect on the lordotic response (Foreman and Hall, 1987; Hamburger-Bar and Rigter,
1975). One important factor to consider when investigating dopamine's role in female sexual
behaviour, is the hormonal treatments administered to female rats, which can clearly influence the
effect of dopamine agonists on sexual behavioural. Differences in the lordotic response to
subcutaneously or orally administered dopamine agonists appear to be partly attributed to the levels of
oestrogen and progesterone present. Lordosis in oestrogen-primed rats was enhanced by dopamine
agonists; however, this effect was inhibited in rats receiving oestrogen and progesterone injections
(Foreman and Hall, 1987). Additionally, microinjection of dopamine or apomorphine into the MPOA
or ventromdial hypothalamus enhanced sexual receptivity in rats receiving low doses of oestrogen.
Such an effect was not observed in rats injected with a high dose of oestrogen. Furthermore, the
dopamine antagonist, haloperidol markedly inhibited lordosis in only those females receiving high
concentrations of oestrogen (Foreman and Moss, 1979). So, it can be seen that there is some
inconsistency in the literature due to the differences in hormonal treatment employed which makes
behavioural data difficult to interpret. More recent studies have aimed to further elaborate on
dopaminergic control of female sexual function. Microdialysis studies have shown an increase in
dopamine levels in the nucleus accumbens in female hamsters and rats during mating (Meisel et al,
1993; Pfaus et al, 1995) which may be due in part to the actions of progesterone (Matuszewich et al
2000). Selective blocking of D1 receptors attenuates neuronal activation in the MPOA and
posterodorsal MeA after manual stimulation of the vaginocervical region (Quysner and Blaustein,
2001).
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Thus, the involvement of dopamine in mediating components of sexual behaviour in hormonally-
primed female rats requires further investigation. However, the findings so far do provide some
promising insight into neural pathways mediating rodent sexual behaviour.
Male sexual behaviour
Many neuropeptides and neurotransmitters have been shown to augment masculine sexual behaviour.
However, after extensive lesioning, pharmacological and neurotransmitter release studies, dopamine
has emerged as one of the most pivotal neuromodulators that can exert differential roles on sexual
behaviour through its widespread diffuse projections in the CNS.
The pro-sexual role of dopamine was first identified in the 1970s after male patients suffering from
Schizophrenia and Parkinson's disease (caused by abnormalities in dopaminergic neurotransmission)
and treated with the dopamine precursor, L-DOPA, displayed increased sexual libido and
hypersexuality (Bowers et al, 1971; Jenkins et al, 1970; Mones et al, 1970; Shapiro, 1973). In animal
models many pharmacological studies have shown that some parameters of male sexual behaviour
(eg. mount latency, frequency of non-contact penile erections, intromission frequency) can be
manipulated by the use of dopamine agonists and antagonists (Brioni et al, 2004; Heaton et al, 2000;
Hsieh et al, 2004; Paredes and Agmo, 2004 for review). Furthermore, studies involving the
measurement of dopamine and its metabolite, 3,4-dihydroxyphenylacetic acid (DOPAC)
concentrations in dialysates within certain brain regions before and during copulation, have shown
there to be a significant increase in both dopamine and DOPAC concentrations in the MPOA and
PVN during presentation of a receptive female and copulation (Hull et al, 1993; Hull et al, 1995;
Melis et al, 2003). So, it is apparent that the actions of dopamine in key central nuclei may have a
substantial influence on appetitive and consummatory functions of sexual behaviour.
Many brain areas that receive dopaminergic innervation have been implicated in sexual behaviour
with the MPOA and PVN in particular considered to be principal sites of dopaminergic
neurotransmission during sexual behaviour.
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1.8.3.1 MPOA
As previously mentioned, there is overwhelming evidence to suggest that the MPOA is the essential
site for male sexual behaviour. Dopamine activity within this nucleus is important for copulatory
function (Dominguez and Hull, 2005; Everitt, 1990; Hansen et al, 1982; Hull et al, 1999; Paredes and
Agmo, 2004 for review). Microinjection of the non-selective dopamine agonist, apomorphine (at
doses of 0.5-2pg), strongly facilitates copulatory behaviour in rats as inferred by the increase in
mounting and intromitting behaviour and a decrease in the ejaculation latency (Hull et al, 1986).
Administration of the D2/D3 preferring agonist Quinelorane, was shown to exert an excitatory role on
seminal emission, suggesting a facilitatory effect during ejaculation (Bitran et al, 1989). Similarly,
intra-MPOA injection of the D1 agonist dihydroxyphenyl-tetrahydrothienopyridine (THP) shortened
the latency to ejaculate and markedly increased the frequency of ejaculations (Markowski et al, 1994).
Additionally, dopamine agonists injected into the MPOA of rats observed as inefficient copulators
have been shown to partially restore consummatory elements of sexual behaviour (Scaletta and Hull,
1990). There is also some emerging evidence to suggest a role for MPOA dopamine in the
motivational phase of sexual behaviour after D1 agonists delivered into the MPOA increased the
length of time male rats spent with receptive females (Beck et al, 2002).
Antagonist studies have revealed that blockade of endogenous dopamine actions in the MPOA have
revealed marked impairment of male sexual behaviour. The relatively non-selective dopamine
receptor antagonists, cis-flupenthixol and haloperidol given systemically or directly into the MPOA,
delayed copulation and rats exhibited significant reductions in the frequency of various copulatory
parameters including non-contact erections and a reduction in the time spent with a sexually receptive
female (Pfaus and Phillips, 1989; Warner et al, 1991), suggesting disruption to sexual desire pathways
Dopamine release studies have shown that during exposure to an inaccessible oestrus female and
during copulation, there are significant increases in dopamine levels in the MPOA. Control males
either exposed to inaccessible males or permitted free use of the running wheel did not display such an
apparent rise in MPOA dopamine release (Hull et a!, 1993; Hull et al, 1995). Thus, the elevation in
dopamine release appears to be correlated with copulatory-specific behaviours.
35
Chapter 1: General Introduction
Therefore, it seems that dopaminergic neurotransmission in the MPOA is a necessary component for
the expression of anticipatory and consummatory sexual parameters which may be mediated via
specific neural circuitries residing in the MPOA.
1.8.3.2 PVN
In comparison to other known brain structures that are recognised as having an integral role in erectile
responses, the PVN is one of the most sensitive brain areas that is responsive to the pro-erectile effects
of the dopamine agonist apomorphine (Chen et al, 1999; Melis et al, 1987). Moreover, lesioning of
the PVN abolishes the erectogenic response induced by apomorphine (Argiolas et al, 1987). Such a
finding has led some researchers to believe that the PVN is the specific central site where dopamine
acts to facilitate penile erection. Intra-PVN and systemic delivery of apomorphine and other
dopamine agonists (particularly D4) are profoundly pro-erectile (Brioni et al 2004, Cowart et al, 2004;
Hsieh et al, 2004; Melis et al, 2005; Rampin et al, 2001) and can elicit remarkable increases in ICP
(Chen et al, 1999). On the other hand, central or microinjection of dopamine receptor antagonists into
the PVN clearly disrupts the expression of penile erection in anesthetised and conscious male rats
(Chen et al, 1999; Hsieh et al, 2004; Melis et al, 2006).
Pairing of male rats with sexually receptive, yet inaccessible female rats is sufficient to induce a
dramatic rise in dopamine concentrations in the PVN, with the highest levels observed during
copulation (Melis et al, 2003). Furthermore dopaminergic ligands are known to activate
paraventricular neurons as evidenced by a significant increase in Fos expression (Bitner et al, 2006).
Thus, taken together the data suggest that the PVN is a crucial site for mediating penile erection
induced by central dopamine pathways.
1.8.3.3 SON
Currently to date there are no data demonstrating a role for dopamine in the SON during sexual
behaviour. What we do know is that supraoptic neurons are stimulated during intromission and upon
36
Chapter 1: General Introduction
ejaculation (Caquineau et al, 2006; Pattij et al, 2005). Thus, such preliminary data gives some
indication that the SON is another structure where dopamine may potentially act to exert its
behavioural effects, those of which may facilitate sexual behaviour.
1.8.3.4 N.Ac
The role of dopamine in the NAc and the regulation of erectile function is not as well established as
other brain regions. Similar to the PVN, appetitive and consummatory elements of male sexual
behaviour enhance dopaminergic neurotransmission in the NAc (Pfaus et al, 1990; Wenkstern et al,
1993). Dopamine depleting lesions have only minor effects on sexual behaviour but relatively modest
effects on penile erection elicited in response to female oestrus cues (Kippin et al, 2004; Liu et al,
1998). Unlike the MPOA and PVN, injection of apomorphine into the NAc does not have any effect
on erectile responses (Melis et al, 1987). Interestingly, such impairments in erectile function are only
observed in lesioned naive rats and not sexually experienced rats. Thus, it seems the NAc appears to
be of marginal importance during the expression of dopamine-mediated sexual behaviour. Since
dopaminergic fibres originating in the PVN project to the NAc (Pinto et al, 2003) it is very possible
that dopaminergic activation of NAc during penile erection is secondary to increased activity in the
PVN as inferred recently by a study showing that dopaminergic stimulation in the PVN induces an
increase in dopamine levels in the NAc during penile erection (Succu et al, 2007).
1.9 Role ofandrogens in penile erection
In addition to the previously mentioned neuromodulators that can mediate the erectile response; sex
steroids play a critical role in the expression of male sexual behaviour. Sex steroids (namely,
testosterone and oestrogen) are synthesised in gonadal tissue and the adrenal glands and have a pivotal
role in stimulating the development of primary and secondary sex characteristics (Wilson and Davies,
2007 for review). In addition to their role in sexual differentiation during developmental and pubertal
phases, these sex steroids also act in the brain and are crucial for the expression of masculine sexual
behaviour in many species (Baum, 2003).
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In males, testosterone is the main circulating steroid that is metabolised by the enzyme, aromatase to
oestrogen (Ryan et al, 1972). Testosterone and oestrogen act via their respective receptors, namely
the androgen and oestrogen receptor and are believed to prime neural circuits regulating sexual
function. The importance of these neurosteroids was first demonstrated by Stone and Colleagues
(1939) who showed that castration completely abolished masculine sexual behaviour in male rats.
Since then, the same effect has been observed in various other species after gonadectomy (Baum,
2003). It is generally accepted that androgens are critical for modulating penile erection and
maintaining penile rigidity via central and peripheral actions. Preclinical and clinical studies have
shown that castration markedly impairs erectile function and hypogonadal men treated with androgen
supplements show an improvement in the achievement and maintenance of penile erection (Kupelian
et al, 2006; Traish and Guay, 2006). Similarly, in rats who underwent bilateral orchidectomy and
displayed impaired penile erection, systemic infusion of increasing doses of testosterone produced
erectile events similar to that of intact rats (Armagan et al, 2006). Systemic or central delivery of
testosterone or oestrogen has been shown to have strong pro-sexual effects in prepubertal and
castrated male rats (Baum, 2003; Bialy and Sachs, 2002; Sachs and Leipheimer, 1988; Manzo et al,
1999). Furthermore, blocking the actions of the converting enzyme, aromatase through the
application of antagonists inihibits the pro-copulatory effect of testosterone. In the same study,
systemic administration of oestrogen fully restored male sexual behaviour (Clancy et al, 2000; Vagell
and McGinnis, 1997). Thus, these neurosteroids are of fundamental importance in regulating
copulatory behaviour. However, precisely where the neurosteriods act to exert the effect is not
presently clear. Androgen and oestrogen receptors are abundantly expressed in many regions of the
CNS including the MPOA, SON, PVN, BNST, MeA and olfactory bulbs (Bingham et al, 2006; Greco
et al, 1998; Portillo et al, 2006). Additionally, the MPOA and MeA have both been identified as
particularly important sites for mediating the actions of testosterone during sexual arousal and
copulation (Putnam et al, 2005; Sato et al, 2005). Thus, it is apparent that the sex steroids act within
specific brain structures (presumably the MPOA and MeA) to influence central pathways mediating
male sexual behaviour. However, identification of those neurochemical correlates that are sensitive to
androgenic effects is still in its infancy.
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1.9.1 Pathways mediating the effects ofsex steroids
Galanin-containing neurons were shown to be partly mediate the effects of sex steroids after
microinjection of galanin into the MPOA facilitated sexual behaviours in testosterone- and oestrogen-
primed male and female rats (Bloch et al, 1996; Bloch et al, 1998). The interaction between oestrogen
and oxytocin during rodent sexual behaviour in females has been well documented (Agmo et al 2008;
Giraldi et al, 2004 for review); however, in male rats very little is known regarding the relationship
between sex steroids and oxytocin during the expression of sexual behaviour. In the male
reproductive tract, smooth muscle contractility and prostate function are believed to be mediated in
part by local circulating oestrogens (Nicholson and Jenkin, 1995; Vignozzi ct al, 2004). However, in
the one study that examined a possible link between sex steroids and central oxytocin pathways
controlling erectile function, they demonstrated that testosterone but not oestrogen restored the
erectile response to centrally administered oxytocin in conscious male rats (Melis et al, 1994). This
finding is further substantiated by many clinical and pre-clinical studies highlighting dopaminergic
targets as one particular group of target cells that are sensitive to circulating levels of testosterone.
1.9.2 Dopamine and testosterone
When measuring erectile responses in castrated rats treated with the classical pro-erectile agonist,
apomorphine, rats remained unresponsive until increasing doses of testosterone were administered
(Heaton and Varrin, 1994). The dopamine D2/D3 agonist, Quinelorane, acting in the MPOA requires
physiological levels of testosterone to induce copulatory behaviour (Charles and McGinnis, 1992).
Furthermore, testosterone was shown to influence nitric oxide activity and mating behaviour by
increasing dopaminergic neurotransmission in the MPOA (Hull et al, 1997; Putnam et al, 2001, 2005).
This androgen-sensitive effect on dopaminergic neurotransmission has also been observed in humans.
Males with c-51hronically low levels of plasma testosterone displayed marked erectile dysfunction
which could not be restored with apomorphine. Such dopamine-mediating drugs only elicited a pro-
erectile response once plasma testosterone levels were increased to physiological levels (Foresta et al,
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2004). Thus, these findings add to a growing number of studies suggesting a critical threshold level of
circulating androgens must exist to facilitate erectile function
The precise mechanism whereby testosterone acts has yet to be established. However, it is believed
that androgens act locally in penile tissue to stimulate the production of nitric oxide and help restrict
venous outflow from the pelvic region (Mills and Lewis, 1999). Additionally, androgens are thought
to act on central pathways (specifically nitrergic fibres) that regulate penile erection, with the MPOA
and PVN known to be particularly sensitive to the effects of androgens. The MPOA appears to be an
important androgen-sensitive brain area as sexual behaviour in castrated males is restored only after
intra-MPOA delivery of testosterone (Putnam et al, 2001). In addition, ICP responses to electrical
stimulation of the MPOA were completely abolished after castration and then restored after
testosterone replacement (Suzuki et al, 2007). In the PVN, the erectogenic response to micro¬
injection of the nitric oxide precursor, L-arginine, is heavily dependent on the presence of
testosterone, as evidenced by the lack of erectile response in male castrates lacking testosterone
supplements (Wu and Hu, 2002).
In addition to a functional role in the brain, androgens are also believed to act in the lumbosacral
spinal cord during reflexive erections (Giuliano and Rampin, 2004). Such a finding was inferred after
direct delivery of testosterone to the lumbosacral spinal cord was shown to improve the occurrence of
reflexive erections after castration (Hart and Haugen et al, 1968). Subsequent studies have revealed
that there is abundant expression of androgen receptors in spinal cord nuclei controlling activity of
perineal striated muscles, penile erection and copulation (Jordan, 1997; Watkins and Keast, 1999).
Thus, it seems that androgens may exert their effects on penile erection by acting at multiple sites in
the peripheral and central nervous system.
The MPOA, PVN and spinal cord contain dopaminergic cell bodies and fibres (Bjorklund et al, 1975;
Weil-Fugazza and Godefroy, 1993) and express androgen receptors (Greco et al, 1998; Hart and
Haugen, 1968; Jordan, 1997). In addition, all three serve as important integrative sites during sexual
behaviour and penile erection (Giuliano and Rampin, 2004). Therefore, it seems entirely plausible
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that centrally-acting androgens may act in these three sites to modulate dopaminergic
neurotransmission and so influence masculine sexual behaviour. However, the involvement of other
androgen-sensitive brain regions such as the medial amygdala (MeA) in erectile function should not
be discounted.
1.10 Dopamine-Oxytocin Interactions
When administered centrally in the male rat, dopamine receptor agonists and oxytocin exert a
facilitatory effect on almost all aspects of male sexual behaviour, particularly penile erection (Paredes
and Agmo, 2004 for review; Bancroft, 2005; Donatucci, 2006; Kita et al, 2006; Hillegaarte et al,
1997). Such findings have led researchers to believe that central dopaminergic and oxytocinergic
pathways may interact with each other to mediate erectile function, although it has yet to be
established whether such an interaction is synergistic, convergent or sequential. As previously
mentioned, the MPOA and the PVN are two hypothalamic brain nuclei that have been shown to be
critical integrative sites for male sexual behaviour (Paredes and Agmo, 2004 for review).
Additionally, there seems to be an emerging role for the SON (Caquineau et al, 2006; Pattij et al,
2005). The MPOA and PVN have both been shown to be highly responsive to the pro-erectile effects
of dopamine receptor agonists and to oxytocin (Melis et al, 2005; 2006; Argiolas and Melis, 2005 for
review; Caldwell et al, 1989; Hull et al, 1986, Pehek et al, 1989). Intra-MPOA or -PVN injection of
dopamine receptor antagonists strongly inhibit dopamine agonist-induced penile erection (Warner et
1991; Melis et al, 2005). In addition, systemic delivery of the dopamine antagonist, clozapine was
shown to inhibit penile erection after central administration of oxytocin (Martino et al, 2005).
Such dopamine-mediated pharmacological effects have yet to be established regarding the SON.
Thus, these three brain nuclei make interesting candidates for potential integration sites of central
dopamine and oxytocin neurotransmission in the regulation of penile erection.
A variety of technical approaches have been employed to investigate the interaction between central
dopamine and oxytocin neurotransmission during penile erection in the male rat. The evidence falls
into three primary categories: neuroanatomical, oxytocin release and behavioural pharmacological
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studies; some of which are more convincing than others for a direct dopamine-oxytocin link. These
will be reviewed in the following sections.
1.10.1 Neuroanatomies evidence
At the cellular level, morphological studies have revealed that terminals of dopaminergic neurons
originating in the incertohypothalamic system lie in close apposition to somatic and dendritic
processes of the magnocellular and parvocellular oxytocin neurons in the PVN and SON (Buijs et al.,
1984; Decavel et al., 1987) which is suggestive of a direct dopaminergic influence.
Immunocytochemical studies have revealed abundant expression of D1 (Czyrak et al., 2000) and D4
receptors (Defagot et al., 1997; Bitner et al., 2006) in the PVN and SON (Defagot et al., 1997) of male
rats; and additionally, D1 and D5 receptors are expressed in the paraventricular and supraoptic nuclei
in primates (Rivkees and Lachowicz, 1997). D2, D3 and D4 receptors were found to be expressed in
the SON (Khan et al, 1998), however this has not been investigated in the MPOA or PVN. The
neuronal phenotype expressing dopamine receptors remains largely unknown. It is often assumed that
dopamine acts on dopamine receptors expressed in oxytocin cell bodies to elicit penile erection, and it
has been hypothesised that endogenous dopamine binds to and activates oxytocin cells via D2-like
receptors, suggesting a direct action of dopamine on oxytocin cell bodies and dendrites. However, it
is important to add that up to now there has been no immunocytochemical confirmation of such a
cellular arrangement. Furthermore, it has been harder to prove that endogenous dopamine acts on
oxytocin cells in vivo.
1.10.2 Oxytocin release studies
One indicator of oxytocin neuron activity is oxytocin release, and several reports have demonstrated
that dopamine plays a dynamic role in regulating this. Early in vitro studies conducted in the 1970s
demonstrated that dopamine and the dopamine receptor antagonist, haloperidol, were able to
significantly increase and decrease oxytocin release, respectively, from hypothalamic explants.
Moreover, i.c.v. or peripheral administration of dopamine or the non-selective dopaminergic agonist
apomorphine increased release of oxytocin into the blood, the hypothalamus, and at other
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extrahypothalamic sites in various rat and primate models (Bridges et al., 1976; Melis et al., 1990;
Cameron et al., 1992; Melis et al., 1992; Argiolas, 1999) (See Figure 1,8A). It is unclear as to which
dopamine receptor(s) are involved in central oxytocin release. Electrophysiological studies may shed
some light on this: the D2/D3 receptor agonist quinpirole, but not the D1 agonist SKF38393, was able
to depolarise oxytocin neurons in the SON in vitro. In the same study dopamine-induced
depolarisation was antagonised by the D2-like preferring receptor antagonists, sulpiride and spiperone
(Yang et al., 1991), implicating the involvement of D2-like receptors in the excitation of supraoptic
oxytocin neurons. As previously stated, oxytocin neurons in the hypothalamus are assumed to be
innervated by incertohypothalamic-derived dopaminergic fibres, although magnocellular oxytocin
cells (in the PVN) are also innervated by intra-PVN dopaminergic fibres (Jourdain et al, 1999). Thus,
there could be a predominantly intra-PVN dopaminergic innervation of magnocellular oxytocin
neurons and, conversely, an incertohypothalamic innervation of parvocellular oxytocin neurons,
which may help to explain the apparent differential involvement of these neurons in sexual behaviour
as evidenced by the selective activation of magnocellular oxytocin neurons during intromission and
ejaculation (Pattij et al, 2005; Caquineau et al, 2006) and the activation of parvocellular oxytocin
neurons during penile erection (Witt and Insel, 1994; Kita et al, 2006).
So, the above evidence indicates that dopamine receptor subtypes are expressed in various
hypothalamic nuclei. Although the neuronal phenotype expressing these receptors is unclear, at least
some are expected to be oxytocinergic. Such an anatomical arrangement provides support for a
potential dopamine-oxytocin link in these key hypothalamic nuclei. It could be postulated that
endogenous dopamine may act via D1 -like and/or D2-like receptors in the MPN, SON and PVN to
activate the hypothalamic oxytocin system. Potentially important sites for the subsequent release of
oxytocin include the PVN, hippocampus (Melis et al, 1992) and spinal cord (Giuliano et al, 2001).
1.10.3 Behavioural pharmacological evidence
The proposed inter-dependent relationship between dopamine and oxytocin neurons in the PVN
during penile erection was substantiated by the attenuation of apomorphine-induced penile erection
after bilateral lesioning of the PVN (Argiolas et al, 1987a) that depletes central oxytocin levels in
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Involvement of dopamine (DA) and oxytocin (OT) during PVN control of erectile function.
Based on references, penile erection mediated via the PVN is influenced by three pathways
investigated thus far. (A) DA action in the PVN stimulates release of OT within the PVN,
plasma, spinal cord and extra-hypothalamic sites to elicit penile erection. (B) DA action in the
PVN also stimulates DA release in the NAc and penile erection which can both be
antagonised by an oxytocin antagonist (OXA). (C) OT action in the VTA also increases DA
levels in the NAc and PVN concomitantly to penile erection which can be blocked by intra-
NAc and intra-PVN delivery of DA antagonists. In summary, DA stimulation of the PVN
induces OT release at central sites which facilitate penile erection perhaps via actions on
incertohypothalamic and mesolimbic dopamine neurons. DA: dopamine, OT: oxytocin, VTA:
ventral tegmental area, OXA: oxytocin antagonist, 0: inhibitory effect.
Chapter 1: General Introduction
extra-hypothalamic brain areas (Hawthorn et al., 1985). Stimulation of penile erection by
apomorphine or the selective D4 receptor agonist, PD 168077 is also prevented by i.c.v., but not intra-
PVN delivery of an oxytocin receptor antagonist (Melis et al, 1992; Melis et al, 2005), suggesting that
oxytocin receptors located outwith the PVN are involved in mediating apomorphine-induced penile
erection.
Thus, it is not clear as to whether during penile erection, dopamine increases oxytocin levels in the
PVN (via magnocellular cells) and/or at sites outwith the PVN (via parvocellular cells) such as in the
spinal cord where pro-erectile centres exist (Veronneau-Longueville et al, 1999) or the hippocampus
(Melis et al, 1992). There is increasing evidence to suggest that parvocellular oxytocin neurons are
part of the neural network controlling penile erection (Witt & Insel, 1994; Veronneau-Longueville et
al, 1999; Kita et al, 2006). It is generally believed that apomorphine-induced penile erection involves,
at least in part, release of oxytocin at extra-hypothalamic areas via these parvocellular fibres; however,
intra-hypothalamic oxytocin release and action cannot be ruled out.
As stated above, dopamine agonist-induced penile erection can be inhibited by a synthetic oxytocin
receptor antagonist (Argiolas et al, 1987b); however, oxytocin-induced penile erection is not inhibited
by the dopamine receptor antagonist, haloperidol (Melis et al, 1997). This would suggest that
dopamine may act upstream to oxytocin in the regulation of penile erection but not vice versa.
Interestingly, in another study, penile erection elicited by oxytocin was antagonised by the generally
non-selective dopamine receptor antagonist, clozapine (although clozapine does have slightly more
affinity for D2-like than Dl-like receptors) (Martino et al, 2005) which contradicts the previous
finding. So, it is not clear if there is a dopamine-oxytocin or oxytocin-dopamine interaction that
results in the stimulation of erectile pathways. Therefore, there may be a synergistic or dual activation
of both the dopaminergic and oxytocinergic systems that may have a parallel involvement in the
mediation of penile erection. Since haloperidol (D2-preferring) did not block erectile responses to
oxytocin and clozapine (D4-preferring) did, it is interesting to postulate that D2 receptors may be
located upstream and D4 receptors located downstream from oxytocin cells. Thus, D2 and D4
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receptors may differentially regulate penile erection via oxytocinergic and/or non-oxytocinergic
pathways.
Many of the current studies support a dopamine-oxytocin relationship in the PVN in relation to
erectile function. However, there are some new findings that implicate other brain nuclei and suggest
a complex communication network exists between the PVN and other brain nuclei known to be
involved in sexual behaviour. Apomorphine and PD168077 (D4 receptor agonist) given intra-PVN
have been shown to increase the levels of dopamine and its metabolite, DOPAC, in the NAc, which
occurs concomitantly with penile erection, and both the increase in dopamine and penile erection were
attenuated by i.c.v. injection of an oxytocin antagonist (Succu et al, 2007). The NAc is generally
associated with sexual motivation and sexual arousal; however, a dopamine-oxytocin-dopamine link
may exist between the PVN and NAc to elicit penile erection. Interestingly, it has recently been
suggested that dopamine and oxytocin neurotransmission form potential underlying neural pathways
between the PVN, NAc and the ventral tegmental area (VTA) during penile erection. Paraventricular
oxytocin fibres project to the VTA (Roeling et al., 1993) where oxytocin receptors are also located
(Freund-Mercier et al., 1987). Intra-VTA administration of oxytocin increased dopamine
concentrations in the NAc and PVN concomitantly with penile erection. Both of these effects were
attenuated after either intra-VTA injection of an oxytocin antagonist or intra-NAc or intra-PVN
injection of the dopamine receptor antagonist, haloperidol (Melis et al, 2007). So, it seems that
oxytocin in the VTA may stimulate as yet unknown excitatory pathways that project (perhaps
indirectly) back to the PVN to enhance dopaminergic neurotransmission and so facilitate penile
erection. Thus, the PVN appears to serve as an important integration site for dopaminerigc and
oxytocinergic neurotransmission. Through its complex interactions with other brain regions
(particularly the NAc and VTA) (summarised in Figure 1.8), the PVN seems to be a crucial regulatory
site for penile erection modulated by dopamine and oxytocin pathways.
From these studies, it can therefore be seen that dopamine-induced pro-erectile effects are not
mediated solely by oxytocin pathways originating in the PVN but by other oxytocin-containing nuclei,
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such as those in the VTA, that form a much larger and highly integrated network subserving central
control of penile erection.
1.11 Dopamine-mediated signalling pathways
It is generally assumed that dopamine receptor stimulation in the PVN triggers a cascade of events
that involves the activation of parvocellular oxytocin neurons and the resultant release of oxytocin at
extra-hypothalamic sites (Argiolas and Melis, 2004). However, the intracellular signalling pathways
and transduction mechanisms activated upon dopamine receptor stimulation and how they facilitate
oxytocin release remain to be elucidated. Many studies have shown a wide range of signalling
pathways activated by administration of dopamine receptor agonists (all of which cannot be
discussed). It is evident however, that many of the signalling pathways are very much dependent on
the brain nucleus in which they occur, the cell type involved and cell location as well as the G-protein
to which the receptor is coupled to. Therefore it is very difficult to ascribe one particular signalling
pathway activated by dopamine in one brain area to another. Evidence for direct and indirect
dopamine-mediated signalling pathways and those correlated with penile erection in the MPN, SON
and PVN are discussed below.
1.11.1 Potential signallingpathways involving oxytocin cells
It is widely known that Dl-like receptors couple positively to adenylate cyclase and are viewed as
stimulatory, whilst the D2-like receptors either couple negatively to adenylate cyclase or act via other
signalling pathways and are reportedly inhibitory. If the general evidence indicates that D2-like
receptors (rather than Dl-like) are involved in oxytocin-mediated penile erection, then it is logical to
assume such receptor stimulation would inhibit oxytocin release. However, it has been suggested that
in the PVN, dopamine-induced oxytocinergic activation may involve a calcium dependent nitric oxide
(NO) pathway rather than the classical cAMP pathway (Succu et al, 1998). Intra-PVN injection of co-
conotoxin-GVIA, a selective antagonist of N-type calcium channels inhibits apomorphine- and
oxytocin-induced penile erection. Moreover, blockade of the N-type calcium channels attenuates the
increase in nitrite and nitrate concentrations (indicators of NO activity) during penile erection (Succu
et al, 1998). The NO generator, neuronal nitric oxide synthase (NOS) is abundantly expressed in
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oxytocinergic neurons (Ferrini et al, 2001; Xiao et al, 2005) where as a gas, NO can act in a paracrine
and an autocrine fashion. Centrally administered NOS inhibitors were shown to prevent dopamine
agonist and oxytocin-induced penile erection. Furthermore, the concentration of NO in PVN
dialysates increases after administration of apomorphine and D2-like agonists, an effect which occurs
concomitantly with penile erection (see Melis and Argiolas, 2005 for review). It has been suggested
that dopamine receptor stimulation initiates the opening of the N-type calcium channels in a similar
manner to NMDA receptors ie. via coupling to a G protein; however, activation of the N-type calcium
channels may be via an as yet unknown intracellular signalling pathway. In line with the former
hypothesis, such increased intracellular calcium levels would activate NOS which in turn stimulates
NO production and the subsequent activation of oxytocin neurons. However, it is important to add
that as yet there is no published data showing that NO directly activates hypothalamic oxytocin
neurons. Interestingly, NO has been shown to inhibit the firing pattern of magnocellular oxytocin
neurons in the SON (Srisawat et al, 2000) so it is unclear as to how NO donors stimulate penile
erection. NO may act intracellulary in oxytocin neurons, secondary to a rise in intracellular calcium
levels as previously described. Alternatively, NO may act extracellulary by acting on
neuromodulatory inputs to oxytocin cells in the hypothalamus, where local NO production levels can
alter excitatory and inhibitory functions (Calka, 2006 for review). Intra-hippocampal delivery of a
low dose of NO donors decreased GABA release in dialysates (Getting et al, 1996). Similarly,
administration of a high dose of NO-stimulating agents into the hippocampus, enhances glutamate
release (Segieth et al, 1995; Sequeira et al, 1997). Thus, NO may stimulate oxytocinergic
neurotransmission and penile erection by altering GABAergic and glutamatergic influences in the
hypothalamus.
In addition to a NO pathway, dopamine may exert its stimulatory effects in a more direct fashion via
an increase in intracellular calcium levels. It has been shown that D2-like receptors coupled to the
chimeric G-protein, Gaq in transfected cell lines increased intracellular calcium levels upon dopamine
stimulation (Moreland et al, 2004); however, it is not known if this G-protein is found in oxytocin
cells or whether D2-like receptors would naturally couple to this G-protein physiologically. In the
neurohypophysis, activation of dopamine D4 receptors leads to inhibition of potassium currents
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(Wilke et al., 1998); thus, D2-like receptors could also have a partial inhibitory effect on cell
hyperpolarisation thereby enhancing oxytocin release.
The D4 receptor agonist, PD-168077 has been shown to induce Fos expression and ERK 1/2
phosphorylation in the PVN of male rats (Bitner et al, 2006). Such an effect was antagonised by A-
381393, a dopamine D4 receptor antagonist, and SL327, an ERK 1/2 phosphorylating inhibitor.
Additionally, D4 receptor expression was co-localised with Fos in PVN neurons, although it is not
known if these were oxytocinergic. Unfortunately in this study the gene expression was not correlated
with penile erection; however, it does suggest that D4 receptors in the PVN mediate the actions of
PD-168077 by activating immediate early gene and/or MAP kinase pathways (Bitner et al, 2006;
potential dopaminergic actions on OXT neurons in the PVN are summarised in Figure 1.9).
There does not appear to be any literature reporting a dopamine-oxytocin link in the MPN in relation
to sexual behaviour, thus even less is known regarding the potential signalling pathways underlying
dopamine-oxytocin interactions in this nucleus. However, it is believed that NO facilitates dopamine
release in the MPOA as shown by a comprehensive study carried out by Sato and Hull (2006) where
they postulated that activation of a NO-cGMP pathway enhanced MPOA dopamine release. An
analogue of cGMP and an inhibitor of its precursor, guanylate cyclase increased and decreased MPOA
dopamine release, respectively. In addition, cGMP was shown to concomitantly increase dopamine
release and ejaculation frequency. Conversely, inhibition of guanylate cyclase decreased ejaculation
frequency (Sato and Hull, 2006). This provides strong evidence for aNO-dopamine link in the
MPOA during male sexual behavior; however, as before the neuronal phenotype expressing NOS is
not known. Because NO can act as an intra- and intercellular messenger and is present in
hypothalamic oxytocin neurons, it could be tempting to suggest an oxytocin-NO-dopamine pathway in
the MPN of the MPOA.
1.11.2 Signalling via interneurons
It is known that a complex cellular hierarchy exists in the SON and PVN whereby oxytocin neurons
are heavily modulated by inhibitory GABAergic and excitatory glutamatergic neurons, which
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Summary diagram of dopamine-mediated signalling pathways during penile erection.
Dopamine may act via (1) a calcium dependent nitric oxide pathway (2) the chimeric G-
protein Gaq to increase intracellular calcium levels (3) presynaptic inhibition of GABA
neurons via D4 receptors, thus disinhibiting oxytocin neurons and leaving them free to
respond to excitatory neuromediators (4) D4 receptors to stimulate ERK 1/2
phosphorylation and/or I EG expression to activate MAP kinase pathways, to excite
parvocellular oxytocinergic cells and stimulate release of oxytocin in areas such as the
spinal cord, hippocampus and VTA. DA: dopamine, GABA: gamma-aminobutyric acid,
OXT: oxytocin, NMDA: N-methyle-D-aspartic acid, Ca: calcium, NOS: nitric oxide
synthase, NO: nitric oxide, IEG: immediate early gene, ERK: extracellular signal-
regulated kinases, MAP: mitogen-activated protein kinase, VTA: ventral tegmental
area.
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themselves can be influenced by a range of synaptic inputs and neurotransmitters present in the
extracellular fluid. GABAergic and glutamatergic neurons heavily synapse with magnocellular
oxytocin soma and dendrites in the PVN and SON whereas dopaminergic innervation of these nuclei
is comparatively scarce (Jourdain et al, 1999). Thus, it seems reasonable to assume that endogenous
dopamine could exert its' effect on oxytocin release by acting indirectly via glutamatergic and/or
GABAergic neurons rather than oxytocin neurons directly. Evidence for an intermediary role for
GABA includes studies showing that intra-PVN injection of muscimol, the GABAa receptor agonist,
inhibits apomorphine- and oxytocin-induced penile erections and, in parallel, attenuates the increase in
nitrite and nitrate concentrations in the PVN (Melis and Argiolas, 2002). In particular, D4 receptor
stimulation has been implicated in the disinhibition of GABAergic and inhibition of glutamatergic
neurotransmission in the SON by acting presynaptically (Price and Pittman, 2001; Azdad et al, 2003).
Although it is unclear as to which system would predominate under physiological conditions, it could
be speculated that dopamine-induced inhibition of GABAergic and glutamatergic neurons would
somehow increase the responsiveness of the postsynaptic cell, conferring on it a greater sensitivity,
free to respond to other excitatory factors such as oxytocin. Thus, it could be that during the initiation
of penile erection, dopamine acts presynaptically to disinhibit oxytocin neurons and so facilitate the
activation of the hypothalamic oxytocinergic system. One study which contradicts this GABA
disinhibition theory showed that Zolpidem, a selective receptor agonist for the GABAa receptor a
subunit, significantly induced Fos expression in magnocellular oxytocin neurons in the PVN;
although, this was not correlated with penile erection (Kiss et al, 2006). As previously described,
activation of GABAa receptors on oxytocin neurons is normally associated with increased
GABAergic inhibition and, thus, reduced activity in oxytocin neurons. But this study found, contrary
to expectations that Fos indicates neuronal excitation; increased magnocellular oxytocinergic
activation in the PVN. However, the SON which is predominantly magnocellular did not show such
an excitatory effect on neuronal activation. Zolpidem also increased Fos expression in the
parvocellular PVN but again the neuronal phenotype expressing the Fos was unknown (Kiss et al.,
2006). Taken together, it seems GABA may differentially modulate oxytocin neurons depending on
the nucleus they are located in. It is possible that in this study, Zolpidem was interacting with the a
subunit in GABAa receptors located pre- and postsynaptically. This may partly explain the increased
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Fos expression in oxytocin neurons. Additionally, GABAa receptors are comprised of a variety of
subunits, each with their own isoforms, thus giving rise to a diverse range of functional GABAa
receptors. It has yet to be demonstrated, but GABAa receptors activated by Zolpidem in this study
may perform in a contradictory manner to conventional GABAa receptors thereby inhibiting
GABAergic neurotransmission (See Figure 1.9).
Thus, there are a range of potential direct and indirect signalling pathways activated upon dopamine
receptor stimulation in the hypothalamus. However, further studies are required to elaborate on the
activation of behaviourally-specific transduction mechanisms and their correlation with the expression
of penile erection.
1.11.3 Dopamine and oxytocin interaction summary
The central neural networks and intracellular signalling pathways controlling penile erection are far
from being fully established. However, central dopamine and oxytocin pathways are clearly involved.
Evidence suggests that dopamine acts at least partly via the oxytocinergic system and the MPN, SON
and PVN are three brain regions that are the most likely sites for dopaminergic control of oxytocin
neurons. However, it is still to be established whether endogenous dopamine acts directly and/or
indirectly via oxytocin neurons to mediate sexual behaviour: other extrahypothalamic areas mediated
by these and other neuromodulators are almost certainly involved. Cross-talk between central
dopaminergic and oxytocinergic neurotransmission in the mediation of penile erection appears to be
an exciting and intriguing prospect which warrants further investigation. Due to the high incidence
and severity of side effects associated with some erectile dysfunction drugs that modulate
dopaminergic transmission, it would be interesting to further investigate how central dopamine and
oxytocin pathways interact. Such dual participation of dopamine and oxytocin in the control of penile
erection could be clinically exploited; particularly the oxytocinergic system, which is a key
therapeutic target due to its pro-erectile effects and seeming lack of ability to cause adverse side
effects. However, more thorough investigation has to be performed to help establish those circuits
that constitute the neuronal basis of male sexual behaviour.
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1.12 Thesis aims
So although it is very apparent that central dopamine and oxytocin are clearly pro-erectile, the
interactions between these two neuromodulators in the CNS remain poorly understood.
Pharmacological, neuroanatomical and oxytocin release studies have all shown support for a
relationship between dopamine and oxytocin in the brain and spinal cord during the expression of
penile erection. However, specific central sites which integrate dopaminergic and oxytocinergic
neurotransmission and by what mechanism are far from being elucidated. Although administering
dopaminergic agents into the hypothalamus can alter oxtyocin release in the CNS and plasma, it is not
clear where the resultant oxytocin response occurs or if it is due to a direct action by dopamine.
Furthermore, if dopaminergic inputs to hypothalamic oxytocin cells can influence the neuronal
activity of oxytocin cells, which dopamine receptors mediate the effects of these ligands and where
are they located?
As previously mentioned the MPN of the MPOA, SON and PVN are three key hypothalamic nuclei
that contain oxytocin neurons and have been implicated in mediating various aspects of masculine
sexual behaviour. Furthermore, the MPN and PVN are highly responsive to the pro-erectile effects of
dopaminergic ligands. Taken together, current findings have provided some evidence that these brain
nuclei may be key anatomical targets where an interaction between dopamine and oxytocin could
occur to facilitate penile erection. However, whether dopamine has any effect on these hypothalamic
oxytocin neurons during penile erection and knowledge of potential oxytocin release sites is not
known. Additionally, oxytocinergic expression of dopamine receptors in the MPN, SON and PVN,
which would be indicative of a direct dopaminergic influence on oxytocin neuronal activity, has not
been reported in any of these brain regions.
1.12.1 Hypothesis
In order to clarify the potential role of dopamine in the excitation of hypothalamic oxytocin neuronal
populations and on oxytocin release in the context of penile erection, we developed the following
hypothesis;
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Dopamine acts via D2-like receptors located on oxytocin neurons in the MPN, SON and PVN, to
stimulate centra! oxytocin neuron activity and oxytocin release in the spinal cord andfacilitate penile
erection in the rat.
This thesis has attempted to address the above hypothesis by conducting three main experiments;
(1) In order to investigate the effect of dopaminergic ligands on hypothalamic oxytocin neurons
during penile erection and using Fos as a marker of neuronal activation, D2-like
dopaminergic ligands were administered centrally to conscious animals and their effect on
erectile responses and oxytocinergic activation were analysed.
(2) To investigate whether the lumbosacral spinal cord is one potential oxytocin release site after
dopaminergic stimulation, the effect of oxytocin receptor blockade in the lumbosacral spinal
cord on dopamine agonist-induced penile erection in anaesthetised rats was examined.
Additionally, the ability of a dopaminergic agonist to elicit an increase in oxytocin release in
the lumbosacral spinal cord was also investigated.
(3) To provide anatomical evidence for a direct dopamine-oxytocin link in the hypothalamus, the
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2.1 Animals
Male Sprague Dawley rats, weighing 225-250g, were used (Charles River, UK) in all experiments.
They were housed in groups of 6 (unless otherwise mentioned) and maintained under standard
conditions with food and water available ad libitum. Rats were maintained throughout on a 12:12h
light:dark cycle (lights on from 7am to 7pm); except in the copulation study, rats were placed under
reverse light cycle on a 12:12h darkrlight cycle (lights on 7pm to 7am). All procedures were approved
by the UK Home Office under the Animals (Scientific Procedures) Act 1986.
2.2 Anaesthesia and analgesia
2.2.1 Recovery - gaseous anaesthetic
Prior to any surgical procedures being performed (for male and female rats in the behavioural study),
rats were placed in an anaesthetic box containing isoflurane. Once sufficiently anaesthetised, the rat
was placed in the stereotaxic frame and maintained by continuous delivery of isoflurane (3% in
600ml/min of oxygen). Isoflurane is a reversible gaseous anaesthetic and muscle relaxant. It acts by
potentiating neurotransmission at GABAa and glycine receptors by interacting directly with proteins
and/or indirectly via the lipid bilayer (Tanner et al, 2000).
2.2.2 Non-recovery - liquid anaesthetic
Rats used in the intracavernous pressure and push-pull perfusion studies were terminally anaesthetised
with an injection of urethane (1.2g/kg, Sigma, UK). Urethane is often the chosen anaesthetic for this
particular study (Allard et al, 2002; Giuliano et al, 2001; Giuliano et al, 2002) because it is less
quickly metabolised than sodium pentobarbitone, and rats remain deeply anaesthetised for several
hours after a bolus injection. Moreover, urethane has minimal effects on respiration whilst
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maintaining spinal reflexes. Urethane acts to enhance function at glycine, GABAa and nicotinic
acetylcholine receptors (Hara and Harris, 2002). In addition, it reduces activity at AMPA and
NMDA receptors, thus it seems both inhibitory and excitatory pathways are selectively modified by
urethane (Hara et al, 2002).
2.2.3 Analgesia
Once anaesthetised and prior to commencing surgery, rats were injected with an analgesic (Rimadyl,
UK, 50pl, s.c.). Rimadyl is a non-steroidal anti-inflammatory (NSAID) agent which acts to relieve
pain and reduce inflammation. As with other NSAID's, Rimadyl can partly modulate the humoral and
cellular immune response. It acts by inhibiting the enzyme, cyclooxygenase which under normal
physiological conditions stimulates prostaglandin release and contributes to the immune response.
2.3 Surgical procedures
On the day of surgery, all surgical instruments including cotton wool, suture thread and needles were
autoclaved and instruments and cannulae were dipped in 70% ethanol followed by saline prior to use.
Incision sites were previously wiped with iodine and a few drops of 70% ethanol to promote sterility.
The lack of the toe-pinch reflex and whisker movement were used as indicators that the rat was
sufficiently anaesthetised. After all surgeries, rats were given saline (1ml, i.p.) to help restore any
fluid loss and then placed in a heated (37°C) recovery box before returning to their home cage.
2.3.1. Subcutaneous (s.c.) injections
For copulation experiments sexually receptive Sprague Dawley female stimulus rats (200-250g) were
used. Ovariectomised females were injected subcutaneously with 15pg/150pl and lOOOpg/lOOpl of
oestradiol benzoate and progesterone (both Sigma, UK) dissolved in 100% ethanol and diluted 90% in
sesame oil, 4 h and 48 h respectively, before experiment day to induce receptivity.
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2.3.2 Intraperitoneal (i.p.) injections
Prior to transcardial perfusion, rats were anaesthetised with an overdose of sodium pentobarbitone
(60mg/ml, 0.8ml, Sagatal, Rhone Merieux, Harlow, UK). Care was taken to ensure the injection
needle entered the abdominal cavity but avoided puncturing of major organs. Sodium pentobarbitone
is a short-acting barbiturate which acts by mimicking the actions of GABA and acting predominantly
at postsynaptic GABAa receptors. It acts to depress and enhance the activity of cationic and chloride
channels respectively and so decreases neuronal firing (Belelli at al, 1999: Richards, 2002 for review).
2.3.3 Intravenous (i. v.) injections
In the experiments involving urethane-anaesthetised rats, either urethane (20pl) or apomorphine
(250pl) was injected via a previously implanted femoral vein cannula. Urethane or apomorphine were
administered i.v. using a 1ml syringe to maintain anaesthesia (and sacrifice animal) and to induce
transient increases in intracavernous pressure, respectively.
2.3.4 Intracerebroventricular (i.e.v.) stereotaxic placement ofguide cannula
Isoflurane-anaesthetised rats were placed carefully in the stereotaxic frame (ASI Instruments Inc.
Michigan, USA); care was taken to ensure the delicate ear bones were not damaged. Lack of any
lateral movement whilst secure in the ear bars signified that the head of the rat was in the correct
position. A small incision was made in the skin and cranial membranes were cleared from the skull.
Lambda and bregma were measured to ensure the skull was level before starting surgery. Prior to
implantation of the cannula, a drill was used to make three holes in the skull; two for screws (Plastics
One, Vancouver, Canada) and one for the guide cannula (22-guage, Plastics One, Vancouver,
Canada). One screw was placed diagonally anterior and another posterior to the cannula implantation
site. These two screws would later serve as anchorage for the implanted cannula. To enable direct
injection of drugs into the lateral cerebral ventricle, a stainless-steel guide cannula was implanted into
a lateral cerebral ventricle (stereotaxic coordinates, 1.6mm lateral and 0.6mm caudal from bregma,
inserted to a depth of 4mm from the skull surface). Once the cannula was in place, dental cement
55
Chapter 2: General Materials and Methods
(comprised of dental powder mixed with acetylamide, Simplex Rapid, Kendent Works, UK) was
carefully poured into the skin opening around the cannula, making sure the screws, the lower part of
the cannula and edges of skin were submerged. Once the dental cement had hardened, the frame
clamp was released from the cannula and a snugly fitting protective cap was placed in the cannula.
2.3.5 Ovariectomy (OVX) preparation
Three weeks prior to experiment day, female rats were anaesthetised (as described above) and placed
on their ventral surface. Bilateral incisions (approximately 1cm in length) were made in the skin mid-
to-lower back, on either side of the spinal cord and just above the gluteus maximus. Careful cuts were
made through the layers of fascia and connective tissue to reveal the abdominal wall. A clean vertical
cut was made in the abdominal cavity and small forceps were used to locate fatty tissue. The fatty
tissue connected to the uterus, ovaries and fallopian tubes was then gently pulled through the incision
site, with the ovaries (dark red in colour) clearly distinguishable from the fatty tissue and uterus.
Using fine sutures (metric 1.5 (4.0), Surgisilk, Sutures Ltd., UK) a double knot was tied around each
fallopian tube and using fine scissors, the ovary and all follicles were removed. The uterus was then
carefully placed back in the abdominal cavity and the abdominal wall was stitched using sutures to
close the wound. Wound clips (Michel suture clips, 7.5x 75mm, Fine Science Tools, Germany) were
then used to close the skin. The wound clips were kept in place for approximately 7-10 days, after
which they were removed under light anaesthesia. Prior to and on experiment day, the female rats
were primed with s.c. injections of progesterone (Sigma, UK) and oestrogen (Sigma, UK) (as
described previously) to induce sexual receptivity.
2.3.6 Intra-PVN injection
The anaesthetised rat was secured in the ear bars of the stereotaxic frame. An incision was made in
the skin and the skull (including bregma) exposed. Measures were taken as described previously to
ensure the skull was level. For PVN injections, the coordinates used were 1.8mm caudal, 0.5mm
lateral (from bregma) and 8.6mm ventral from the skull surface. A 23G hypodermic needle, held in a
micromanipulator was lowered vertically to mark the injection site coordinates on the surface of the
parietal bone. At this point, a small hole approximately 1-1.5mm in diameter was drilled. The needle
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was then lowered vertically into the brain. Using a lOpl Hamilton syringe (Hamilton, Switzerland),
drugs were injected in a volume of 2pl over 2 min. After each injection the needle was kept in place
for a further 30 sec to allow diffusion of the compound and to prevent backflow into the needle tract.
2.3.7 Intraspinal injection
Intraspinal injection was performed using a binocular microscope (Wild Heerbrugg MS-C,
Switzerlan) at lOx magnification. The anaesthetised rat was placed on its ventral surface and an
incision was made at the level of the thoracic vertebra which proceeded caudally approx 6-7cm. The
junction that lies between the T13 and LI vertebra level was located by identifying the beginning of
the fused sacral spinal vertebrae and then counting rostrally (six vertebra in total) toward the thoracic
spinal cord level. An incision was made at the T13 and LI junction and muscle and connective tissue
were carefully removed to expose the dorsal vertebral lamina. Bone surrounding the joint was
carefully removed to make a small "window" which exposed part of the lumbosacral (L4-L6) spinal
cord. Care was taken to avoid rupturing the central vein or membranes surrounding the spinal cord.
The animal was then placed on the flat platform of the stereotaxic frame in a supine position, the
upper body elevated and rolled forward towards the tail to expose the spinal cord. Using a
micromanipulator, spinal cord injection was performed lateral to the central vein, approximately 1mm
deep in to spinal cord tissue. Using a lOpl Hamilton syringe, the injection needle was lowered
vertically and drugs were injected in a volume of 3pl over 3 min.
2.3.8 Cannulation ofthefemoral artery and vein
After preparing the spinal cord and prior to intraspinal injection, anaesthetised male rats were placed
in the supine position on a homeothermic blanket (Harvard Apparatus, UK) to maintain body
temperature at 37°C. An incision was made approximately 1.5-1.8cm above the penile opening and
proceeded laterally towards the knee joint, an opening in the subcutaneous tissue was made and all
connective tissue was removed to expose the femoral vein and artery. The femoral vein was
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catheterised (0.63mm in diameter, 30cm in length, Portex Ltd., UK) to allow additional doses
intravenously (i.v.) as necessary to maintain anaesthesia during the experiment. Additionally, the
femoral artery was also catheterised (0.80mm in diameter, 30cm in length, Portex Ltd., UK) for
measurement of systemic blood pressure. The same procedure was used to cannulate both the vein
and the artery. A ligature (metric 1.5 (4/0), Surgisilk Ltd., UK) was tied in a double knot at the distal
end of the vein and another ligature tied loosely in a single knot was placed at the proximal end of the
vein. Fine forceps were placed under the vein and opened to stretch the vessel. A small incision was
made in the vein to allow insertion of the cannula. Before careful insertion of cannulae into the vein
and artery, each catheter was filled with urethane and heparinised saline (25UI/ml, CP
Pharmaceuticals, UK) respectively, and all air bubbles expunged. Using thin forceps, approximately
1-1,5c.m of the tip of the cannula was carefully inserted into vein. Once the cannula had been inserted
into the vessel, the loosely tied ligature at the proximal end was tightened and tied in a double knot
once the cannulae were in place. The proximal ligatures of the artery and vein cannulae were finally
tied together so that both cannulae lay in the same plane and were secured.
2.3.9 Measurement ofcorpus cavernosum pressure
After cannulation of the femoral artery and vein, the penis was dissected and a needle inserted in one
corpus cavernosum to record intracavernous pressure (ICP). The penile opening was cut and all
connective tissue at the base of the penis was carefully removed. Holding the glans penis, the middle
third of the penis was denuded of skin and the surrounding connective tissue removed by careful
rubbing with a cotton bud. A catheter attached to a 25-gauge needle (25G, 15mm in diameter, 30cm,
Venofix, Braun) was stretched to 30% more than its original length and was filled with heparinised
saline (25UI/ml). The 25G needle was inserted into one corpus cavernosum in the middle third of the
penis for measurement of ICP. The ICP catheter was connected to pressure transducers (EM 750,
Eclomatic, Glasgow, UK). Once the needle was in place, the penis was flushed with lOOpl of
heparinised saline (25U/ml) to ensure there were no holes or leakages in the penile tissue.
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In all the intracavernous pressure experiments, catheters were flushed with lOOpl saline (Fresenius
Kabi, UK) before and after drug injection to wash out urethane and drug in the catheter, respectively.
Basal conditions were recorded for 10 min prior to any injection and for 30 min after the injection of
apomorphine.
2.4 Proceduresfor i.e.v. injection via a guide cannula
The animals were housed individually after surgery and allowed 2 days to recover. The conscious rats
were handled daily to familiarise them with the injection procedure. On experiment day, each rat was
gently restrained in his home cage. The injection cannula was connected by polyethylene tubing filled
with vehicle or drug, to a gas-tight lOpl Hamilton syringe that was then inserted into the guide
cannula. Drug or vehicle was injected into the left lateral ventricle in 2pi over 2 min via an injection
cannula (28 gauge) which extended into the ventricle 1.0mm below the tip of the guide cannula. The
animals were allowed to freely move around during drug administration to reduce any stress endured.
The injection cannula was kept in place for a further 30 seconds to allow the drug to diffuse from the
injection site and to avoid a backflow of the drug into the cannula.
2.5 Examination of injection site
2.5.1 i.c.v.
Whilst cutting the brains on the microtome, the site of the ICV cannula tip was localised following the
cannula track through a series of brain sections (48pm in thickness). Only animals in which the
cannula tip was positioned in the left lateral ventricle were considered for statistical analysis (see
Figure 2.1A)
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Figure 2.1: Brain maps showing central injection sites
(B) intra-PVN
(C) intraspinal
Diagrammatic representation of injections sites (filled bars) in the lateral ventricle
(A), PVN (B) and L5 spinal level of the lumbosacral spinal cord (C), in coronal
view.
Chapter 2: General Materials and Methods
2.5.2 Intraspinal and intra-PVN
Once each rat was sacrificed, the brain or L4-L6 region of the spinal cord were then dissected out and
stored in formalin (with 4% paraformaldehyde) for 24 hours before being cut on a cryostat (Leica CM
3050, UK) (30pm in thickness). Brain sections containing the PVN or L4-L6 spinal cord sections
were mounted onto gelatinised microscope slides (76x26mm, Menzel-Glaser, Braunschweig) (3g
gelatine (Sigma, UK) in 600ml dH20, once dissolved add 0.3g chromium potassium sulphate (Sigma,
UK). Sections were then firstly placed in decreasing ethanol concentrations (100 x2, 90, 70. 50x2 %)
followed by methylene blue (Pro-lab diagnostics, UK) and then dehydrated in increasing ethanol
concentrations (50x2, 70, 90, 100x2) and histoclear (National Diagnostics, UK) x2 for 2 min each.
Sections were then coverslipped and allowed to dry before locating the site of injection using a light
microscope (x20 magnification) (See Figure 2. IB and 2.1C).
2.6 Brain and spinal cord tissue processing
2.6.1 Perfusion
Rats were terminally anaesthetised with an overdose of sodium pentobarbitone (60mg/ml, 0.8ml i.p.,
Sagatal, Rhone Merieux, UK). The toe pinch reflex test was conducted to ensure the rat was
terminally anaesthetised. Once the animal had stopped breathing and there was no longer a reflex
response, a vertical incision was made in the abdominal cavity which proceeded rostrally toward the
thoracic cavity. Using thick forceps to grip the sternum, two cuts were made on either side of the
ribcage which was then bent backwards and held open by a clamp to expose the still beating heart.
Care was taken to cut the diaphragm and any connective tissue surrounding the heart. A blunt 25G
needle attached to a perfusion pump was then inserted into the apex of the left ventricle of the heart
and guided towards the aorta. One atria was then snipped immediately afterwards to allow blood to be
flushed out of the heart.
Rats were perfused with heparinised saline (200-250ml) until the blood ran clear and then 4%
paraformaldehyde in 0.1M PB (350ml) until there was definite stiffening of the rat's body and
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paraformaldehyde was running from the nose. To remove the brain, bone crushers were used to
carefully remove any skull bone encasing the fixed brain and brainstem. The overlying dura layer was
cut and removed using fine scissors. Before removal of the brain, a cut was made at the rostral end of
the brain between the olfactory lobes and the cortex. The head of the rat was then turned upside down
to allow the brain to fall naturally out of its position. Using fine scissors and working caudally to
rostrally, any surrounding connective tissues were cut as the brain was increasingly freed from its
position. At the rostral end, care was taken to delicately snip the optic tract as any damage to the optic
tracts could result in loss of the SON. Finally, a small spatula was used to scoop the brain into a
falcon tube containing post-fix soution (50:50 30% sucrose solution in 0.1M PB and 4%
paraformaldehyde in 0.1 M PB) in which the brain was left for 24 hours and then transferred into 30%
sucrose solution for 24-48 hours or until the brain had sunk. Such post-fix solution acts in a dual
manner to firstly cryoprotect the brain tissue. The sucrose solution acts to absorb any remaining water
molecules in the tissue and so prevents any crystallization which is especially important when cutting
fine sections of the brain on a freezing microtome. Secondly, the paraformaldehyde solution acts to
form strong cross-linking aldehyde bonds throughout the tissue helping to preserve protein expression.
The immersion of the brain in a second, more concentrated sucrose solution is an extra precautionary
measure to avoid ice crystals forming and damage to the tissue. Using a sharp blade, a lateral cut was
made at the caudal end of the brain to remove the unwanted brainstem tissue. Brains were
immediately frozen in dry ice and stored at -70°C until use. Brain sections containing the MPN, SON
and PVN were cut at 48pm on a freezing microtome and placed temporarily into petri dishes of 0.1 M
PB and then separated into three different vials containing cryoprotectant. Sections were cut at 48pm
to allow more thorough and accurate quantitative analysis of the densely cell packed hypothalamic
nuclei, particularly the SON. One vial was used for each immunocytochemical study to examine Fos
or Fos and oxytocin expression. Once cut, brains sections were either stored in cryoprotectant at -
20°C or used immediately.
2.6.2 Using Fos immunocytochemistry as a markerfor neuronal activation
The expression of Fos (protein product of the immediate early gene c-fos) has been widely used to
map neural circuitries subserving various forms of behaviour such as aggression and paternal
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behaviour (Hasen and Gammie, 2005; Meddle et al, 2007; Haller at al, 2006). In addition, it has been
extensively used to establish those neuroanatomical pathways that subserve male sexual behaviour in
particular (Pfaus and Heeb, 1997). Specific copulatory parameters such as intromission and
ejaculation are known to induce Fos expression in clusters of neurons in the SON, PVN, MPOA and
subdivisions of the BNST and MeA of rats and birds (Balthazart and Ball, 2007; Bialy and
Kaczmarek, 1996; Caquineau et al, 2006; Pattij et al, 2005; Parfitt and Newman, 1998; Pfaus and
Heeb, 1997; Witt and Insel, 1994). Induction of Fos expression can be elicited via a range of
numerous extracellular factors such as the activation of ion channels and the binding of
neurotransmitters, excitatory amino acids and polypeptide fragments. Fos acts as a transcription
factor by forming homomeric and/or heteromeric (with Jun) dimers which specifically bind to DNA
sequence elements and influence transcriptional activity of certain proteins, namely AP-1 (activator
protein 1) or CREB (cAMP responsive element binding) sites which subsequently activate their target
genes. Thus, increased Fos expression may reflect permanent changes in neuronal re-modelling and
neuronal plasticity (Bialy and Kaczmarek, 1996; Curran and Morgan, 1995).
Because Fos is expressed in the cell nucleus, Fos immunocytochemistry can be combined with
neuropeptide immunocytochemistry to identify neuronal phenotype. In this instance, we used
oxytocin to examine co-localisation of neuropeptide cytoplasmic labelling (oxytocin) with nuclear Fos
protein expression. Such double immunocytochemical staining allows detection of discrete functional
neurochemical pathways involved in the regulation of sexual behaviour.
To identify whether dopamine affected neuronal activation during male sexual behaviour, single Fos
immunocytochemistry was performed and the number of Fos-positive cells were quantified to give a
measure of activation in the relevant brain regions. Double immunocytochemistry for Fos and
oxytocin was also performed and the number of Fos-positive oxytocin cells were counted, similarly.
It is often debated that only one run of double immunocytochemistry for Fos and oxytocin is sufficient
for quantification of Fos alone and co-localised Fos and oxyocin expression. However, it is thought
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that during double immunocytochemistry and due to the additional vigorous washes, some of the Fos
antiserum may be washed off and so some signal will be lost. When comparing the quantified Fos
only expression after single and double immunocytochemistry in our studies, it was found that Fos
only expression was consistently higher after single immnocytochemistry compared with double
immunocytochemsitry (although only marginally and no differences between groups were observed).
In addition, with single immunocytochemistry for Fos only, the brain sections tend to have lower
background staining which allows for clearer and more accurate quantification. This was particularly
important when analysing the densely populated SON.
2.6.3 Brain sections
As previously described, the MPN, SON and PVN are three brain nuclei that are believed to mediate
consummatory aspects of male sexual behaviour. Thus, Fos and double Fos and oxytocin expression
were immunocytochemically examined in these three brain areas.
Because the PVN is comprised of various parvocellular and magnocellular subdivisions, in addition to
examining the PVN as a whole, each individual subregion within the PVN was also analysed
separately (Figure 2.2).
(1)
Bregma: -0.92mm Bregma: -1.40mm
Bregma: -1.80mm Bregma: -2.10mm
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Figure 2.2: Subdivisions of the rat PVN examined, rostral-caudal (1-4). The coordinates are chosen
according the rat brain atlas (Paxinos and Watson, 1988). ap = anterior parvocellular; dp = dorsal
parvocellular; mp = medial parvocellular; pm = posterior magnocellular; lp = lateral parvocellular.
Thus, neuronal activation was analysed in each of the four hypothalamic levels and within each
particular subregion as illustrated in Figure 2.2.
2.7 Generalprinciples of immunocyochemistry
Immunocytochemistry is the principal technique employed to detect the presence of antigens in tissue
samples. Antigens are molecules that can elicit immune responses and these can include proteins,
infectious agents, nucleic acids and polysaccharides. The fundamental premise of
immunocytochemistry was first described by Coons et al in 1949 and over the years it has become a
highly refined and versatile investigative tool used by many researchers. The concept of
immunocytochemistry is the binding of an antibody to it's antigen in a tissue sample or medium
followed by a labelling reaction to visualise the antibody-antigen interaction. Such labelling reactions
can include an enzyme reaction or fluorescent dye to visualize the antibody-antigen complex. It is the
surface of an antigen that interacts with the antibody, also known as the epitope. There are a variety
of factors that can determine the success of antigen-antibody binding such as the location of the
antigen in the sample, the location of an epitope, the antigen-detection method employed and the type
and/or concentration of fixative used. To ensure good antibody binding and successful
immunolabelling, it is vital that the antigenic epitope remains preserved and easily accessible to
circulating antibodies.
Antibody molecules are glycoproteins consisting of four polypeptide chains (two identical heavy
chains and two identical light chains) (see Figure 2.3). Antibody polypeptide chains are comprised of
a variable domain (V) due to the variation in amino acid composition and one or three constant (C)
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domains for the light and heavy polypeptide chains, respectively. The chains are held together by
covalent and non-covalent bonds and form a stable, bilateral structure. It is the variable amino acid
terminals at the end of both the light and heavy chain that constitute the antigen-binding sites (Figure
2.3).
Figure 2.3: Diagram of an immunoglobulin. Immunoglobulins are comprised of light and heavy
chains, each containing variable and constant domains. V=variable; C=constant; Cl=constant region
one; C2=constant region two; C3=constant region three.
Antibodies can be either monoclonal where they have only a single epitope site (antigenic binding
site) or polyclonal where they have multiple epitopes and are directed towards various regions of the
antigen molecule. An advantage of using monoclonal antibodies is that they have a single highly
specific binding site for an antigen, thus they are less likely to bind to non-specific factors. However,
if the epitope site becomes conformationally changed or damaged eg. during tissue fixation then the
monoclonal antibody would loose all is antigenic properties and being reactive with only one
antigenic site may involve fewer antibodies binding to the antigen, thus producing a weaker signal.
Using polyclonal antibodies can overcome such a problem as they have multiple epitope sites.
However, polyclonal antibodies can bind to non-specific sites in the tissue samples to produce
"phantom" antigen-antibody complexes. A good antibody must have sufficient avidity and affinity
properties to ensure that the interaction between the antigen and antibody is relatively stable and that
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the paratropic binding of the antibody to the antigenic epitope is strong enough (good stereochemical
compatibility). High avidity is a necessary component of a good antibody as it helps to prevent any
antibody being washed off the tissue samples during the series of immunocytochemical washes and
staining processes.
Visualisation
Visualisation of the antigen-antibody complex can be performed with visible labelling such as an
enzyme marker like horseradish peroxidase which reacts with a substrate and a chromagen to produce
a coloured precipitate that can be viewed with a light microscope. For this reaction to occur
endogenous peroxidase present in cells such as macrophages must be blocked to reduce non-specific
background staining. Thus, prior to the reaction, tissue sections are washed in a hydrogen peroxide
solution containing methanol which inhibits formation of endogenous peroxidase. The coloured end-
product is visualised using the common diaminobenzidine (DAB) (supplier details noted on P.91)
method, which acts as a peroxidase substrate. The horseradish peroxidase binds to a pre-formed
complex of avidin and biotin aptly named the avidin-biotin peroxidase complex (ABC) (Figure 2.4).
Such a complex binds to the previously bound biotinylated secondary antibody and acts to amplify the
antigen-antibody signal.
When performing double immunocytochemistry, the DAB reaction can involve the addition of nickel
ammonium sulphate (to produce a black precipitate) or not (to produce a brown precipitate). The
chromagen, DAB is usually a colourless substance which acts as a substrate for the peroxidase
reaction. The DAB solution contains glucose and glucose oxidase, thus the actions of glucose oxidase
result in the release of an oxygen atom which then reacts with water to form hydrogen peroxide. This
newly formed hydrogen peroxide reacts with DAB to form an instable DAB/peroxidase complex. The
horseradish peroxidase catalyses the oxidation of DAB by hydrogen peroxide to produce an insoluble
black granular precipitate, which is enhanced in the presence of nickel ammonium sulphate.
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Diagram of the avidin-biotin complex (ABC) method. (1) The primary antibody
(rabbit anti-rat when using rat sections) binds to the antigen present in the
tissue. (2) The biotinylated secondary antibody (goat anti-rabbit) subsequently
binds to the primary antibody. (3) The pre-formed avidin-biotinylated
peroxidase complex (ABC) then binds to sites on the biotinylated secondary
antibody. The chromagen DAB is oxidised by the horseradish peroxidase
complex to produce a black precipitate, a reaction which is enhanced by the
presence of nickel ammonium sulphate.
Adapted from Pollak and Van Noorden, 2003
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2.7.1 Protocolfor Fos immunocytochemistry
Ninety min after drug injection (penile erection study) or being placed with a receptive female
(intromission study), rats were deeply anaesthetised and transcardially perfused as described
previously. The transient increase in Fos protein expression in response to neuronal stimulation, is
generally observed between 30 and 60 min, with levels returning to half the maximal value at 120 min
(Kaczmarek, 2002; Vosatka, 1989). Most sexual behaviour studies using Fos immunocytochemistry
to functionally map CNS involvement, generally use a 60-90 time period for Fos protein induction
after copulation (Pfaus and Heebs, 1997; Veening and Coolen, 1998). Thus, 90 min appears to be an
appropriate time period to allow for maximal Fos protein expression when investigating dopamine
ligand-mediated control of penile erection.
Solutions for perfusion fixation:
1. Heparinised Saline(0.9%): 1L dH20 + 0.9% NaCl (cat nos. S7653, Sigma, UK) + 0.0129%
heparin (cat nos. H0777, Sigma, UK).
2. 4% Paraformaldehyde in Phosphate Buffer (PB) (pH 7.3-7.4): For 1L, 500ml dH20 + 4%
paraformaldehyde (cat nos. P6148, Sigma, UK). NaOH pellets (cat nos. 480878, Sigma, UK)
were added to the solution to aid salt dissolution) + 500ml 0.2M PB.
3. Post-fix solution (4% paraformaldehyde + 15% sucrose in 0.1M PB): For 100ml,
15% sucrose (cat nos. S0389, Sigma, UK) / 100ml 4% paraformaldehyde in 0.1 M PB.
4. 30% sucrose solution: For 1L, 30% sucrose / 1000ml 0.1M PB
5. Cryoprotectant to store brain sections at -20°C: For 1L, 20% glycerol (cat nos. 10484K, VWR,
UK) + 30% ethylene glycol (cat nos. 24407.326, VWR, UK) + 500ml 0.2M PBS (phosphate buffered
saline, for 1L, 0.2M PB + 0.9% NaCl).
Solutions for immunocvtochemistrv:
1. 1M phosphate buffer (PB) (pH 7.35-7.4): for 1L, add 11.5% disodium hydrogen orthophosphate
(cat nos. S/4440/53, Fisher Scientific, UK) + 2.72% sodium dihydrogen orthophosphate (cat nos.
S/3770/53, Fisher Scientific, UK) to 1000ml dH2Q.
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2. 0.1M PBT (O.IM PB + 0.2% Triton X-100): for 1L, add 2ml Triton X-100 (cat nos. 437002A,
VWR, UK) to 1000ml 0.1M PB.
3. 0.1M phosphate buffered saline (PBS): for 1L, add 0.9% NaCl to 1000ml 0.1M PB.
4. 0.2M sodium acetate buffer: for 1L, add 1.64% sodium acetate (anhydrous) (cat nos. 102365R,
VWR, UK) to 1000ml dH20, pH to 6.0 with acetic acid.
5. Glucose oxidase-Nickel-DAB solution: for 100ml (comprised of two solutions), solution one;
50ml 0.2M PB + 2.5g Nickel II sulphate (cat nos. 83751.230, VWR, UK) + 0.4g glucose (cat nos.
G7528, Sigma, UK) + 0.08g ammonium chloride (cat nos. 100173D, VWR, UK), solution two;
DAB (cat nos. D8001, Sigma, UK) (25mg/ml) aliquot is added to 49ml dH20 and filtered before
adding to solution one. Immediately prior to use 0.003g glucose oxidase (cat nos. G6641, Sigma,
UK) is added to the Nickel-DAB solution.
6. Hydrogen peroxide DAB solution: for 100ml (comprised of two solutions), solution one; 50ml
0.2M PB + lOOpl hydrogen peroxide (cat nos. 316989, Sigma, UK), solution two; DAB
(25mg/ml) aliquot is added to 49ml dH20 and filtered before adding to solution one.
7. Gelatine (for subbing slides): for 1L, add 5g gelatine (cat nos. 48723, Sigma, UK) + 0.5g
chromium (III) potassium sulphate-12 hydrate (cat nos. 243361, Sigma, UK) to 1000ml warmed
dH20, allow to cool and store at 4°C.
2.7.1 Fos immunocytochemistry
Each vial containing brain sections with the MPN, SON and PVN were drained and separated from
cryoprotectant. Sections were briefly immersed in 0.1M PB prior to draining using small aluminium
baskets, placed on a shaker (70 r.p.m.) at room temperature and initially washed in 0.1M PBT ( 2x5
and 2x 10 min) and then 0.1M PB ( lx 5 min). This was replaced with 20% methanol and 1% H202 in
0.1M PB for 15 min to quench endogenous peroxidase activity in the tissue. The sections were
washed with 0.2M PBT ( 2x 7.5 min ) and 0.1M PB ( lx 5 min ) which was then replaced with 1%
normal sheep serum (NSS) (cat nos. 3772, Sigma, UK) in PB-T for 1 hr at room temperature (r.t.),
which acts as a pre-incubation block and helps to reduce the non-specific staining in sections.
Sections were then incubated in vials containing rabbit anti-rat polyclonal anti-Fos antibody (1:1000,
cat nos. 624401, Cambridge Bioscience, UK), 1% NSS, 0.1M PB-T for 24h at 4°C. The following
day the sections were washed in 0.1M PBT (3x5 and 2x10 min or 8x4 min for double labeling). The
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sections were incubated in a secondary antibody solution containing biotinylated goat anti-rabbit IgG,
normal goat serum (cat nos. PK-6106, Vectastain Elite, Vector Laboratories, Inc.) and 0.1M PBT for
lh at room temperature. The sections were washed again in 0.1 M PBT ( 3x5 mins ) prior to
incubation with Avidin DH and biotinylated horseradish peroxidase (ABC Kit, Vector) and 0.1M
PBT for 1 hr at RT°C. Tissue sections were then further washed in 0.1M PBT ( 2x10 mins ) and
0.1M sodium acetate buffer (pH6) ( 1x5 min).
Fos labeling was visualized using the DAB (diaminobenzamide) method. For this method two
solutions were initially made; Nickel II sulphate, glucose and ammonium chloride were added to
0.2M sodium acetate buffer and DAB (25mg/ml) was added to dH20. The DAB solution was filtered
before being added to the Nickel II sulphate solution and glucose oxidase type Vii-S was added
immediately prior to use. The sections were immersed in the above visualisation solution and closely
monitored to observe the reaction which took approximately 5-7 mins to occur. During this time, a
control section was briefly removed from the DAB solution and viewed under a light microscope to
confirm progress of the DAB reaction. Fos labelling was seen as a solid black nuclear precipitate.
Sections were then washed with 0.1M sodium acetate buffer for 5 minutes and then rinsed in 2x5 and
1x10 min wash in 0.1M PB.
Brain sections were mounted on gelatinised slides and dehydrated through increasing concentrations
of ethanol (50%, 70%, 90%, 95% for 5 minutes) and through 100% ethanol 2x10 min before being
washed in xylene twice for another 10 min. The sections were finally coverslipped (Depex, BDH)
and allowed to dry.
2.7.2 Fos and oxytocin immunocytochemistry
Double immunocytochemistry for Fos and oxytocin was performed on free-floating coronal sections
cut from the same brain regions and at the same thickness as detailed above. The sections were
processed in the same way as described above, however, after Fos visualisation, the sections were
placed in 2x5 mins PB-T washes and this was replaced with a 0.3% H2O2 wash for 15 mins. The
sections were placed in a further 2x10 min PB-T washes and then incubated in a solution containing
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polyclonal antiserum against oxytocin (cat nos. PC226L, 1:1000; Calbiochem, UK), 1% NSS and PB-
T for 24h at 4°C. The sections were washed in PB-T for 3x10 min and then incubated in the
secondary biotinylated antibody and then in the avidin-biotin complex using ABC kit as described
above. Sections were washed in 0.1M PB for 5 min and visualisation was achieved using a solution
composed of DAB, 0.2M PB and H2O2 resulting in brown cytoplasmic labelling within 1 min.
Sections were washed in 6x5 min 0.1M PB washes before mounting on gelatinised slides and dried
through alcohols as described above.
Controls
Although studies using the above Fos and oxytocin antiserum have been published previously in our
lab (Brunton et al, 2006; Caquineau et al, 2006), steps were taken to confirm the effectiveness and
specificity of the Fos and oxytocin antiserum. The following negative controls were carried out:
Fos
(1) Omission of the primary antibody - 0.1M PBT and 1% NSS
Oxytocin
(1) Omission of the primary antibody - 0.1M PBT and 1% NSS
(2) Substitution of primary antibody with NRS - 0.1M PBT, 1 % NSS and NRS (1:1000
dilution).
It can be seen that with omission of either primary antibody, no labelling was detected in any of the
tissue sections. With substitution of the oxytocin antibody with NRS, there was very little non¬
specific staining in the PVN (Figure 2.5), suggesting that there is minimal background staining
associated with application of the oxytocin antisereum
2.7.3 lmmuno labelled cell quantification
Fos
Using a light microscope (x25 magnification) and coded slides, Fos-positive cells were counted as
those with black nuclear staining in the MPN, SON and PVN. Because the MPN was not as clearly
defined as the SON and PVN, nearby neuroanatomical landmarks (the anterior commisure and fornix,
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Figure 2.5: Negative controls for Fos and oxytocin antiserum
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Labelling of oxytocin antiserum in the PVN (A). Negative controls for
oxytocin antiserum are shown in B (substitution of oxytocin antibody with
NRS) and C (omission of oxytocin antibody). Negative control for Fos
antiserum is shown in D (omission of Fos antibody). Filled arrows indicate
oxytocin-positive cell bodies and empty arrows show oxytocin-positive
fibres. Scale bars represent 100pm.
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see Figure 1.3) were used as reference regions when analysing each MPN region. This helped to
maintain consistency when measuring Fos expression in the MPN. For the MPN and SON,
approximately 2 and 4 sections per rat, respectively, were counted. For the PVN, Fos-positive cells
were quantified in 4 sections per rat in the following PVN subdivisions; anterior parvocellular, dorsal
parvocellular, medial parvocellular, posterior magnocellular and lateral parvocellular (ap, dp, mp, pm
and lp) and then summed together to give a value for the PVN as a whole. All values were averaged
per rat and then per group.
Fos and oxytocin
For quantification of Fos and oxytocin cells, the counts were performed as described above. A Fos-
positive oxytocin cell was counted as a cell with black nuclear staining surrounded by brown
cytoplasmic labelling. In addition, to Fos only counts however, the total number of oxytocin cells and
the number of co-localised oxyocin cells with Fos protein were quantified separately in the each of the
three brain nuclei. The number of Fos-positive oxyocin cells were expressed as a percentage of the
total number of oxytocin cells.
2.8 Immunofluorescence - colocalisation ofD2-like dopamine receptors with oxytocin neurons
The double immunofluorescence technique was chosen to investigate co-localisation of D2-like
receptors and oxytocin because (1) receptor labelling can give a much weaker signal in comparison to
neuropeptide labelling, thus using fluorescently labelled molecules to bind to the dopamine receptor
primary antibody would show fluorescently labelled receptor protein against a black background and
so make the labelling comparatively easier to visualise than using the Nickel-DAB method and (2)
double immunofluorescence enables the visualisation of more than one fluorescently labelled
molecule in the same cellular compartment. Thus by altering the excitation light (light of longer
wavelength), one can change the fluorescent signal emitted and so distinguish two or more
fluorescently labelled areas of the sample. This is especially important when looking for co-
localisation as, a confocal microscope will capture each fluorescently labelled image separately and
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then overlay the two fluorescent images thus making it easier and clearer to visualise co-localisation
sites.
Dopamine receptor immunofluorescence was initially perfomed without an additional amplification
stage, termed direct immunofluorescence. Here, brain sections were washed in 0.1 M PB and 0.1M
PBT prior to incubation in the blocking serum. However, the receptor signal and cellular resolution
was difficult to visualise due to high levels of non-specific background labelling. Thus, it was
decided to introduce additional endogenous biotin blocking steps, termed indirect
immunofluorescence. Here, prior to incubation in the blocking serum, the brain sections were firstly
immersed in a medium containing unlabelled streptavidin which binds to endogenous biotin in the
tissue sample. The sections were then exposed to unlabelled biotin which in turn blocked streptavidin
sites. The normal blocking and labelling-steps were then performed as with the direct method. As
can be seen in Figure 2.6, when comparing non-amplified and amplified dopamine receptor
immunolabelling; there is greater dopamine receptor signal intensity for the D2, D4 and to a lesser
extent for the D3 receptor (cat nos. 324393, 324402, 324405, all rabbit polyclonal IgG, used at
1:1000, 1:3000 and 1:1000 dilution respectively, all Calbiochem, UK).
The Alexa-fluor fluorescent secondary antibody 568 (red) was initially used to visualise dopamine
receptor expression, however, it was decided that the Alexa-fluor 488 (green) was the better
fluorophore to use for the dopamine receptor signal (Figure 2.7) due to the natural, inherent brightness
of the 488 fluorophore compared to the others.
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Non-amplified and amplified dopamine receptor staining for the D2, D3 and D4
receptor in the PVN. (Scale bar is the same for all images and represents
100pm). It is clear that there is greater dopamine receptor signal intensity
(particularly for the D2 and D4 receptor) with the amplification stage.
Figure 2.7 : The use of Alexa-fluor 488 versus Alexa-fluor 568





Dopamine receptor expression in positive control brain sections using the
Alexa-fluors 568 and 488 in the striatum for the D2 and D4 receptors and in
the olfactory tubercle for the D3 receptor. (Scale bar is the same for all
images and represents 100pm). The Alexa-fluor 488 stained sections show
brighter staining with clearer cellular resolution.








Figure 2.8: Structure of (Fab')2 fragment of an Alexa-fluor antibody. F(ab')2 contains the antigen-
binding domains and only a small proportion of the constant heavy chains.
For the fluorescently labelled secondary antibodies, F(ab')2 fragments of the antibody were used as
opposed to the entire immunoglobulin. The F(ab')2 fragments are comprised of antigen-binding sites,
bound at the hinge through disulfide bridges (Figure 2.8). They are void of most, but not all, of the
immunoglobulin constant regions. F(ab')2 fragments have high avidity and are the preferable choice
for secondary detection because interactions with the constant-regions of the antibody with receptor-
bearing membranes is prevented due to the absence of these antibody domains. Thus, using these
fragmented immunoglobulins helps to reduce the extent of non-specific background labelling and so
improve cellular resolution when visualising.
2.8.1 Protocolfor dopamine D2-Iike receptor and oxytocin immunofluorescence
Brains were cut on the microtome as described above. Washes were all done on shakers at room
temperature unless stated otherwise. Using a 6x4 multi-well plate, 1-2 sections were placed in several
chambers and washed in 4x15 min 0.1M PB washes. Using the biotin blocking kit (Oncogene
Sciences, UK), brain sections were immersed in 3-4 drops of reagent A for 30 min and this repeated
for reagent B followed by 4x10 min washes in 0.1M PB. Sections were then incubated in 1% BSA
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(bovine serum albumin, Sigma, UK) in 0.1 M PB-T overnight at 4°C. The following day, sections
were co-incubated with anti-D2, anti-D3 or anti-D4 and anti-oxytocin (cat nos. MAB5296, mouse
monoclonal IgG 1:1000, Chemicon, UK) antibodies in 1% BSA in 0.1 M PB-T for 48 h at 4°C. After
4x10 min washes in 0.1 M PB-T, sections were washed with a secondary biotinylated anti-rabbit IgG
(1:1000, Vectastain Elite, Vector Laboratories, UK) in 1% BSA and 0.1M PB-T for lh. After another
4x10 min 0.1M PB-T washes, sections were co-incubated with Strepavidin-Alexa Fluor 488 goat anti-
rabbit (for all dopamine receptors, cat nos. A11070, 1:1000, Invitrogen, UK) and Strepavidin-Alexa
Fluor 568 goat anti-mouse (for oxytocin, cat nos. A11019, 1:1000, Invitrogen, UK) in 1% BSA and
0.1M PB-T for 1 h. From this point, all sections were protected from light. Sections were washed in
0.1M PB for 3x10 min before mounting onto slides using 0.05M PB and Molviol. Once dried slides
were wrapped in foil and stored at 4°C to preserve the immunofluorescence signal. Photomicrographs
were taken using a Zeiss confocal microscope.
Autofluorescence (fluorescence emitted from non-specific cell proteins present in sample) can often
make it difficult to distinguish between specific fluorescence signal and background staining. This
emitted signal is due to endogenous flourophores within certain cells and most of the autofluorescence
originates from intracellular structures such as mitochondria and lysosomes. The following negative
controls were included to see the specificity of the primary antibody and to establish the extent of
autofluorescence in the sample:
(1) removal of primary antibody from incubation medium.
(2) substitution of primary antibody with immune serum from the species the primary antibody
was raised in.
Omission of the dopamine receptor antibody resulted in a complete loss of immunofluorescence signal
(Figure 2.9). The same effect was also observed with the oxytocin antibody. Additionally,
substitution of the primary antibody with pre-immune serum produced relatively low levels of non¬
specific staining (Figure 2.10).
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Dopamine receptor expression in the PVN (A,B,C) compared to the negative
control (omission of primary antibody) (D,E,F). (Scale bar is the same for all
images and represents 100pm). Little or no receptor staining can be seen in the
the negative control sections.
Figure 2.10 : Negative controls for dopamine receptor antiserum
(2)
Dopamine receptor expression in the PVN (A) compared to the
negative control (omission of primary antibody and substitution
with normal rabbit serum) (B). (Scale bar is the same for all
images and represents 100pm).
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Photobleaching can occur when the fluorescently labelled specimens are exposed to high intensities of
excitation light. The fluorescent signal can fade and eventually become non-flourescent (this is
thought to be due to in part oxidisation of fluorescent molecules Becker et al, 1996; Chen et al, 1995).
To reduce the effects of photobleaching sample sections were permanently wrapped in foil and
exposure to light was minimised.
2.8.2 General principles ofconfocal microscopy
Confocal microscopy was first established by Marvin Minky (1 Minky Memoir on inventing the
confocal microscope, Scanning) in the 1950s and principally it allows the creation of highly resolved
images that would otherwise appear blurred using conventional microscopes. Confocal microscopes
act to transmit in-focus light and reject out-of-focus light, thus creating a much sharper and more
contrasting image. During scanning of a specimen, only one point of the sample is illuminated at a
time, allowing constructing of 2D and 3D images pixel by pixel. Thus using the vertical axis, a 3D
image of the specimen can be constructed by combining a series of thinner slices.
The choice of objective lens and numerical aperture (light-gathering ability) are extremely important
elements in confocal microscopy. Signal intensity is dependent on the numerical aperture used (signal
intensity increases with numerical aperture) and numerical aperture is dependent on the objective used
(higher objectives have greater numerical apertures). Additionally, the pinhole diameter is equally
important, as too small a pinhole size may reduce the number of fluorescent emissions reaching the
detector, likewise if the pinhole diameter is too large then the light intensity may be too great and lead
to photobleaching and degradation of the fluorophore. As previously stated, the pinhole aperture acts
to prevent out-of-focus light entering the focal plane, however, it strongly determines the thickness of
the optical sectioning (emitted light form sample slice collected by detector)
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Fluorophores are molecules that are activated by high energy (excitation) light of a particular
wavelength. Fluorophores absorb the light and become highly excitable, however, they loose energy
very quickly due to molecular collisions and so exhibit a relatively lower energy state. The lower
excitable state involves the fluorophore emitting light of longer wavelength than the excitation light
(Figure 2.11). Thus, when a fluorescent sample is illuminated with blue excitation light for example,
the fluoresced light is green.
Figure 2.11: Emission of fluorescence light
When light (excitation) of a certain wavelength is shined on a sample, the excitation light is reflected
off a dichroic mirror and onto the fluorescent specimen. Emitted light from the sample is then
transmitted through the dichroic mirror via a pinhole and is measured by a detector. Only light of
longer wavelengths are transmitted whilst light of shorter wavelengths are reflected, thus the
experimentor should see emitted light from the sample and not other generated scattered or non¬
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Figure 2.12: Simplified version of how a fluorescence microscope works. Light of a certain
wavelength (in this case blue) is reflected off a dichroic mirror and onto the specimen. Fluorophores
in the specimen adsorb this light and transmit emitted light of lower energy (in this case green).
When using confocal microscopy, steps must be taken to reduce technical errors and the creation of
false positive results. Light reflected and light transmitted by dichroic mirror and pinhole is not
always 100% efficient. Thus emissions of one fluorophore may be detected in the channel of another
fluorophore and so obscure the visualisation of captured images, this is termed bleed-through. To
reduce the likelihood of bleed-through the following measures were performed;
(1) single labelled controls were used and using single-tracking on the confocal laser, (where
only one laser is activated at a time), this allowed the detection of any signal (cross-talk or
bleed-through) received in the alternate channel.
(2) sequential scanning (multitracks) on the confocal laser was used - here the laser in one
channel is activated and emission light is collected before the laser in the second channel is
activated and emission light is collected, thus reducing any excitation / emissions overlap
between the respective channels.
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Once under the confocal microscope, an optimal and accurate pinhole size and thickness of optical
slice was chosen so as to minimise exposure of the sample to high intensity light. The pinhole size
determines the thickness of the specimen slice from which emitted light is collected (optical section).
A small pinhole diameter produces thinner optical sections and gives better Z axis resolution;
however, the signal intensity can be decreased. The same optical thickness was used for all channels.
Included in the confocal software is a facility called "range indicator" which establishes more
objective acquisition settings and so reduces the subjective creation of high contrast, saturated images
by the experimenter.
2.8.3 Analysis ofco-localisation
The main purpose of performing the dopamine receptor and oxytocin immunofluorescence study was
qualitative and not quantitative. We primarily wanted to establish an anatomical link between central
dopamine receptors and oxytocin by looking for dopamine D2-like receptor and oxytocin co-
localisation in the MPN, SON and PVN. Double-labelled immunofluorescence images were captured
via sequential scanning (as described before) on a Zeiss confocal microscope.
2.9 Behavioural techniques
2.9.1Female receptivity
As previously described, OVX sexually receptive females were used in the intromission study. After
s.c. injection of progesterone and oestrogen 48h and 4h, respectively prior to experiment day, the
female rats were placed with virgin males to check for sexual receptivity. Only those females
displaying proceptive behaviour such as jumping, darting and ear wiggling and receptive behaviour
such as lordosis (where the female extends her body and arches her back to allowing the mounting
male to intromit) on experiment day were used in the study.
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2.9.2Male sexual experience
In the intromission study, sexually-experienced male rats were used to ensure they were capable of
copulation. Sexual experience was gained by placing a male with a receptive female over 2-3 nights;
copulation through to ejaculation was confirmed by the presence of a vaginal plug of semen. This was
repeated twice to allow 2 runs of sexual experience. Those males who did not mate after 4 days of
being placed with a female were excluded from the study.
2.9.3 Penile erection observations
Rats were placed individually into Plexiglas cages (30cm x 30cm x 30cm) during observation and
recording of behaviour under normal light. After drug injection the number of stretching, yawning
and penile erection episodes were counted for 60 min in sexually naive rats. Penile erection was
scored when the penis emerged from the penile sheath, accompanied by penile grooming and hip
flexion.
2.9.4 Intromission observations after placement with a receptive female
Male rats were placed into the transparent Plexiglas cage (30cm x 30cm x 30cm) of a receptive female
during observation and recording of behaviour. All behavioural experiments were conducted in dark
red light. Males were randomly assigned to two separate groups: those placed alone in a novel
environment (clean cage with bedding) with no female or female cues (ALONE) and those placed
with a receptive female. During the test period, it became apparent that some rats would display
mounting but not intromitting behaviour. Thus, the paired males comprised two groups; males that
did not intromit (NI) and those that did intromit (I). A drug was given 15 min prior to the male being
placed with the receptive female. Once placed in the cage with the female and via remote viewing,
the following copulatory parameters were recorded in each male rat for 15 min; mount and
intromission latency (ML and IL) and mount and intromission frequency (MF and IF). Mount and
intromission latency define the times taken for the male to display his first mount and intromission
from when he is initially placed with the receptive female. Mount and intromission frequencies define
the number of mounts and intromissions achieved prior to ejaculation during the 15 min being placed
with the receptive female. Mounts were scored when the male was situated directly behind the female
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and placed his front paws on the female's caudal back but did not show pelvic thrusting when the
female rat displayed lordosis. Intromissions were scored when the male successfully mounted the
female directly from behind and displayed a series of pelvic thrusts whilst the female expressed
lordosis. Behavioural analysis was conducted by individuals who were on most occasions blind to the
treatments administered.
2.10 Intracavernosal pressure (ICP) analysis
2.10.1 General principles
Measurement of intracavernous pressure (ICP) as an index of erectile function has been frequently
used in previous studies and allows for a direct measurement of penile erection in anaesthetised rats
(Allard et al, 2002; Chen et al, 1999; Giuliano et al, 2001) and various other species (Hayes and
Adaikan, 2002; Lavoisier et al, 1990; Lin et al, 1996; Mizusawa et al, 2002 for review). During
erection, the penis becomes engorged with blood and by placing a cannula attached to a pressure
detector in one corpus cavernosum, measurement of intracavernosal pressure serves as a consistent
and accurate physiological marker of penile erection. The ICP model has been used to investigate
control of penile erection in various sexual contexts such as, pharmacologically-induced erection in
isolated males, non-contact erections, reflexive erections and copulation-based penile erection
(Bernabe et al, 1995, 1999; Chen et al, 1999; Giuliano et al, 1994). The sexual context that elicits the
most powerful increases in ICP is that associated with copulatory behaviour (Giuliano et al, 1994;
Bernabe et al, 1999) where mounting, intromitting and ejaculation progressively increase ICP
responses. This is to be expected as in a mating environment with a receptive female, the male rat
will receive olfactory and sensory cues which will stimulate multiple pathways that converge on those
autonomic circuitries controlling erection. However, it is important to add that transient and robust
increases in ICP can also be seen in anaesthetised rats under a range of experimental conditions
including after injection of known pro-erectile agents (Allard at al, 2002; Chen et al, 1999; Hayes and
Adaikan, 2002; Kimura et al 2006), upon electrostimulation of peripheral penile nerves (Chen et al,
1999; Martinez-Pineiro et al, 1994; Sezen and Burnett, 2000; Xing et al, 2005) and after electrical
activation of known brain nuclei influencing penile erection (Chen et al, 1992; Chen et al 1997;
Giuliano et al, 1996; Sato and Christ, 2000). The anaesthetised preparation is a useful in vivo model
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because in most cases, physiological responses (albeit to a lesser degree in some cases) are
maintained. Thus, the ICP model proves to be an extremely refined investigative tool when trying to
establish particular neural pathways underlying context-specific penile erection. In our study we are
using the ICP model to investigate the pathways recruited by the non-selective dopaminergic agonist,
apomorphine. The surgical procedures involved in this experimental set up have been previously
described in section 4.
2.10.2 Analysis ofICP recordings
ICP tracings were analysed retrospectively using computer software in the Pfizer laboratory. ICP
increases were detected as rises above a certain threshold value; this value was calculated as the ICP
value averaged over the 10 min baseline recording before drug injection plus two standard deviations.
These rises in ICP served as physiological markers of penile erection and were considered erectile
events. For each trace the following parameters were calculated:
1. percentage of rats displaying at least one ICP rise during the experiment
2. mean number of ICP rises per rat
3. duration of ICP rises
4. latency to first ICP rise
In addition to recording ICP, blood pressure (BP) was also recorded in each rat, as changes in blood
pressure can impact on blood supply to the penile vasculature and so affect ICP responses in the
anaesthetised rat (Giuliano et al, 1993). Thus, in these studies, the amplitude of each ICP rise was
normalised according to the corresponding mean BP, termed ICPmax/BP ratio. If more than one ICP
rise occurred during the test period then the ICPmax/BP ratio was averaged over the total number of
ICP rises per rat, then per group. Additionally, the area under the curve of each ICP rise was
calculated relative to the corresponding mean blood pressure (AUC/BP). If several ICP rises occurred
then the SUM of AUC/BP of all ICP rises were calculated for each rat. The SUM AUC/BP gives an
indication of overall erectile function. So the following additional measurements were also
performed:
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5. ICPmax/BP
6. SUM AUC/BP
Figure 2.13: An example trace showing increased ICP after apomorphine injection (i.v.). Measured
parameters for each ICP rise were as follows: latency to first response (Lat); duration of the response
(Dur); area under the ICP curve (AUC); maximal ICP value reached during the ICP rise (ICPmax).
Figure 2.13 illustrates an example of a typical ICP and BP tracing after injection of a pro-erectile
drug, such as apomorphine. As can be seen, the BP baseline remains relatively stable whilst, transient
increases in the ICP baseline are observed after durg injection.
2.11 Analysis ofoxytocin release in the lumbosacral spinal cord - sampling extracellularfluid
2.11.1 General principles
Initially microdialysis was used in this study to measure oxytocin release. The concept of
microdialysis involves the use of a probe with a semi-permeable membrane at the tip that is inserted
into tissue or fluid of interest and continually perfused with a cerebrospinal fluid substitute solution.
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The probe membrane acts as an endogenous membrane whereby molecules diffuse across the
membrane and down their concentration gradient.
In our studies, a microdialysis probe secured to a stereotaxic frame was inserted into the lumbosacral
spinal cord of an anaesthetised male rat. For microdialysis, the probe was connected to a lOpl
Hamilton syringe via polyethylene tubing and mounted on a perfusion pump set at an infusion rate of
lOpl / min. The probe outlet tube was placed in a sterile eppendorf for sample collection.
We also used push-pull perfusion in our studies to extract extracellular fluid from the lumbosacral
spinal cord. Conceptually, push-pull perfusion is similar to microdialysis, however, the probe does
not contain a semi-permeable membrane and acts simply as a conduit for delivering perfusion fluid
into extracellular space and removing extracellular fluid at the same rate. Thus, the limit on peptide
uptake is much less restrictive than microdialysis and so allows the total amount neuropeptide in the
extracellular fluid sample to be assayed. With push-pull perfusion, larger volumes of perfusate can be
delivered and extracted from the area of interest. Thus, push-pull perfusion may allow extraction of
samples with higher oxytocin concentrations that can be detected when assaying. Because push-pull
perfusion extracts cells present in the extracellular space, the collected sample will contain those
extracellular constituents in addition to oxytocin molecules, such as most amino acids and degradation
enzymes. So it may be that the "purity" of collected sample is reduced when compared with
microdialysis samples and the oxytocin present in the sample may be degraded by the enzymes also in
the sample. However, by adding a preventative agent such as HC1 should help to reduce the actions of
the endogenous biodegradors.
Reagents
1. Artificial cerebrospinal fluid (ACSF) (pH 7.3-7.4): For 500ml volume, add 4.03g NaCl, 0.134g
KC1, 0.39g NaHCOj, 0.035g Na2HP04, 0.09g CaCl2, 0.120gMgCl2 and 0.065gurea (all Sigma,
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UK) to 500ml dH20. Osmolality was measured using an osmometer and adjusted to 300m osmol
kg'/HaO"1.
2. 4% Paraformaldehyde in 0.1 M PB
3. Toluidine blue: lOmg toluidine blue powder (Sigma, UK) and lOOmg sodium borate (Sigma, UK)
in 100ml dH20.
4. Acetic acid fixative: 10 ml formaldehyde (40%) (Sigma, UK) and 5ml glacial acetic acid (BDH,
UK) in 85ml absolute ethanol.
2.11.2 Protocolfor measuring oxytocin release
Rats were anaesthetised as described before and the dissection of the spinal cord and cannulation of
the femoral vein were performed as previously described.
The rat was mounted in a stereotaxic frame. Stereotaxic ear bars were replaced with a 2ml syringe
attached to a blunted 16G needle which would provide anchorage for the lumbosacral vertebae. The
rat was placed on its ventral surface and each 16G needle was used to anchor each side of the LI
vertebra in the stereotaxic frame, this aided in exposing the L4-L6 region of spinal cord. Once fixed
and secured, a plastic vial (approximately 5cm x 2cm x 2cm) was placed under the metal shaft of each
blunted needle to provide additional support and to maintain the elevation of the spinal cord (Figure
2.14). This set up also helped to reduce movement of the lumbosacral spinal cord during breathing.
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Figure 2.14: Technical set-up for push-pull perfusion. The LI vertebra was anchored each side to a
16G needle. A supporting plastic vial was then placed under the metal shaft of each needle to help in
elevating the spinal cord. Once elevated, the "window" exposing the L4-L6 spinal cord located in the
junction between the T13 and LI becomes widened allowing for more accurate insertions of the
probe.
Additionally, a warmed paper blanket was wrapped around the rat and contained an opening round the
thoracic cavity thus allowing the rat to breathe more freely and to reduce breathing-induced movement
of the spinal cord. In order to avoid breathing difficulties and mucus accumulation in the throat, the
head and neck of the rat was held at slight elevation. A microdialysis probe with the membrane
removed was used for push-pull perfusion collection of extracellular fluid i.s. The push-pull probe
was clamped in the probe holder of the stereotaxic frame and the inlet tube of the probe was connected
to a tubing adaptor attached to fluorinated ethylene propylene tubing (FEP) (50 cm in length, diameter
0.12mm, CMA Microdilaysis, Linton Instrumentation, UK). The FEP tubing was then fitted to a 1ml
Hamilton syringe filled with ACSF warmed to 37°C in the perfusion pump via another tubing adaptor.
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The outlet tube of the probe was connected to FEP tubing (25cm in length, diameter 0.12mm) via a
tubing adapter and then to larger FEP tubing (42cm in length, diameter 0.8mm, CMA microdialysis,
Linton Instrumentation, UK) within the peristaltic pump (Figure 2.15). The probe was carefully
lowered into the same lumbosacral site as previously described, once the probe was visibly adsorbed
by the spinal cord tissue (approximately 1mm), the two pumps were started simultaneously to
commence the equilibration period. The collecting tube was held continually in dry ice to freeze the
sample as soon as possible. Samples were collected in dry ice in a sterile eppendorf containing 3%
0.2M HC1 to help prevent the activity of endogenous degrading enzymes. Samples were then stored
at -20° until processed by radioimmunoassay.
The injection site was carefully observed and monitored to ensure there was no fluid leakage and to
avoid air bubbles entering the tubing. After an initial 30 min equilibration period, two baseline
samples were collected and after injection of 250pg/kg apomorphine (or vehicle, saline + 0.1%
ascorbic acid) at 90 min, three 30 min analyte samples were collected thereafter (Figure 2.16).
Since the dynamics of tissue and ACSF fluid are different, flow rates may change, Thus, the infusion
pump (push) and peristaltic pump (pull) were calibrated twice before the start of each experiment; (1)
prior to insertion of probe into the spinal cord and (2) after insertion of the probe into the spinal cord
during the 30 min equilibration time. The probe was placed in either ACSF (1) or spinal cord tissue
(2). The "push" pump was set at 10-11 pl/min and the "pull" pump was set at a speed of 0.55 arbitary
units. Measuring the weight of an eppendorf (determined gravi-metrically) before and after a 10 min
sample collection period allowed an approximate calculation of the flow rate per min. In these
experiments a flow rate of lOpl/min was used for a 30 min sample period sample to produce a sample
volume
of 300pl.
After use, the probe and tubing were flushed with saline (30pl/min) and then distilled water
(30pl/min) for 15 min each to dissolve any small blood clots surrounding the probe and to flush out
any remaining ACSF within the tubing thus preventing microbial growth.
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At the end of the experiment, the spinal cord segment containing the injection site and tissue
approximately 2mm above and below the injection site was dissected out and placed in 4%
paraformaldehyde for 48-72 hours before being cut on a cryostat at 30pm and stained with toludine
blue to locate the site of injection as described previously.
(42cm, 60(jI total volume)
Figure 2.15: A push-pull probe, inserted into the lumbosacral spinal cord, is attached to a separate
"push" and "pull" pump via FEP tubing. The area of interest is perfused with ACSF at set flow rates
to generate a collecting sample of 300pl/min.
The total volume capacity for all tubing was 69pl of perfusion fluid. Thus at a flow rate of lOpl / min,
it took approximately 7 min for the fluid to travel from the "push" pump to the "pull" pump and then
to the collecting eppendorf. From the spinal cord to the collecting eppendorf it took approximately
6min and 18 sec (63pl), thus at the end of each 30 min sample a further 6 min 18 sec was allowed to
collect the fluid from that sample travelling from the spinal cord thus avoiding contamination of
samples (Figure 2.15). Thus, the time of i.v. injection of apomorphine or vehicle were calculated
accordingly to ensure correlation with precise timing of sample collection.
Breathing frequency was recorded at various intervals over the experimental time period: 60, 85, 95,
185, 195 min. Breathing frequency was monitored by observing the number of inspirations over 1
"push" pump (25cm, 3pl total
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Figure 2.16: Push-pull sample collection
i.v. injection of apomorphine
(250pg/kg) or vehicle (saline +
0.1% ascorbic acid)
I
0 30 60 90 120 150 180 mjn
11 1} UK tf fl fl
initial start baseline baseline analyte analyte analyte
ACSF sample one sample two sample sample sample
wash (1) (2) one two three
(3) (4) (5)
Sample collections: after the collection of two 30 min baseline samples,
drug or vehicle was injected at 90 min and three 30 min analyte
samples were subsequently collected.
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min at the time periods listed above. This was carried out because apomorphine can have adverse
effects on respiration and can act as a permanent cardiovascular depressant. Also there was some
slight movement around the probe injection site so it was important to know that any increase in
oxytocin concentrations were due to the effect of apomorphine and not local tissue damage.
Oxytocin radioimmunoassay
Oxytocin radioimmunoassay was performed by Rainer Landgraf (Max Planck Institute of Psychiatry,
Kraepelinstr.2, Munich) as described previously by Landgraf (1981). Briefly, perfusate samples were
lyophilised and suspended in assay buffer. Samples were the redissolved in acidifed distilled water
and then extracted using Chroprep Si60 (Merck, FRG). Sensitivity of the oxytocin radioimmunoassay
was 0.3pg / sample and cross-reactivity levels with other related neuropeptides was less than 0.7%.
Samples containing either perfusate or synthetic oxytocin were assayed at the same for validation.
2.12 General statistics
All data are presented as means ± SEM. The statistical tests applied for each experiment are detailed
in each individual chapter, however, in general terms; the following statistical analyses were
conducted. Analysis of all behavioural and neuronal activation data involved the use of either a Chi-
squared test, One Way ANOVA (followed by an appropriate Post-Hoc test) or unpaired Student's t-
test. For analysis of oxytocin release data, either an unpaired Student's t-test or One Way ANOVA
for repeated measures was applied. P values <0.05 were considered statistically significant.
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3.1 The Effect ofD2-like Receptor Ligands on Hypothalamic Oxytocin Neurons During Male Sexual
Behaviour
Modulation of central dopaminergic function and their subsequent effects on sexual behaviour by
relatively non-selective pharmacological tools such as the dopamine receptor agonist apomorphine
and the dopamine receptor antagonists clozapine and haloperidol are well documented. (Guiliano and
Allard for review, 2001; Brioni et al, 2004; Hsieh et al, 2004; Melis et al, 2005). Dl-like receptors
(Dl, D5) have been implicated in the control of penile erection, where D1 receptor agonists can elicit
spontaneous erections in conscious rats (D'Aquila et al, 2003) and D5 receptors seem to mediate the
rewarding aspects of consummatory behaviour such as intromissions (Kudwa et al, 2005). However,
it is the D2-like receptor (D2, D3, D4) studies that display the most convincing evidence and have an
established role in the regulation of male copulatory function. The D2-like dopaminergic receptor
agonists, Quinelorane (D2/D3 receptor agonist) and PD 168077 (selective D4 receptor agonist) have
long been shown to have facilitatory effects on penile erection (Foreman and hall, 1987; Eaton et al,
1991; Bazzett et al, 1991; Doherty and Wisler, 1994; Melis et al, 2005; Melis et al, 2006). Likewise,
the D2-like dopaminergic receptor antagonists, L-741,626 (D2 preferring receptor antagonist),
nafadotride (D3 preferring receptor antagonist) and L-745,870 (D4 preferring receptor antagonist) are
able to reduce the occurrence of various copulatory parameters in male rats such as ejaculation, penile
erection, mounting and intromitting behaviour (Clement et al, 2007; Melis et al, 2005; Melis et al,
2006; Millan et al, 2000; Stafford and Coote, 2006; Succu et al, 2007). The above dopamine receptor
ligands show comparatively greater selectively for the D2-like receptors than the conventional
pharmacological agents previously described.
3.1.1 Dopamine-oxytocin interactions
The precise D2-like dopamine receptor(s) and neural pathways activated by dopaminergic agents
during erectile function remain to be elucidated. Central serotonergic and cholinergic pathways have
been proposed to partly mediate the pro-erectile effects of dopamine agonists (Maeda et al, 1994;
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Stancampiano et al, 1994). However, central oxytocinergic pathways originating in the PVN, have
received greater attention, primarily due to fact that their central projections terminate in areas known
to be actively involved in sexual behaviour, namely, MPOA, VTA, amygdala and the spinal cord
(Condes-Lara et al, 2007; Kirchgessner et al, 1988; Longueville et al, 1999; Roeling et al, 1993). In
vitro studies using hypothalamic explants, have shown that dopamine and the antagonist, haloperidol,
can increase and decrease oxytocin release respectively. Additionally, in-vivo studies have shown that
intra-PVN, intracerebroventricular (i.c.v.) or peripheral administration of dopamine or the non¬
selective dopaminergic agonist, apomorphine, increases release of oxytocin into the blood and
hippocampus in rats and monkeys, an effect which occurs concomitantly with the expression of penile
erection (Argiolas, 1999; Cameron et al, 1992; Melis et al, 1990, 1992). However, it is not known if
dopamine acting in the MPN, SON or PVN can influence oxytocin neuron activity (and perhaps
oxytocin release) within the hypothalamus and if such an effect occurs in parallel with sexual
behaviour. It has recently been shown that during copulation there is increased oxytocin release
within the PVN (Waldherr and Neumann, 2007). Because we know that dopamine and oxytocin
action in the PVN can produce similar facilitatory effects on sexual behaviour, it seems plausible to
assume that dopamine may enhance oxytocin release in the PVN during the expression of copulatory
behaviour. Additionally, electrical stimulation of the PVN increases release of oxytocin in the nucleus
tractus solitarius (NTS) and the dorsal motor nucleus of the vagus nerve (DMV) (Landgraf et al, 1990)
implicating PVN oxytocin fibres in the mediation of autonomic functions which partly mediate penile
erecion. Two other oxytocin-containing brain nuclei that have been implicated in sexual behaviour
are the MPN and SON. However, the involvement of these oxytocin populations in the expression of
penile erection after dopamine agonist administration is not known.
3.1.2 Neuronal activation
Fos immunocytochemistry has proved to be an extremely powerful investigative tool when trying to
establish potential brain neural networks subserving behaviours, particularly sexual behaviour (Pfaus
and Heeb, 1997; Robertson et al, 1991). It allows mapping of functional neural networks (specific
localisation of anatomical structures expressing Fos due to a physiologic or behavioural stimuli) and
provides high cellular resolution. Fos (protein product of c-fos gene) expression is used as a marker
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for neuronal activation and can often be combined immunocytochemically to identify a range of
peptidergic neuronal phenotypes such as vasopressin and oxytocin. During intromission and
ejaculation, supraoptic oxytocin neurons are activated (Caquineau et al, 2006; Pattij et al, 2005) and
oxytocin-induced penile erection increases Fos expression in oxytocin neurons in the paraventicular
parvocellular (pPVN) oxytocin neurons (Kita et al, 2006). Additionally, masculine sexual behaviour
increases oxytocin neuronal activation in subregion-specific divisions of the pPVN (Witt and Insel,
1994). Regarding the MPN (part of MPOA), copulation-induced Fos expression has been shown
(Lumley and Hull, Balthazart and Ball, 2007); however, the neuronal phenotype expressing the Fos
protein is not known. Copulation-induced Fos expression in oxytocin neurons has not previously been
investigated in the MPN. Furthermore, regarding the MPN, SON and PVN, the effect of D2-like
dopaminergic ligands on sexual behaviour-induced Fos expression in these three hypothalamic nuclei
is unknown.
The PVN is one brain area in particular that is highly sensitive to the pro-erectile effects of
apomorphine so it is believed that oxytocin neurons in the PVN mediate the pro-erectile effects of
apomorphine. However, it is not known if oxytocin neurons in the MPN and SON also partly mediate
the pro-erectile effects of dopamine. Thus, the aim of this study was to replicate the facilitatory and
inhibitory effects of dopamine agonists and antagonists on male sexual behaviour as previously
reported and to investigate the effects of these pharmacological agents on hypothalamic oxytocin
neurons (in the MPN, SON and PVN). Therefore, our hypothesis was that D2-like agonists and
antagonists facilitate and reduce the incidence of penile erection in the conscious male rat,
respectively and do so via the activation and attenuation of oxytocin neuronal activity, respectively, in
the MPN, SON and PVN. To test this hypothesis, the study was comprised of two parts; (1) to
investigate oxytocin neuronal activation associated with D2-like agonist-induced penile erection and
(2) to examine the effect of intromission-induced oxytocin neuronal activation after dopamine
receptor blockade.
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3.2 Methods
3.2.1 Effects ofD2-like agonists on penile erection and the activation ofoxytocin neurons
3.2.1.1 Animals
Naive Sprague-Dawley male rats (200-250g) were used and maintained throughout on a 12:12h light
dark cycle (lights on from 07:00am to 7:00pm). Experiments were conducted between 1 lam and
2pm.
3.2.1.2 Drugs
D2/D3 agonist, Quinelorane (EC50 values: 0.7, 1.7, 7 nM for the D2, D3 and D4) or selective D4
agonist, PD 168077 (EC50 values: 5.6, >10,000, >10,000 for D4, D3, D2) (both Sigma, UK) were
dissolved in saline, diluted with distilled water and administered i.e.v. in a 2pl volume over 2 min. A
dose of lpg Quinelorane was administered as previously done by Bitran and colleagues (1989) for
erectile observations. At the time of this study, PD 168077 had not been injected i.c.v. according to
the literature. It had however, been injected unilaterally into the PVN (1 pig) (Melis et al, 2005), thus
an approximate estimation of 4.5pg was injected i.c.v. Interestingly, in a later published study, where
a dose-response curve was constructed, 5pg (i.c.v.) of PD 168077 was shown to be the submaximal
dose for generating erection episodes in conscious male rats (Melis et al, 2006).
3.2.1.3 Behavioural observations
After i.c.v. cannulation, rats were handled daily (as explained in General Methods). Two days after
surgery, rats were housed individually in Plexiglas cages (30cm x 30cm x 30cm) during observation
and recording of behaviour. Rats were injected with Quinelorane (lpg) (n=8), PD168077 (4.5pg)
(n=10) or vehicle (saline, 2pl) (n=8) via an i.c.v. injection cannula over 2 min. The injection cannula
was kept in place for a further 30 sec to allow diffusion and prevent backflow of the drug in to the
injection cannula. After drug injection, the number of stretching, yawning and penile erection
episodes were counted for 60 min. Penile erection was scored when the penis emerged from the
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penile sheath, accompanied by penile grooming and hip flexion. Additionally, any apparent changes
in motor function were also noted during the observation period.
3.2.1.4 Perfuse fixation and immunocytochemistry
Ninety min after drug administration, rats were terminally anaesthetised with sodium pentobarbitone
(i.p.) and perfused transcardially with 200 ml of 0.9% heparinised saline followed by 300 ml of 4%
paraformaldehyde in 0.1 M PB (pH 7.35-7.4) (as described in General Methods, section 2.6). Brains
were then removed and placed in post-fix solution (50% 4% paraformaldehyde and 50% 30% sucrose)
for 24 hr followed by immersion in 30% sucrose solution for 48-72 hr. Brain sections containing the
MPN, SON and PVN were sliced into 48pm coronal sections using a freezing microtome.
Fos and combined Fos and oxytocin immunocytochemistry was carried out using the ABC (avidin-
biotin peroxidase complex) method as explained in General Methods sections 2.7.1 - 2.7.3.
3.2.1.5 Immunocytochemistiy analysis
Fos
Using a light microscope (x25 magnification) and on coded slides, Fos-positive cells were counted as
those with black nuclear staining in the MPN, SON and PVN. For the MPN and SON, approximately
2-4 sections per rat were counted and area per section profile calculated. For the PVN, Fos-positive
cells were quantified in 4 sections per rat in the following PVN subdivisions; anterior parvocellular,
dorsal parvocellular, medial parvocellular, lateral parvocellular and posterior magnocellular. The
average per profile section was calculated and then summed together to give a value of the PVN as a
whole. All values were averaged per rat and then per group.
Fos and oxytocin co-localisation
For quantification of Fos and oxytocin cells, the counts were performed in each of the brain areas as
described above. In addition to Fos only counts, the total number of oxytocin cells and co-localised
oxyocin cells with Fos protein were quantified separately in the each of the three brain nuclei. The
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number of Fos-positive oxyocin cells were expressed as a percentage of Fos and oxytocin-expressing
cells divided by the total number of oxytocin cells.
3.2.1.6 Statistics
The incidence of penile erection was defined as the percentage of rats displaying one or more
erections during the 60 min observation period. Statistical evaluation was determined by Chi-squared
test with Yates correction where P<0.05 was considered significant. The mean number of penile
erections were analysed between groups using One Way ANOVA when the data was normally
distributed. When the data was not normally distributed, a One Way ANOVA on Ranks followed by
Dunn's multiple comparison test or Mann-Whitney rank sum test was performed. P values <0.05
were considered significant. Differences in the numbers of Fos-positive neurons or the percentage of
Fos-positive oxytocin cells were assessed for statistical significance across treatment groups by One
Way ANOVA and where necessary, post hoc Dunn's or Student-Newman-Keuls pairwise comparison
tests were applied. When the data was not normally distributed a Kruskal-Wallis One Way ANOVA
on Ranks test was perfomed. As above P values <0.05 were considered significant.
3.2.2 Effects ofD2-!ike antagonists on intromission and the activation ofoxytocin neurons
3.2.2.1 Animals
Male and female Sprague-Dawley rats (200-250g) were used and placed under reverse light cycle on a
12:12h dark light cycle (lights on 7:00pm to 07:00am). Experiments were conducted between 1 lam
and 2pm when female rats were sexually receptive and males were at their most sexually rigorous.
Sexually-experienced male rats were used to ensure they were capable of copulation on the day of the
experiment. On experiment day, females were screened by placing them with spare virgin males and
only those females who were highly receptive were used in the study.
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3.2.2.2 Drugs
The D2 antagonist, L-741, 626 (D2A), D3 antagonist, nafadotride (D3A) and D4 antagonist, L-745,
870 (D4A) were dissolved in DMSO (for L-741,626) and saline (for nafadotride and L-745,870) and
then diluted with saline. Each drug was injected i.e.v. in a 2pl volume over 2 min. Ki values are
shown in Table 3.1.
D2 receptor D3 receptor D4 receptor
D2A 2.4 100 220
D3A 5 0.52 269
D4A 960 2300 0.51
Table 3.1: Ki values (nM) for the D2A, D3A and D4A.
3.2.2.3 Behavioural observations
After i.c.v. cannulation rats were placed into individual cages and handled daily (as explained in
General Methods). Two days after surgery and on experiment day, each male rat was placed into a
transparent cage of a receptive female to allow observation and recording of behavior. Males were
placed in to the receptive female's cage to reduce the levels of stress (which would be increased if
placed in a novel environment i.e. an adult male's cage) endured by the female rat and thus make the
female more likely to mate with the male rat. This experimental protocol for sexual behavior studies
has been published before from our lab (Caquineau et al, 2006). Males were originally placed into
five different drug groups: vehicle (DMSO, n=14, control for L-741,626); D2 receptor antagonist (L-
741,626, n=9, lpg and n=12, 10pg); saline (n=12, control for nafadotride and L-745,870); D3
receptor antagonist (nafadotride, n=12, 5pg) and D4 receptor antagonist (L-745,870, n=18, 7pg). The
males were then randomly assigned to two separate groups: those placed alone in a novel environment
with no female or female cues (ALONE) and those placed with a receptive female and allowed to
intromit (I). The experiment was carried out on three consecutive weeks. It was soon apparent that
during the test period, some rats (vehicle- and drug-treated rats) displayed mounting but not
intromitting behavior. Thus, those rats that did not intromit in this study, comprised a non-
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intromiting (NI) group. Thus, for each drug treatment and corresponding vehicle group, there were
the following groups; ALONE, NI and I.
Drug injection was given (as described previously) 15 min prior to the male being placed with the
receptive female. Once placed in the cage with the female the following copulatory parameters were
recorded for 15 min; mount and intromission latency (ML and IL) and mount and intromission
frequency (MF and IF).
3.2.2.4 Perfuse fixation and imnmnocytochemistry
Perfusions, Fos and combined Fos and oxytocin immunocytochemistry and analysis were performed
as described in General Methods (and section 3.2.2.3).
3.2.2.5 Statistics
The incidence of mounting and intromitting was defined as the percentage of rats displaying one or
more mounts and intromissions during a 15 min observation period. Statistical evaluation was
determined by Chi-squared test with Yates correction where P<0.05 was considered significant. The
mean number of mounts and intromission and the frequency of mounts and intromissions were
analysed between groups using One Way ANOVA when the data was normally distributed. When the
data was not normally distributed, a One Way ANOVA on Ranks followed by Dunn's multiple
comparison test or Mann-Whitney rank sum test was performed. P values <0.05 were considered
significant. Differences in the numbers of Fos-positive neurons or the percentage of Fos-positive
oxytocin cells were assessed for statistical significance across treatment groups by One Way ANOVA
and where necessary, post hoc Dunn's or Student-Newman-Keuls pairwise comparison tests were
applied. When the data was not normally distributed a Kruskal-Wallis One Way ANOVA on Ranks
test was perfomed. As above P values <0.05 were considered significant.
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3.3 Results
3.3.1 Effects ofdopamine agonists on penile erection and neuronal activation in the MPN, SON and PVN.
3.3.1.1. Effects ofD2-like agonists on general behaviour
Rats receiving Quinelorane and PD168077 at the doses used did not exhibit any extrapyramidal side
effects such as those often associated with administration of dopaminergic agonists which may have
otherwise impaired their ability to achieve penile erection.
3.3.1.2. Effects ofD2-like agonists on penile erection
Quinelorane (lpg) or PD168077 (4.5pg) given to sexually-experienced male rats (i.c.v), elicited
significant increases in the incidence (expressed as a percentage) of penile erection (Figure 3.1 A) (Chi-
squared test with Yates correction, P<0.005; P<0.05 vs vehicle) compared to vehicle-treated rats, which
did not exhibit any penile erection episodes. Interestingly, 2/7, 6/8 and 2/10 rats exhibited yawning
behaviour (not shown) and 3/7, 6/8 and 4/10 exhibited stretching behaviour (not shown) after vehicle,
Quinelorane and PD 168077, respectively. Quinelorane but not PD 168077 also significantly increased the
mean number of erections per rat (Figure 3.IB) (One-way ANOVA on Ranks followed by Dunn's
multiple comparison test, P<0.05).
3.3.1.3. Effects ofD2-like agonists on Fos expression
MPN
Photomicrographs in Figure 3.2A illustrate Fos expression in the MPN after i.c.v. administration of
Vehicle, Quinelorane and PD 168077. When quantified (Figure 3.2B), neither Quinelorane or PD 168077




Figure 3.1: Effects of Quinelorane and PD 168077 on penile erection















































Effect of Quinelorane (Q, n=8, 1 jug) and PD-168077 (PD, n=10, 4.5 gg) on the
incidence (%) of penile erection (A) and mean number of penile erections per rat (B).
Male rats were observed for 60 min to quantify penile erection episodes. Values are
the group means ± SEM. Q and PD significantly increased the % of rats exhibiting
penile erection compared to V (Chi-sqaure test with Yates correction , *P<0.05;
**P=0.005 vs V). Q but not PD significantly increased the mean number of penile
erections per rat compared to V (One-way ANOVA on Ranks followed by Dunn's
multiple comparison test, *P<0.05).
Figure 3.2: Effects of Quinelorane and PD168077 on Fos expression in the MPN
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Effects of Vehicle (V, n=7, 2pl), Quinelorane (Q, n=8, lpg) and PD168077 (PD,
n=10, 4.5pg) on Fos expression in the MPN. V, Q and PD-induced Fos expression
in the MPN are illustrated in the photomicrographs in 3.2A. The dotted line shows
the area comprising the MPN. Values are the group means ± SEM. In Figure 3.2B,
neither Q or PD had any significant effect on Fos expression in the MPN (One Way
ANOVA) compared to V. Arrows indicate Fos-positive nuclei. Scale bars
represent 100pm. 3v=third ventricle.
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Photomicrographs in Figure 3.3A show Fos expression in the SON after i.c.v administration of Vehicle,
Quinelorane and PD168077. Upon quantification (Figure 3.3B), neither Quinelorane or PD168077
significantly increased the number of Fos-positive nuclei in the SON compared to Vehicle (Kruskal-
Wallis One Way ANOVA on Ranks).
PVN
Photomicrographs in Figure 3.4A show Fos expression in the PVN after i.c.v administration of Vehicle,
Quinelorane and PD168077. Quinelorane but not PD168077 induced significant Fos expression in the
parvocellular PVN (pPVN) (One-Way ANOVA followed by Dunnetf s multiple comparison test,
*P=0.05, Figure 3.4B) but not the magnocellular PVN (mPVN) compared to the corresponding Vehicle.
PVN subdivisions
Photomicrographs in Figure 3.5A illustrate Fos expression in the medial parvocellular subdivision of the
PVN after i.c.v. administration of Vehicle or Quinelorane. Quinelorane but not PD 168077 significantly
increased Fos expression in the medial parvocellular subregion of the PVN One-Way ANOVA followed
by Dunnetf s multiple comparison test, *P<0.05) compared to Vehicle (Figure 3.5B). No effects were
seen in any of the other PVN subdivisions after drug/vehicle administration.
3.3.1.4. Effects ofD2-like agonists on Fos expression in oxytocin neurons
MPN
Photomicrographs in Figure 3.6A show Fos expression in oxytocin neurons in the MPN after i.c.v.
administration of Vehicle, Quinelorane and PD168077. Quinelorane and PD168077 did not have any
significant effect on Fos expression in oxytocin neurons in the MPN (Kruskal-Wallis One Way ANOVA
on Ranks) compared to Vehicle (Figure 3.6B).
SCW
Photomicrographs in Figure 3.7A show Fos expression in oxytocin neurons in the SON. after i.c.v.
administration of Vehicle, Quinelorane and PD168077. Quinelorane and PD168077 did not have any
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Effects of Vehicle (V, n=7, 2pl), Quinelorane (Q, n=8, lpg) and PD168077 (PD,
n=10, 4.5pg) on Fos expression in the SON. V, Q and PD-induced Fos expression
in the SON are illustrated in the photomicrographs in Figure 3.3A. Values are the
group means ± SEM. As seen in Figure 3.3B, neither Q or PD had any significant
effect on Fos expression in the SON (Kruskal-Wallis One Way ANOVA on Ranks)
compared to V. Arrows indicate Fos-positive nuclei. Scale bars represent 50pm.
OX=optic chiasm.

























g parvocellular PVN (pPVN)
U magnocellular PVN (mPVN)
Q PD
Drug Treatment
Effects of Vehicle (V, n=7, 2pl), Quinelorane (Q, n=8, lpg) and PD168077 (PD, n=10,
4.5pg) on Fos expression in the PVN. V, Q and PD-induced Fos expression in the PVN
are illustrated in the photomicrographs in Figure 4.4A. Values are the group means ±
SEM. As seen in Figure 4.4B Q but not PD significantly increased Fos expression in the
pPVN (One-way ANOVA followed by Dunnett's multiple comparison test, *P=0.05)
compared to V. No differences in Fos expression were observed between Q, PD and V
in the mPVN. Arrows indicate Fos-positive nuclei. Scale bars represent 100pm.
3v=third ventricle; dp=dorsal parvocellular; mp=medial parvocellular; pm=posterior
magnocellular.
Figure 3.5: Effects of Quinelorane and PD168077 on Fos expression in the
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Subdivisions of the PVN
Effects of Vehicle (V, n=7, 2|rl) and Quinelorane (Q, n=8, l^g) on Fos expression in the
subdivisions of the PVN. V and Q-induced Fos expression in the medial parvocelllular (mp)
subregion of the PVN are illustrated in the photomicrographs in Figure 3.5A. Values are the
group means ± SEM. As seen in Figure 5.3B Q but not PD significantly increased Fos
expression in the the mp subdivision of the PVN (One-way ANOVA followed by Dunnett's
multiple comparison test, *P<0.05) compared to V. No differences in Fos expression were
observed between treatment groups in any of the other PVN subdivisions. Scale bars
represent 100pm. 3v=third ventricle; ap=anterior parvocellular; dp=dorsal parvocellular;
mp=medial parvocellular; lp=lateral parvocellular; pm=posterior magnocellular.
Figure 3.6: Effects of Quinelorane and PD168077 on Fos expression in















Effects of Vehicle (V, n=7, 2pl), Quinelorane (Q, n=8, lpg) and PD168077 (PD, n=10,
4.5pg) on Fos expression in oxytocin neurons in the MPN. V, Q and PD-induced Fos
expression in the MPN are illustrated in the photomicrographs in Figure 3.6A. The dotted
line shows the area comprising the MPN. Values are the group means ± SEM. As seen in
Figure 3.6B, Neither Q or PD had any significant effect on Fos expression in oxytocin
neurons in the MPN (Kruskal-Wallis One Way ANOVA on Ranks) compared to V. Scale
bars represent 100pm and 50pm in I, 111, V and II, IV, VI respectively. Arrows show a
Fos-positive oxytocin cell and arrowheads illustrate a Fos-negative oxytocin cell. 3v=third
ventricle.
Figure 3.7: Effects of Quinelorane and PD168077 on Fos expression in


























Effects of Vehicle (V, n=7, 2pl), Quinelorane (Q, n=8, lpg) and PD168077 (PD, n=10,
4.5gg) on Fos expression in the SON. V, Q and PD-induced Fos expression in the SON are
illustrated in the photomicrographs in Figure 3.7A. Values are the group means ± SEM.
As seen in Figure 3.7B, neither Q or PD had any significant effect on Fos expression in
oxytocin neurons in the SON (One Way ANOVA) compared to V. Scale bars represent
100pm. Arrows shows Fos-positive oxytocin cells and arrowheads illustrate Fos-negative
oxytocin cells. OX=optic chiasm.
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effect on Fos expression in oxytocin neurons in the SON (One Way ANOVA) compared to Vehicle
(Figure 3.7B).
PVN
Photomicrographs in Figure 3.8A and 3.9A show Fos expression in oxytocin neurons in the PVN after
i.c.v. administration of Vehicle, Quinelorane and PD168077. As seen with the Fos only results,
Quinelorane but not PD168077 significantly increased the percentage of Fos-positive oxytocin cells
expressed in the pPVN (One-way ANOVA followed by Dunnett's multiple comparison test, P=0.05) but
had no effect in the mPVN compared to Vehicle (Figure 3.8B).
P VN subdivisions
As seen in Figure 3.9A and 3.9B, Quinelorane but not PD168077 significantly increased the percentage of
Fos-positive oxytocin cells expressed in the medial parvocellular (mp) subdivision of the PVN (One-way
ANOVA followed by Dunnett's multiple comparison test, P=0.001) compared to Vehicle. No differences
between the drug groups were seen in any of the other PVN subregions.
3.3.2 Effects ofD2-like antagonists on intromission and neuronal activation in the MPN, SON and PVN.
3.3.2.1 Effects ofD2-like antagonists on general behaviour
At the doses used, no apparent impairments in motricity or gait, often associated with administering high
concentrations of dopamine antagonists, were observed in rats treated with D2A, D3A and D4A (data not
shown).
3.3.2.2 Effects ofD2-like antagonists on the incidence of intromission
Sexually-experienced male rats treated with D2A (lpg or lOpg), D3A (5pg), D4A (7gg) or the
corresponding vehicle (DMSO or saline) (all i.c.v.) displayed mounting and intromitting behaviour during
the 15 min test period. Such behaviour was shown as the incidence (expressed as the percentage) of
mounting and intromitting. Only those rats displaying one or more mounts and only those displaying one
or more intromissions were included in statistical analysis. Those rats receiving the D2A (lpg or 10pg)
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Figure 3.8: Effects of Quinelorane and PD168077 on Fos expression in













□ parvocellular PVN (pPVN)




Effects of Vehicle (V, n=7, 2pl), Quinelorane (Q, n=8, 1 pig) and PD168077 (PD, n=10, 4.5pig) on
Fos expression in the PVN. V, Q and PD-induced Fos expression in the PVN are illustrated in the
photomicrographs in Figure 3.8A. Values are the group means ± SEM. As seen in Figure 3.9B, Q
but not PD significantly increased Fos expression in the pPVN (One-way ANOVA followed by
Dunnett's multiple comparison test, *P=0.05) compared to V. No differences in Fos expression
were observed between Q, PD and V in the mPVN. Scale bars in I, III, V and II, IV, VI represent
100pm and 50pm respectively. Arrows shows Fos-positive oxytocin cells and arrowheads illustrate
Fos-negative oxytocin cells 3v=third ventricle.
Figure 3.9: Effects of Quinelorane and PD168077 on Fos expression in
^ oxytocin neurons in the subdivisions of the PVN
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□ Quinelorane (D2-like agonist)




Effects ofVehicle (V, n=7, 2^1), Quinelorane (Q, n=8, l^g) and PD168077 (PD, n=10, 4.5|j.g)
on Fos expression in the subdivisions of the PVN. V and Q-induced Fos expression in the
medial parvocelllular (mp) subregion of the PVN are illustrated in the photomicrographs in
Figure 3.9A. Values are the group means ± SEM. As seen in Figure 3.9B, Q but not PD
significantly increased Fos expression in the the mp subdivision of the PVN (One-way ANOVA
followed by Dunnett's multiple comparison test, *P=0.001) compared to V. No differences in
Fos expression were observed between treatment groups in any of the other PVN subdivisions.
Scale bars in I, III and II, IV represent 100pm and 50pm respectively. Arrows shows Fos-
positive oxytocin cells and arrowheads illustrate Fos-negative oxytocin cells 3v=third ventricle;
ap=anterior parvocellular; dp=dorsal parvocellular; mp=lateral parvocellular; lp=lateral
parvocellular.
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did not show any significant deficits in mounting or intromitting behaviour (Figure 3.1 OA). Likewise, the
D3A did not significantly affect mounting behaviour, however, the D3A did reduce the incidence of
intromitting behaviour which was almost significant (Chi-squared test with Yates correction, P=0.09)
(Figure 3.1 OB). The D4A did not affect the incidence of mounting, however, it did significantly decrease
the incidence of intromission (Chi-squared test with Yates correction, P<0.05) (Figure 3.IOC).
3.3.2.3 Effects ofD2-like antagonists on mount and intromission latencies
Those rats who did not mount or intromit within the 15 min observation period were assigned a value of
900 sees and excluded from statistical analysis. Neither the D2A (lpg or lOpg), D3A (5pg) or D4A (7pg)
had any significant effects on intromission latency (Mann-Whitney Rank Sum test) (Figure 3.11A-C) in
those males displaying intromitting behaviour. Interestingly, the D4A but not the D2A or D3A
significantly increased the latency to mount in those males displaying mounting behaviour (Mann-
Whitney Rank Sum test, P<0.05) (Figure 3.11C). Latency graphs A-C in Figure 3.11 show a
representative bar chart for each treatment group.
3.3.2.4 Effects D2-like antagonists on mount and intromission frequencies
Those rats who did not mount or intromit within the 15 min observation period were assigned a value of
zero and excluded from statistical analysis. Neither the D2A (lpg or lOpg), D3A (5pg) or D4A (7pg) had
any significant effects on mount or intromission frequency in those males exhibiting mounting and
intromitting behaviour, respectively (One-way ANOVA or Student's t-test) (Figure 3.12).
3.3.2.5. Effects ofD2-like antagonists on Fos expression
MPN
Photomicrographs shown in Figures 3.13A and 3.14A show Fos expression in the MPN after i.e.v.
injection of the D2A (lpg or lOpg), D3A (5pg) or D4A (7pg) respectively of intromitting (I) males. The























The effect of L-741,626 (D2A low, 1 pg, n= 10 and D2A high, 1 Opg, n= 12) (3.1 OA),
nafadotride (D3A, 5pg, n=12) (3.10B), L-745,870 (D4A, 7pg, n=18) (3.10C) and the
corresponding vehicle (DMSO, n=14 or saline, n=12) on the incidence (%) of mounts and
intromissions in male rats placed with receptive females during 15 min observation period.
Values are the group means ± SEM. Neither the D2A, D3 A or D4A had any effect on the
incidence of mounting. The D4A but not the D2A or D3 A significantly decreased the
incidence of intromission (Chi-square test with Yates correction, *P<0.05).















































The effect of L-741,626 (D2A low, 1 jag, n=10 and D2A high, lOgg, n=12) (3.11 A), nafadotride (D3A,
5(ig, n=12) (3.1 IB), L-745,870 (D4A, 7^tg, n=18) (3.11C) and the corresponding vehicle (DMSO,
n=14 or saline, n=12) on mount and intromission latencies (ML and IL). Those rats that did not mount
or intromit during the 15 min experimental time period were assigned a value of 900 sees and excluded
from statistical analysis. Values are the group means ± SEM. The D4A but not the D2A or D3A
significantly increased ML (Mann-Whitney Rank Sum test, *P<0.05). Neither the D2A, D3A or D4A






































The effect of L-741,626 (D2A low, lpg, n=10 and D2A high, lOpg, n=12) (3.12A),
nafadotride (D3A, 5pg, n=l2) (3.12B), L-745,870 (D4A, 7pg, n=18) (3.12C) and the
corresponding vehicle (DMSO, n=14 or saline, n=12) on mount and intromission frequencies
(MF and IF, respectively). Those rats that did not mount or intromit during the 15 min
experimental time period were assigned a value of zero sees and excluded from statistical
analysis. Values are the group means ± SEM. Neither the D2A, D3 A or D4A had any effect
on MF and IF (One Way ANOVA or Student's t-test).
Figure 3.13: Effects of D2A on Fos expression in the MPN
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lv; ,-;-j v '; < ■ v" ■ • ' ."
l.v : - .: •••••• 1- > ... '
i* ... v-vr.-.v:'■I . . • " • • • * ' r\ • . - . ,4 a >; ?3v 'v;. ■ f
T ;V
1































The effect of L-741,626 (D2A low, lpg and D2A high, 10(ug) and the corresponding vehicle
(DMSO, n=6) on Fos expression in the MPN of those males placed alone (ALONE), those
who did not intromit (NI) and those who did intromit (I). Photomicrographs in Figure 3.13A
show the effect of DMSO, D2A low and D2A high on Fos expression in the MPN of I males.
Values are the group means ± SEM. As seen in Figure 3.13B, neither dose of the D2A (D2A
low=Tpg, n=3 and D2A high=10pg, n=6) had any significant effect on Fos expression in the
MPN of I males (One Way ANOVA) compared to vehicel (DMSO, n=6). No effect between
treatment groups was seen in the ALONE and NI males. Black arrows indicate Fos-positive
nuclei. Scale bars represent 200pm . 3v=third ventricle.
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The effect of nafadotride (D3A 5(ag), L-745,870 (D4A 7 (ug) and the corresponding vehicle
(saline) on Fos expression in the MPN of those males placed alone (ALONE), those who did
not intromit (Nl) and those who did intromit (I). Photomicrographs in Figure 3.14A show the
effect of saline, D3A and D4A on Fos expression in the MPN of I males. Values are the group
means ± SEM. The D3A (n=5) but not the D4A (5) significantly decreased the Fos expression
in the MPN of I males (Student's t-test, P<0.01) compared to vehicle (saline, n=9) (Figure
3.14B, 3.14C). Black arrows indicate Fos-positive nuclei. No effect between treatment groups
was seen in the ALONE and Nl males. Scale bars represent 100pm. 3v=third ventricle.
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nuclei in the MPN of I male rats (Student's t-test, P<0.01) (Figure 3.13B and 3.14B) compared to Vehicle
(DMSO or saline). No differences were detected between treatment groups in the males placed alone
(ALONE) or those who did not intromit (NI).
SON
Photomicrographs shown in Figures 3.15A and 3.16A show Fos expression in the SON of intromitting (I)
males, after i.e.v. injection of the D2A (lpg or lOpg), D3A (5pg) or D4A (7pg) respectively. The D3A
but not the D2A (D2A low or D2A high) or D4A (n=5) significantly decreased the number of Fos-positive
nuclei in the SON of I males (Student's t-test, P<0.05) compared to Vehicle (Figure 3.15B and 3.16B).
No differences were detected between treatment groups in the males placed alone (ALONE) or those who
did not intromit (NI).
PVN
Photomicrographs shown in Figures 3.17A and 3.18A show Fos expression in the whole pPVN of
intromitting (I) males, after i.c.v. injection of the D2A (lpg or lOpg), D3A (5pg) or D4A (7pg)
respectively, of intromitting (I) males. The D3A but not the D2A (D2A low or D2A high) or D4A
significantly decreased the number of Fos-positive nuclei in the pPVN of I male rats (Student's t-test,
P<0.05) compared to vehicle (DMSO, n=6 or saline, n=9) (Figure 3.17B and3.18B). No differences were
detected between treatment groups in the males placed alone (ALONE) or those who did not intromit (NI).
P VN subdivisions
Figure 3.19 displays Fos expression in the individual subregions of the pPVN after i.c.v. injection of the
D2A (lpg or lOpg) in intromitting rats only. The high dose (lOpg, n=6) but not the low dose (lpg, n=3)
of the D2A significantly increased the number of Fos-positive nuclei in the anterior parvocellular
subdivision of the PVN of I males (One-way ANOVA followed by Dunnett's multiple comparison test;
*P<0.05) compared to vehicle (DMSO, n=6). No other treatment effects were observed in any of the
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The effect of L-741,626 (D2A low, 1 jug and D2A high, lOpg) and the corresponding vehicle
(DMSO) on Fos expression in the SON of those males placed alone (ALONE), those who did
not intromit (NI) and those who did intromit (I). Photomicrographs in Figure 3.15A show the
effect of DMSO, D2A low and D2A high on Fos expression in the SON of I males. Values are
the group means ± SEM. Neither dose of the D2A (D2A low=lpg, n=3 and D2A high=10pg,
n=6) had any significant effect on Fos expression in the SON of I males (One Way ANOVA)
compared to vehicel(DMSO, n=6) (Figure 3.15B). No effect between treatment groups was
seen in the ALONE and NI males. Black arrows indicate Fos-positive nuclei. Scale bars
represent 100pm . OX=optic chiasm.
Figure 3.16: Effects of D3A and D4A on Fos expression in the SON
A
saline D3A D4A
(saline) on Fos expression in the SON of those males placed alone (ALONE), those who did
not intromit (NI) and those who did intromit (I). Photomicrographs in Figure 3.16A show the
effect of saline, D3 A and D4A on Fos expression in the SON of I males. Values are the group
means ± SEM. The D3A (n=5) but not the D4A (n=5) significantly decreased the Fos
expression in the SON of I males (Student's t-test, P<0.05) compared to vehicle (saline, n=9)
(Figure 3.16B, 3.16C). Black arrows indicate Fos-positive nuclei. No significant effect
between treatment groups was seen in the ALONE and NI males. Scale bars represent 100pm.
OX=optic chiasm.
Figure 3.17: Effects of D2A on Fos expression in the whole pPVN



























The effect of L-741,626 (D2A low, lpg and D2A high, lOpg) and the corresponding vehicle
(DMSO) on Fos expression in the PVN of those males placed alone (ALONE), those who did
not intromit (NI) and those who did intromit (I). Photomicrographs in Figure 3.17A show the
effect of DMSO, D2A low and D2A high on Fos expression in the anterior PVN of I males.
Values are the group means ± SEM. Neither dose of the D2A (D2A low=lpg, n=3 and D2A
high=10pg, n=6) had any significant effect on Fos expression in the PVN of 1 males (One
Way ANOVA) compared to vehicle (DMSO, n=6) (Figure 13.7B). No effect between
treatment groups was seen in the ALONE and NI males. Black arrows indicate Fos-positive
nuclei. Scale bars represent 100pm . 3v=third ventricle.
Figure 3.18: Effects of D3A and D4A on Fos expression in the PVN
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The effect of nafadotride (D3A 5pg), L-745,870 (D4A 7 fj.g) and the corresponding vehicle
(saline) on Fos expression in the PVN of those males placed alone (ALONE), those who did
not intromit (Nl) and those who did intromit (I). Photomicrographs in Figure 3.18A show the
effect of saline, D3A and D4A on Fos expression in the PVN of I males. Values are the group
means ± SEM. The D3A (n=5) but not the D4A (n=5) significantly decreased Fos expression
in the pPVN of 1 males (Student's t-test, P<0.05) compared to vehicle (saline, n=9) (Figure
3.18B, 3.18C). No effect between treatment groups was seen in the ALONE and Nl males.
Black arrows indicate Fos-positive nuclei. Scale bars represent 200pm. 3v=third ventricle.





























ap dp mp Ip
The effect of L-741,626 (D2A low, 1 pg and D2A high, 1 Opg) and the corresponding vehicle
(DMSO) on Fos expression in the subdivisions of the PVN of intromitting (I) males. Values
are the group means ± SEM. The high dose (lOpg, n=6) but not the low dose (lpg, n=3) of
the D2A significantly increased the number of Fos-positive nuclei in the ap subdivision of
the PVN of I males (One-way ANOVA followed by Dunnetf s multiple comparison test;
*P<0.05) compared to vehicle (DMSO, n=6). No other treatment effects were observed in
any of the other subregions. ap=anterior parvocellular; dp=dorsal parvocellular; mp=medial
parvocellular; lp=lateral parvocellular.
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other subregions. No differences were observed in ALONE and NI rats after D2A, D3A or D4A (data not
shown).
Photomicrographs in Figure 3.20A illustrate Fos expression in the dorsal and medial parvocellular
subdivisions of the pPVN after i.c.v. injection of the D3A (5pg) or vehicle (saline) in intromitting (I)
males. The D3A but not the D4A significantly inhibited the number of Fos-positive nuclei expressed in
the dorsal and medial parvocellular subregions of the pPVN in I males (Student's t-test; *P<0.05)
compared to vehicle (saline, n=9) (Figure 3.20B). Additionally, the antagonistic effect of the D3A in the
lateral parvocellular subregion was almost significant (Student's t-test, P=0.07). No treatment effect was
observed in the anterior parvocellular subregion. The D4A had no effect on Fos expression in any of the
subregions. Additionally, no differences in Fos expression in ALONE and NI rats after D2A, D3A or
D4A were observed (data not shown).
mPVN
Graphs displayed in Figure 3.21 show Fos expression in the mPVN after i.c.v. injection of the D2A (lpg
or lOpg), D3A (5pg) or D4A (7pg) respectively, in intromitting (I) males. Neither the D2A (D2A low,
n=3 or D2A high, n=6), D3A (n=5) or D4A (n=5) had any significant effect on Fos expression in the
mPVN of I males (One Way ANOVA or Student's t-test) compared to corresponding vehicle (DMSO,
n=6 or saline, n=9). No differences were detected between treatment groups in the males placed alone
(ALONE) or those who did not intromit (NI).
3.3.2.6 Effects ofD2-like antagonists on Fos expression in oxytocin neurons
MPN
Photomicrographs shown in Figures 3.22 (A,B), 3.23 (A,B) and 3.24 (A,B) show Fos expression in
oxytocin neurons in the MPN after i.c.v. injection of the D2A (lpg or lOpg), D3A (5pg) or D4A (7pg),
respectively, of intromitting (I) males. Neither D2A (D2A low or D2A high) (Figure 3.22C), D3A (Figure
102













































ap dp mp Ip
The effect of nafadotride (D3A 5pg), L-745,870 (D4A 7 jag) and the corresponding vehicle
(saline) on Fos expression in the subdivisions of the PVN of intromiting (I) males.
Photomicrographs in Figure 3.20A show the effect of saline and D3A on Fos expression in the
dorsal and medial pPVN. Values are the group means ± SEM. The D3A (n=5) but not the
D4A (n=5) significantly decreased Fos expression in the dorsal and medial pPVN of I males
(Student's t-test, P<0.05) compared to vehicle (saline, n=9) (Figure 3.20B, 3.20C). No effect
between treatment groups was seen in the other subdivisions. Scale bars represent 200pm.
3v=third ventricle; ap=anterior parvocellular; dp=dorsal parvocellular; mp=medial
parvocellular; lp=lateral parvocellular.














































































The effect of L-741,626 (D2A low, 1 \xg and D2A high, lOgg) (3.20A), nafadotride
(D3A 5gg, n=5) (3.20B), L-745,870 (D4A 7 gg, n=5) (3.20C) and the corresponding
vehicle (DMSO or saline) on Fos expression in the mPVN of those males placed alone
(ALONE), those who did not intromit (Nl) and those who did intromit (I). Values are
the group means ± SEM. Neither the D2A (D2A low, n=3 or D2A high,n=6) D3 A
(n=5)or D4A (n=5) had any significant effect on Fos expression in the mPVN of I
males (One Way ANOVA or Student's t-test) compared to corresponding vehicle
(DMSO, n=6 or saline, n=9). No effect between treatment groups was seen in the
ALONE and Nl males.
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The effect of L-741,626 (D2A low, lpg and D2A high, lOpg) and the corresponding vehicle
(DMSO) on Fos expression in oxytocin cells in the MPN of those males placed alone
(ALONE), those who did not intromit (NI) and those who did intromit (I). Photomicrographs
in Figure 3.22A and 3.22B (magnification of highlighted areas in 3.22A) show the effect of
DMSO, D2A low and D2A high on Fos expression in oxytocin cells in the MPN of 1 males.
Values are the group means ± SEM. Neither dose of the D2A (D2A low=lpg, n=3 and D2A
high=10pg, n=6) had any significant effect on Fos expression in oxytocin cells in the MPN of
I males (One Way ANOVA) compared to vehicle (DMSO, n=6) (Figure 3.22C). Filled
arrows show a Fos-positive oxytocin cell and empty arrows show a Fos-negative oxytocin
cell. No effect between treatment groups was seen in the ALONE and NI males. Scale bars
represent 200pm and 50pm in 3.22A and B respectively. AC=anterior commissure; 3v=third
ventricle.





















The effect of nafadotride (D3A , 5pg) and the corresponding vehicle (saline) on Fos
expression in oxytocin cells in the MPN of those males placed alone (ALONE), those who did
not intromit (NI) and those who did intromit (I). Photomicrographs in Figure 3.23A and
3.23B (magnification of highlighted areas in 3.23A) show the effect of saline and D3A on Fos
expression in oxytocin cells in the MPN of 1 males. Values are the group means ± SEM. The
D3A (n=5) did not significantly decrease the percentage of Fos-positive oxytocin cells in the
MPN of I males (Student's t-test) compared to vehicle (saline, n=5) (Figure 3.23C). Filled
arrows show a Fos-positive oxytocin cell and empty arrows show a Fos-negative oxytocin
cell. No effect between treatment groups was seen in the ALONE and Nl males. Scale bars
represent 200pm and 50pm in 3.23A and B respectively. AC=anterior commissure; 3v=third
ventricle.
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The effect of L-745, 870 (D4A , 7pg) and the corresponding vehicle (saline) on Fos expression
in oxytocin cells in the MPN of those males placed alone (ALONE), those who did not
intromit (NI) and those who did intromit (I). Photomicrographs in Figure 3.24A and 3.24B
(magnification of highlighted areas in 3.23A) show the effect of saline and D4A on Fos
expression in oxytocin cells in the MPN of I males. Values are the group means ± SEM. The
D4A (n=5) did not significantly decrease the percentage of Fos-positive oxytocin cells in the
MPN of I males (Student's t-test) compared to vehicle (saline, n=9) (Figure 3.23C). Filled
arrows show a Fos-positive oxytocin cell and empty arrows show a Fos-negative oxytocin
cell. No effect between treatment groups was seen in the ALONE and NI males. Scale bars
represent 200pm and 50pm in 3.24A and B respectively. AC=anterior commissure; 3v=third
ventricle.
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3.23C) or D4A (Figure 3.24C) significantly decreased the percentage of Fos-positive oxyocin cells
expressed in the MPN of intromitting (I) males (One Way ANOVA or Student's t-test) compared to
vehicle (DMSO, n=6 or saline, n=9). No differences were detected between treatment groups in the males
placed alone (ALONE) or those who did not intromit (NI).
SON
Photomicrographs shown in Figures 3.25A and 3.26A show Fos expression in oxytocin neurons in the
SON after i.c.v. injection of the D2A (lpg or lOpg), D3A (5pg) or D4A (7pg) respectively of intromitting
(I) males. The D4A (Figure 3.26C) but not the D2A (D2A low or D2A high) (Figure 3.25B) or D3A
(Figure 3.26B) significantly decreased the percentage of Fos-positive oxytocin cells expressed in the SON
of I males (Student's t-test, P<0.05) compared to vehicle (DMSO, n=6 or saline, n=9). No differences
were detected between treatment groups in the males placed alone (ALONE) or those who did not intromit
(NI).
PVN
Photomicrographs shown in Figures 3.27, 3.28 and 3.29 (A-B) show Fos expression in oxytocin neurons
in the PVN after i.c.v. injection of the D2A (lpg or lOpg), D3A (5pg) or D4A (7pg) respectively of
intromitting (I) males. Neither the D2A (D2A low or D2A high) (Figure 3.27C), D3A (Figure 3.28C) or
D4A (Figure 3.29C) had any significant effect on the percentage of Fos-positive oxytocin cells expressed
in the pPVN of I males (One Way ANOVA or Student's t-test) compared to vehicle (DMSO or saline).
No differences were detected between treatment groups in the males placed alone (ALONE) or those who
did not intromit (NI).
PVN subdivisions
Figure 3.30 displays the percentage of Fos-positive oxytocin cells in the individual subregions of the
pPVN after i.c.v. injection D2A (lpg or lOpg) (Figure 3.30A), D3A (5pg) (Figure 3.30B) or D4A (7pg)
(Figure 3.30C) respectively of intromitting (I) males. Neither the D2A (D2A low or D2A high), D3A or
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Figure 3.25: Effect of the D2A on Fos expression in oxytocin neurons in the
SON
A
DMSO D2A low D2A high
B
The effect of L-741,626 (D2A low, lpg and D2A high, lOpg) and the corresponding vehicle
(DMSO) on Fos expression in oxytocin cells in the SON of those males placed alone
(ALONE), those who did not intromit (NI) and those who did intromit (1). Photomicrographs
in Figure 3.25A show the effect of DMSO, D2A low and D2A high on Fos expression in
oxytocin cells in the SON of I males. Values are the group means ± SEM. Neither dose of the
D2A (D2A low=lpg, n=3 and D2A high=10pg, n=6) had any significant effect on Fos
expression in oxytocin cells in the SON of I males (One Way ANOVA) compared to vehicle
(DMSO, n=6) (Figure 3.25B). Filled arrows show a Fos-positive oxytocin cell and empty
arrows show a Fos-negative oxytocin cell. No effect between treatment groups was seen in
the ALONE and NI males. Scale bars represent 100pm OX=optic chiasm.
Figure 3.26: Effect of the D3A and D4A on Fos expression in oxytocin
neurons in the SON
saline D3A D4A
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The effect of nafadotride (D3A, 5fag) and L-745, 870 (D4A , 7pg) and the corresponding
vehicle (saline) on Fos expression in oxytocin cells in the SON of those males placed alone
(ALONE), those who did not intromit (Nl) and those who did intromit (I). Photomicrographs
in Figure 3.26A show the effect of saline, D3A and D4A on Fos expression in oxytocin cells
in the SON of I males. Values are the group means ± SEM. The D4A (n=5) but D3A (n=5)
significantly decreased the percentage of Fos-positive oxytocin cells expressed in the SON
(Student's t-test, *P<0.05)of I) males compared to vehicle (saline, n=9) (Figure 3.26 B and
3.26C). Filled arrows show a Fos-positive oxytocin cell and empty arrows show a Fos-
negative oxytocin cell. No effect between treatment groups was seen in the ALONE and Nl
males. Scale bars represent 100pm OX=optic chiasm.
Figure 3.27: Effect of the D2A on Fos expression in oxytocin neurons in the
pPVN






















The effect of L-741,626 (D2A low, 1 jug and D2A high, lOpg) and the corresponding vehicle
(DMSO) on Fos expression in oxytocin cells in the pPVN of those males placed alone
(ALONE), those who did not intromit (Nl) and those who did intromit (I). Photomicrographs
in Figure 3.27A and 3.27B (magnification of highlighted areas in 3.27A) show the effect of
DMSO, D2A low and D2A high on Fos expression in oxytocin cells in the pPVN of I males.
Values are the group means ± SEM. Neither dose of the D2A (D2A low=l pg, n=3and D2A
high=10pg, n=6) had any significant effect on Fos expression in oxytocin cells in the pPVN of
I males (One Way ANOVA) compared to vehicle (DMSO, n=6) (Figure 3.27C). Filled
arrows show a Fos-positive oxytocin cell and empty arrows show a Fos-negative oxytocin
cell. No effect between treatment groups was seen in the ALONE and Nl males. Scale bars
represent 200pm and 50pm in 3.27A and B respectively. 3v=third ventricle.
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The effect of nafadotride (D3A , 5pg) and the corresponding vehicle (saline) on Fos
expression in oxytocin cells in the pPVN of those males placed alone (ALONE), those who
did not intromit (NI) and those who did intromit (I). Photomicrographs in Figure 3.28A and
3.28B (magnification of highlighted areas in 3.28A) show the effect of saline and D3A on Fos
expression in oxytocin cells in the pPVN of I males. Values are the group means ± SEM. The
D3A (n=5) did not significantly decrease the percentage of Fos-positive oxytocin cells
expressed in the pPVN of I males (Student's t-test) compared to vehicle (saline, n=9) (Figure
3.28C). Filled arrows show a Fos-positive oxytocin cell and empty arrows show a Fos-
negative oxytocin cell. No effect between treatment groups was seen in the ALONE and NI
males. Scale bars represent 200pm and 50pm in 3.28A and 3.28B respectively. 3v=third
ventricle.





■I.; - r*'-- - r • 5.V .. .
fiyti -'-Ji *-*S —v •• _ tfcjviSi.
• i " ~ ' ...
. - -J1- -
3v
. ■ 3v -®ML< V "
■
?2'-- ■























The effect of L-745, 870 (D4A , 7pg) and the corresponding vehicle (saline) on Fos expression
in oxytocin cells in the pPVN of those males placed alone (ALONE), those who did not
intromit (NI) and those who did intromit (I). Photomicrographs in Figure 3.29A and 3.29B
(magnification of highlighted areas in 3.29A) show the effect of saline and D4A on Fos
expression in oxytocin cells in the pPVN of 1 males. Values are the group means ± SEM. The
D4A (n=5) did not significantly decrease the percentage of Fos-positive oxytocin cells
expressed in the pPVN of I males (Student's t-test) compared to vehicle (saline, n=9) (Figure
3.29C). Filled arrows show a Fos-positive oxytocin cell and empty arrows show a Fos-
negative oxytocin cell. No effect between treatment groups was seen in the ALONE and NI
males. Scale bars represent 200pm and 50pm in 3.29A and B respectively. 3v=third
ventricle.
Figure 3.30: Effect of the D2A. D3A and D4A on Fos expression in



































































































The effect of L-741,626 (D2A low, ljxg and D2A high, 10)ug) (3.30A), nafadotride (D3A
5pig) (3.30B), L-745,870 (D4A 7 pg) (3.30C) and the corresponding vehicle (DMSO or
saline) on Fos expression in oxytocin cells in the subdivisions of the PVN of those males
those who intromitted(I). Values are the group means ± SEM. Neither the D2A (D2A low,
n=3 or D2A high, n=6), D3A (n=5) or D4A (n=5) had any significant effect on Fos
expression in oxytocin cells in the subdivisions of the PVN of I males (One Way ANOVA
or Student's t-test) compared to corresponding vehicle (DMSO, n=6 or saline, n=9). No
effect between treatment groups was seen in the ALONE and NI males, (data not shown).
3v=third ventricle; ap=anterior parvocellular; dp=dorsal parvocellular; mp=medial
parvocellular; ip=lateral parvocellular.
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D4A had any significant effect on Fos expression in oxytocin cells in any of the subdivisions of the PVN
of I males (One Way ANOVA or Student's t-test) compared to corresponding vehicle (DMSO or saline).
No differences were detected between treatment groups in the males placed alone (ALONE) or those who
did not intromit (NI) (data not shown).
mPVN
Figure 3.31 displays the percentage of Fos-positive oxytocin cells in the mPVN after i.c.v. injection D2A
(1 pg or lOpg), D3A (5pg) or D4A (7pg) respectively of intromitting (I) males. Neither the D2A (D2A
low or D2A high) (Figure 3.31A), D3A (Figure 3.31B) or D4A (Figure 3.31C) had any significant effect
on Fos expression in oxytocin cells in the mPVN of 1 males (One Way ANOVA or Student's t-test)
compared to corresponding vehicle (DMSO or saline). No differences were detected between treatment
groups in the males placed alone (ALONE) or those who did not intromit (NI).
104
Figure 3.31: Effect of the D2A, D3A and D4A on Fos expression in














































































The effect of L-741,626 (D2A low, 1 jj.g and D2A high, 10|ig) (3.31 A), nafadotride
(D3A 5|ag) (3.31B), L-745,870 (D4A 7 ng) (3.31C) and the corresponding vehicle
(DMSO or saline) on Fos expression in oxytocin cells in the mPVN of those males
those who intromit ted(I). Values are the group means ± SEM. Neither the D2A (D2A
low, n=3 or D2A high, n=6), D3A (n=5) or D4A (n=5) had any significant effect on Fos
expression in oxytocin cells in the mPVN of I males (One Way ANOVA or Student's t-
test) compared to corresponding vehicle (DMSO, n=6 or saline, n=9). No effect
between treatment groups was seen in the ALONE and Nl males.
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Chapter 3
3.4 Discussion
3.4.1 Effects ofD2-Iike ligands on penile erection
3.4.1.1 Effects ofD2-like agonists on penile erection
Both Quinelorane and PD168077 were potent stimulators of penile erection in naive conscious male
rats. Those rats receiving the dopaminergic agonists did not display any stereotypic side-effects often
associated with application of high doses of dopaminergic agents which include excessive sniffing,
gnawing, frequent head bobbing and a locomotor stimulant response. Thus, the enhancement of
penile erection episodes observed in this study was primarily due to the actions of dopaminergic
agents on central erectile pathways and not due to adverse effects on those controlling locomotion.
3.4.1.2 Quinelorane (D2/D3 agonist) andpenile erection
Quinelorane, a D2/D3 receptor agonist, was particularly effective in eliciting penile erection in the
male rats. Quinelorane was chosen because it has been shown to have facilitative effects on rat
copulatory behaviour (Foreman & Hall, 1987) and penile erections in rhesus monkeys (Pomerantz,
1991). When given into the PVN (Eaton et al, 1991), MPOA (and paired with physiological levels of
testosterone) (Bazzett et al, 1991) or subcutaneously (Doherty et al, 1994), Quinelorane strongly
induces penile erections and decreases the latency to the first penile erection (Eaton et al, 1991).
Quinelorane has also been known to have a biphasic effect with low to moderate doses (lpg)
facilitating penile erection and high doses (lOpg) inhibiting erectile function and facilitating seminal
emission in the supine male rat (Bitran et al, 1989; Eaton et al, 1991). Thus, in this study, a lpg dose
of Quinelorane was given i.c.v to examine the effects on penile erection in the isolated conscious male
rat.
Consistent with previous studies, Quinelorane showed clear pro-erectile effects in conscious male rats
by increasing the percentage number of rats exhibiting erections and also the mean number of
erections per rat. Additionally, Quinelorane was equally effective in eliciting stretching/yawning
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behaviour in 80-90% of the rats. Such an effect has been previously reported (Docherty and Wisler,
1994) and can be attributed to the relative non-selectivity of Quinelorane at the D2/D3 receptors.
However, it is unclear as to which receptor (D2 and/or D3) mediates the pro-erectile effects of
Quinelorane. It is believed that this dual behavioural effect is due to activation of D2 receptors in the
stimulation of penile erection and activation of D3 receptors in eliciting stretching/yawning.
However, it has proved very difficult to establish an in vivo model that will discriminate between D2
and D3 receptor-mediated activities, primarily due to the lack of commercially available highly
selective D2-like receptor agonists. Quinelorane-induced penile erection and yawning are inhibited
by the D2-preferring antagonist, haloperidol (Docherty and Wisler, 1994) and several D3-preferring
receptor antagonists (Collins et al, 2005). Additionally, the D3 receptor agonist, 7-OH-DPAT can
also facilitate penile erection (Ferrari and Giuliani, 1995). Thus, it seems that both receptors have a
modulatory role at least, in mediating penile erection and stretching/yawning, although it is not clear
whether there is reciprocal or sequential involvement of D2 and D3 receptors. Interestingly, it is
understood that in any population of hypothalamic D2-like receptors, the D2 receptor type is more
abundantly expressed than D3 and D4 receptors (Khan et al, 1998). Thus perhaps proportionately,
more D2 receptors will be activated compared to D3 or D4 receptors. So, we can speculate that the
pro-erectile effect of Quinelorane is likely to be due in part to preferential activation of central D2
receptors.
3.4.1.3 PD168077 (D4 agonist)
PD168077 is a highly selective D4 receptor agonist which acts as a partial agonist in-vitro (Gazi et al,
2000). PD 168077 has strong pro-erectile effects when given subcutaneously, i.c.v., or intra-PVN
(Hsieh et al, 2004; Melis et al, 2005; Melis et al, 2006). In this study, as expected, when given i.c.v.,
PD 168077 significantly increased the % of rats displaying erection as seen in previous studies (Hsieh
et al, 2004; Melis et al, 2006) and non-significantly increased the number of erections per rat
compared to vehicle. Only 60% of rats receiving PD168077 displayed penile erection, while other
studies found 80% of PD168077-treated rats showed erection (Hsieh et al, 2004), despite similar
doses being used. An explanation for this may be due to the different drug volumes applied (2pl in
our study versus 5pl in Hsieh et al, 2005) or alternatively due to the physical environment where the
106
Chapter 3.4: Dopamine ligands and penile erection - Discussion
observations were made. We did not see any spontaneous erections in the vehicle-treated group which
was surprising as the literature generally indicates that at least 10% of rats are expected to display
approximately 0.8-1 penile erection episode per rat within a 60 min observation period. However,
during our experiment, penile erection episodes were observed under a normal light cycle (lights on
07:00am-7:00pm), approximately 4 hours in to the light period, as opposed to during the dark period
as seen by Hsieh and colleagues. It is well known that rats will generally only display copulatory
behaviour during the second phase of the dark period. Therefore, our vehicle-treated and perhaps
drug-treated rats may have elicited more erectile episodes if placed in the dark prior to and during the
test period.
3.4.1.4. Effects ofD2-like antagonists on intromission
D2A
Rats receiving the dopaminergic antagonists did not show any apparent deficits in sniffing, gnawing
or locomotor behaviours. Thus, the reduction in the expression of penile erection episodes observed
in this study was primarily due to the actions of dopaminergic agents partly blocking central erectile
pathways and not due to adverse effects on those controlling locomotor behaviour.
We investigated the effects of the D2-like antagonists, L-741,626 (D2A), nafadotride (D3A) and L-
745,870 (D4A) on intromission in males placed with receptive females. During copulation, neither
dose of the D2A (lpg and lOpg) sufficiently inhibited intromitting behaviour. Both a low and a high
dose of D2A were separately administered because previous studies have shown dopaminergic ligands
such as Quinelorane and apomorphine to have biphasic effects where they facilitate penile erection at
low doses and inhibit penile erection at high doses (Bitran et al, 1989; Eaton et al, 1991; Hull et al,
1992). Thus, to pharmacologically confirm this, we gave low and high doses of the D2A to see if they
could inhibit and facilitate penile erection, respectively. Unfortunately, only 6/14 rats in the
corresponding vehicle-treated group (isotonic saline with DMSO comprising 20% of overall volume)
for the D2A displayed intromission which was unexpectedly low, as normally approximately 80% of
rats in the control group should display full copulatory behaviour. This impairment in copulatory
behaviour after central administration of compounds containing DMSO has been reported once before
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by Bitner and colleagues (2006). They administered PD168077 dissolved in 100% DMSO and found
that none of their PD168077-treated rats displayed any penile erection (Bitner et al, 2006). The reason
for this remains unclear; however, it seems logical to assume that DMSO may somehow interrupt
central neural pathways and/or intracellular signalling pathways that mediate penile erection. This
may be due to general cellular toxicity effects of DMSO or it may be a behaviourally-specific effect
(eg. penile erection). Conversely, other studies that have used DMSO to dissolve their drug have
shown no apparent detrimental effects in regard to the pro-erectile activity of the drug (Melis et al,
2005; Melis et al, 2006; Succu et al, 2007). However, the experimental design was different in these
studies since Melis and colleagues studied penile erection in conscious isolated males. Perhaps,
DMSO interferes with social and olfactory cues which would affect the male when pairing with a
receptive female (as opposed to affecting a socially isolated male) and therefore impact on sexual
arousal. This seems unlikely however, as all vehicle-treated and most of the D2A-treated males
displayed mounting behaviour and anogenital investigation. Therefore, perhaps it is the integration of
olfaction with the stimulation of central pathways that regulate sexual arousal that is affected by
DMSO.
Because the vehicle-treated rats performed poorly, this finding makes it very difficult to interpret the
effects of the D2A (both low and high doses) on intromission. With the low dose of D2A only 30% of
rats exhibited intromission whilst 50% (similar to vehicle) of rats were able to intromit with the high
dose of D2A, thus it is tempting to suggest that the D2A may act in biphasic manner. Further studies
are needed to confirm this.
DM
D3 receptors have recently been implicated in central control of ejaculation in anaesthetised rats
(Clement et al, 2007; Kitrey et al, 2007); however, it is not known if blockade of central D3 receptors
impacts on penile erection in males placed in a mating environment. Prior to this study and after an
extensive literature search, it was apparent that nafadotride had not been injected i.c.v. previously, so
it was unclear as to which dose to administer. From studies administering nafadotride i.p., an
approximate estimation of a central dose was calculated. Here, we showed that the D3A (nafadotride,
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5pg) inhibited the percentage of rats achieving intromission (which was almost significant), yet had
no effect on any other copulatory parameters. Thus, blockade of central D3 receptors appears to affect
the pro-erectile effects of endogenous dopamine. Expression of central D3 receptors is comparatively
scarce compared to D2 and D4 receptor expression. Thus, it seems unlikely that D3 receptors
primarily mediate penile erection induced by endogenous dopamine. However, it can be said that D3
receptors may play a minor role in the expression of erectile function.
D4A
Due to the recent (particularly since 2000) introduction of highly selective D4 receptor
pharmacological ligands, studies on the role of D4 receptors during penile erection have proved most
convincing (Melis et al, 2005; Melis et al, 2006; Succu et al, 2007). The effect of i.c.v. injection of
the D4A (L-745,870) on penile erection had not been published prior to this study, although it had
been administered unilaterally into the PVN at a dose of lpg. Thus, as with the D3A, an approximate
estimation of an i.c.v dose was calculated, which was slightly higher than that of the intra-PVN dose
in order to compensate for dilution of the D4A in the CSF and distribution to areas other than the three
hypothalamic nuclei of interest. In our study, the D4A (L-745,870, 7pg) proved to be the most
effective of the three antagonists used in inhibiting intromission and also increased the length of time
for mounting behaviour to be displayed. This increase in mount latency after D4A injection lightly
touches on a possible role for the D4 receptor in sexual arousal in the rat as recent evidence suggests
in humans (Ben Zion et al, 2006). The inhibitory effect of the D4A during copulation has not been
reported before. Here we show that whilst the D4A inhibited the incidence of intromission, it did not
affect intromission latency or frequency which suggests that D4 receptor activation is involved in the
initiation and achievement of penile erection. However, sexual events (eg. frequency of
intromissions, pelvic thrusting) occurring after penile erection may be modulated via other dopamine
receptors and/or additional direct/indirect pathways. Thus, central D4 receptors appear to be
important in mediating the effects of endogenous dopamine during penile erection in a physiologically
sexually exciting environment. Moreover, for the first time, these data tentatively indicate that central
D4 receptors may also be involved in the more appetitive phases of sexual behaviour.
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3.4.2 Effects ofD2-like ligands on neuronal activation in the MPN, SON and PVN
It has been shown that dopaminergic ligands acting on hypothalamic nuclei can alter oxytocin release
(Bridges et al, 1976) and so it has been suggested that dopaminergic agonists and antagonists that
facilitate and inhibit penile erection, respectively, may do so via acting on hypothalamic oxytocin
neurons (Melis et al, 1989a, 1989b, 1990). As the SON, PVN, and to a lesser extent the MPN, are
rich in oxytocin, and Fos is an accepted marker of neuronal activation, we performed single Fos and
double Fos and oxytocin immunocytochemistry in rats treated with a range of pharmacological tools
that can mimic or block the effects of endogenous dopamine.
3.4.2.1 Effects ofQuinelorane and PD168077 on neuronal activation
Rats receiving Quinelorane (D2/D3 receptor agonist) but not PD 168077 (D4 receptor agonist) showed
increased Fos expression in the pPVN (particularly the medial parvocellular subdivision) but neither
drug had any effect in the MPN, SON or mPVN. Likewise, Quinelorane but not PD168077 increased
the percentage of oxytocin cells expressing Fos in the pPVN (particularly the medial parvocellular
subdivision), indiating that D2/D3 receptor stimulation activates parvocellular oxytocin neurons. The
apparent lack of effect on magnocellular oxytocin neurons may be unexpected, since Quinelorane has
been shown to act on mPVN neurons to stimulate peripheral release of oxytocin in male rhesus
monkeys (Amico et al, 1993). However, here we show that during penile erection, Quinelorane
selectively activates parvocellular oxytocin neurons. The pPVN is comprised of different subregions,
these include: anterior, dosal, medial and lateral parvocellular subdivisions (ap, dp, mp and lp).
Oxytocin neurons in some of these regions (namely, the dorsal, medial and lateral parvocellular
regions) project to the spinal cord (Hallbeck et al, 2001; Swanson & Sawchenko, 1980; Wagner et al,
1993), and synapse onto parasympathetic nuclei in the lumbosacral spinal cord to stimulate autonomic
functions such as penile erection in males (Veronneau-Longueville et al, 1999; Tang et al, 1998) and
uterine contractions in the female rat (Benoussaidh et al, 2005). It has been suggested there might be
a pPVN subregion(s) specifically activated during male sexual behaviour. The lateral parvocellular
oxytocin cells have been shown to be activated in copulating male rats (Witt and Insel, 1994).
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Additionally, penile neuronal nitric oxide synthase (PnNOS), a stimulatory protein required for
erection, was found to be expressed in the medial parvocellular regions of the PVN (Ferrini et al,
2003); although it is not known if pnNOS was found to be co-localised with oxytocin.
3.4.2.2 Quinelorane and oxytocin neuronal activation
We show that medial parvocellular oxytocin neurons are activated by Quinelorane (almost significant
effects were observed in the lateral parvocellular region too, P=0.08) which adds to some previous
studies implicating the selective involvement of pPVN regions in the mediation of penile erection
(Kita et al, 2006; Witt and Insel, 1994). Kita and colleagues previously showed that the dorsal, medial
and lateral parvocellular subregions which all project to the spinal cord, were shown to be activated
during penile erection after i.c.v injection of oxytocin (Kita et al, 2006). It is of interest that although
the Quinelorane-treated rats expressed more penile erection episodes, they also displayed greater
yawning behaviour when compared with vehicle-treated rats. Yawning and penile erection have both
been shown to involve activation of medial parvocellular oxytocin neurons (Kita et al, 2006), thus it is
not entirely clear if the increased activation is associated with yawning and/or penile erection. It does
appear to be partly due to penile erection as when superficially comparing those vehicle- and
Quinelorane-treated males displaying yawning behaviour only, no significant differences in
oxytocinergic activation were observed. Because dopaminergic agents like Quinelorane are potent
inducers of stretching-yawning behaviour as well as penile erection (such stretching-yawning effects
have not previously be seen with PD168077), care had to be exercised when examining Fos induction
after Quinelorane and PD168077 administration. After quantifying stretching-yawning-induced Fos
expression only, after each drug treatment, it could be seen that there were no significant differences
between vehicle, Quinelorane and PD168077 (although "n" numbers were very low, approximately 1-
3) (data not shown). However, when comparing Fos expression with vehicle -treated rats that
exhibited stretching-yawning but not penile erection with Quinelorane-treated rats that expressed
stretching-yawning and penile erection, significant differences in Fos expression were observed (no
significance was observed in PD168077-treated rats). Thus, the significant induction of Fos
expression in Quinelorane-treated rats compared to vehicle-treated rats is primarily due to the pro-
erectile effects of Quinelorane and not the accompanying stretching-yawning effects. Another
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possible reason as to why we saw an increased expression of Fos-positive oxytocin cells in the medial
parvocellular area in particular is that this subregion of the PVN receives a significantly dense
dopaminergic innervation compared to the other subregions of the pPVN (Swanson et al, 1981).
Thus, with such an anatomical arrangement it seems logical to assume that the medial parvocellular
oxytocin cells play some role in mediating the pro-erectile effects of Quinelorane.
Therefore, we speculate that medial (and perhaps lateral) parvocellular oxytocin neurons originating
in the PVN and projecting to the spinal cord, mediate the pro-erectile effect of Quinelorane. It is has
been demonstrated, that descending paraventriculospinal oxytocin pathways may have more of a
modulatory rather than primary role in the control of penile erection. Indeed, paraventricular lesions
destroying descending projections significantly reduced apomorphine and oxytocin-induced penile
responses (Argiolas et al, 1987). However, it has also been demonstrated that selective chemical
lesions of the parvocellular neurons do not significantly affect copulation but can reduce seminal plug
weights (Ackerman et al 1997), increase the latency and reduce the number of non-contact erections
(NCE) (Liu et al, 1997). Thus, overall copulatory function is not significantly impaired and only
selected parameters specific to penile erection seem to be affected. In the lesion studies, the apparent
lack of effect on copulation could be attributed to increased peripheral involvement and / or the
presence of genital stimulation during coitus which may subsequently overcome the spinal oxytocin
deficits induced by PVN lesions.
Thus, it seems spinally-projecting oxytocinergic fibres may primarily have a permissive role in penile
erection and perhaps a relatively minor role in copulation. During penile erection, it seems likely that
other key central neuromodulators have an equally important role. Dopaminergic agonists acting in
the lumbosacral spinal cord have also been shown to have a strong facilitative effects on penile
erection (Guiliano et al, 2001) and spinally-projecting serotonergic fibres may also contribute to
central control of penile erection (Bancila et al, 1999) and facilitate ejaculatory parameters (Stafford et
al, 2006). Thus, it would appear that achievement of penile erection is a summative effect of
activation of multiple neural substrates including central dopaminergic, oxytocinergic and
serotonergic pathways.
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3.4.2.3 PDJ68077 and oxytocin neuronal activation
Although the D4 receptor agonist, PD 168077 was clearly pro-erectile, it was not as potent as the
D2/D3 receptor agonist, Quinelorane, and did not appear to have any significant effect on Fos or
combined Fos and oxytocin expression in the MPN, SON or PVN. This was surprising as PD168077
has previously been shown to induce Fos expression in the PVN (Bitner et al, 2006). However, that
study did not record penile erection and the neuronal phenotype expressing Fos protein was not
reported (Bitner et al, 2006). Additionally, different routes of administration were applied
(subcutaneous versus i.c.v. in our study) which could also have affected the outcome of the results. It
is apparent that PD 168077 elicits penile erection in the conscious rat but not via hypothalamic
oxytocin neurons, suggesting D4 receptor activation stimulates alternative or indirect pathways.
These findings are based on administration of single doses, ideally full dose response curves should be
constructed to further confirm the effects of Quinelorane and PD 168077 on the activation of oxytocin
neurons.
One such pathway may involve hypothalamic GABAergic fibres which may serve as a potential
indirect pathway in the expression of penile erection. It is known that a complex cellular hierarchy
exists in the SON and PVN whereby oxytocin neurons are heavily modulated by inhibitory
GABAergic and excitatory glutamatergic neurons which themselves can be influenced by a range of
synaptic inputs and neurotransmitters. GABAergic and glutamatergic neurons synapse with
magnocellular oxytocin soma and dendrites in the PVN and SON whereas dopaminergic innervation
of these nuclei is comparatively scarce (Jourdain et al, 1999). Thus, it seems reasonable to assume
that endogenous dopamine could exert it's effect on oxytocin release by acting indirectly via
glutamatergic and/or GABAergic neurons rather than via oxytocin neurons directly. Evidence for an
intermediary role for GABA includes that intra-PVN injection of muscimol, the GABAa receptor
agonist, inhibits apomorphine- and oxytocin-induced penile erections (Melis and Argiolas, 2002). In
particular, the D4 receptor has been implicated in the disinhibition of GABAergic and inhibition of
glutamatergic neurotransmission in the SON by acting presynaptically (Price and Pittman, 2001;
Azdad et al, 2003). Although, it is unclear as to which system would predominate under physiological
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conditions. It could be speculated that dopamine-induced inhibition of GABAergic and glutamatergic
neurons would somehow increase the responsiveness of the postsynaptic cell, conferring on it a
greater sensitivity, free to respond to other excitatory factors such as oxytocin. So, it could be that
during penile erection, dopamine acts presynaptically to disinhibit oxytocin neurons and so facilitate
the activation of the hypothalamic oxytocinergic system.
From the present study, it appears that the D2/D3-preferring agonist, Quinelorane, is a potent inducer
of penile erection and may stimulate penile erection by acting on pPVN oxytocin cells but not those in
the MPN and SON. Very little is known regarding the role of the SON during sexual behaviour.
Supraoptic oxytocin cells have been implicated in intromission and ejaculation (Caquineau at al,
2006; Pattij et al, 2005). In the penile erection study, we looked at the effects of a dopamine agonist
on penile erection only in sexually naive male rats placed individually in cages in a male only
experimental room and there were no females rats present. Thus, our males had not intromitted or
ejaculated and had not even been exposed to female oestrus cues which may explain the lack of effect
on magnocellular oxytocin neurons. Perhaps a stronger environmental and/or physiological stimulus
is required for dopamine agonists to activate magnocellular oxytocin cells or perhaps these neurons
are only activated upon intromission and ejaculation.
Likewise, even less is known regarding oxytocin cells in the MPN in the sexual behaviour context.
The MPN is part of the MPOA, in addition to being highly sensitive to the dopaminergic agonist,
apomorphine, it is fundamentally important in the control of male copulatory function (Paredes and
Agmo, 2004 for review). However, to our knowledge, there are no data examining the effect of
dopaminergic agonists on oxytocin neurons within the MPN during penile erection in the rat. Here,
we show that penile erection elicited by Quinelorane and PD168077 does not involve the activation of
MPN oxytocin cells, suggesting that dopamine-receptor mediated penile erection in the MPN is
mediated via another neuronal phenotype(s). Alternatively, the MPN is not a particularly important
integration site for dopamine-mediated penile erection yet crucial for dopamine-mediated copulation
as previously reported.
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Thus, both Quinelorane and PD168077 have a facilitatory effect on erectile function in the conscious
male rat. Only Quinelorane, however, appeared to significantly activate oxytocin neurons in pPVN
and was without effect in the MPN, SON and mPVN. Therefore it could be postulated that activation
of D2-like receptors stimulates penile erection via acting on oxytocinergic pathways, dependent upon
the receptor subtype and selected neuronal populations in specific hypothalamic nuclei. However,
non-oxytocinergic pathways cannot be ruled out.
3.4.2.4 Effects ofD2-like antagonists on intromission-induced neuronal activation
D2A and oxytocin neuronal activation
The D2A (both lpg and lOpg) did not affect Fos or double labelled Fos and oxytocin expression in
the MPN, SON or PVN during intromission, suggesting that hypothalamic oxytocin neurons do not
mediate D2-receptor mediated penile erection in a sexually exciting environment. As previously
stated, the D2A data must be interpreted with caution due to the unexpectedly low number of control
males displaying mounting and intromitting behaviour. The low dose of the D2A had a marginally
inhibitory effect in the MPN, SON and PVN but the high dose of the D2A did not have any significant
effect in any of the three brain nuclei. However, a significant increase in Fos expression after the high
dose of D2A was seen in the anterior parvocellular subdivision of the pPVN. The reason for this is
unclear, but perhaps at such high doses the D2A is acting at dopamine autoreceptors and so acts to
increase dopamine concentrations in the synaptic cleft. Or as with the biphasic effects of the agonists,
apomorphine and Quinelorane, the D2A also has a biphasic effect with high doses facilitating penile
erection. This is unlikely however, as all rats in the D2A groups displayed poor copulatory
performance, possibly due to DMSO as discussed earlier. Finally, it is known that the D2-preferring
antagonist, haloperidol induces c-fos mRNA and Fos protein expression in the striatum and nucleus
accumbens, however, this was not observed in a sexual behaviour context (Nguyen et al, 1992; Rogue
and Vincendon, 1992). This Fos inducing effect has not been shown for L-741,626, however, it may
help to explain the lack of an effect of the low dose of D2A on intromission-induced Fos and
combined Fos and oxytocin expression.
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D3A and oxytocin neuronal activation
The most surprising finding of this study was the ability of the D3A (nafadotride) to inhibit
intromission-induced Fos expression in the MPN, SON and PVN, yet it did not significantly inhibit
the percentage of oxytocin cells expressing Fos in these three nuclei. For the first time, we have
shown that the D3A inhibits certain copulatory parameters in conscious male rats, however, it does
not appear to act through the hypothalamic oxytocinergic system but via other unknown hypothalamic
neuronal phenotype(s). With oxytocin as the exception, very little is known regarding the intra-
hypothalamic neural circuitries that facilitate male sexual behaviour. The MPN, SON and PVN are
nuclei that are separately involved in many various and specific neuroendocrine-mediated behaviours
and so each express a heterogenous cellular population. Thus, in our study it is very difficult to
postulate which particular cell phenotype(s) within the nuclei displayed attenuated Fos expression
after administration of the D3A. In the MPN gonadal steroid-dependent galanin and GnRH neurons
have both been implicated in the regulation of sexual behaviour and could serve as potential target
neurons for endogenous dopamine (Dennison et al, 1996; Bloch et al, 1993; Bloch et al, 1998). In the
PVN, NMDA and the melanocortin, a-MSH, are both believed to enhance consummatory aspects of
male sexual behaviour (Caquineau et al, 2006; Giuliano 2004; Melis et al, 1994; Melis et al, 2004).
Flowever, it is not known if glutamatergic or A-MSH-containing neurons express dopamine receptors
or whether dopamine modulates these neurons via indirect methods, for example via the hypothalamic
endocannabinoid system. It has recently been shown that blockade of the cannabinoid CB1 receptors
in the PVN stimulates penile erection (Castelli et al, 2007); an effect which occurs concomitantly to
an increase in glutamic acid (a precursor for glutamate) concentrations in the PVN (Melis et al, 2006;
Succu et al, 2006). Thus, endocannabinoids may mediate penile erection via the modulation of
GABAergic and/or glutamatergic transmission in the PVN. The SON neurons generally express
oxytocin and vasopressin and no other neuronal populations in the SON have been shown to be
involved in sexual behaviour as yet, although, they co-express many other neuropeptides. A possible
explanation for the attenuated Fos expression we observed in the SON, may be that D3A indirectly
inhibits the activation of oxytocin neurons via acting on glutamatergic neurons that normally provide
excitatory input to supraoptic oxytocin cells. The D3A may inhibit glutamatergic neurotransmission
and subsequently oxytocin activity in the SON, although this is highly speculative.
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D4A and oxytocin neuronal activation
The D4A (L-745,870) did not inhibit intromission-induced Fos expression in the hypothalamic
regions analysed but it did significantly attenuate the percentage of Fos-expressing oxytocin cells in
the SON but not the MPN or PVN. Therefore, we show that D4-receptor mediated intromission is
mediated (in part) by supraoptic oxytocin neurons. This finding contrasts with our penile erection
study, where the D4 receptor agonist, PD168077 did not appear to activate supraoptic oxytocin cells
during penile erection. It is important to note that the two experiments were designed differently
however. In this study, the rat was placed with a receptive female and allowed to copulate (as
opposed to the D4 agonist study where the rat was in isolation). Thus perhaps such olfactory and
chemosensory stimuli in addition to intromission (as seen in the intromission study) are required for
the D4A to have an inhibitory effect on the activation of oxytocin cells in the SON as opposed to D4-
receptor stimulation alone, in isolated males (D4 agonist study). It is interesting to state that in all
studies which have implicated the SON in male sexual behaviour, all rats had at least intromitted and
most had ejaculated (Caquineau et al, 2006; Pattij et al, 2005; Philips-Farfan et al, 2007). Thus, it
seems that D4-receptor mediated penile erection alone is not sufficient to activate oxytocin neurons in
the SON. As to how L-745,870 inhibits the activity of oxytocin neurons is unclear. PD168077 (D4
agonist) and L-745,870 (D4A) have been shown to presynaptically inhibit and disinhibit, respectively,
GABAergic neuron activity in the SON (Azdad et al, 2003). So as briefly described before, it is likely
that L-745,870 acts presynaptically on GABAergic neurons to enhance GABAergic transmission and
inhibit oxytocin neuron activity. Alternatively, if oxytocin cells in the SON express D4 receptors
(investigated in chapter 4), L-745,870 may act directly on oxytocin cells to produce an inhibitory
effect.
As expected each of the D2-like antagonists did not have any effect on neuronal activation in the non-
intromitting males (those displaying only anogenital investigation and mounting behaviour).
However, the males placed alone (in a novel environment without a female or female olfactory cues)
showed relatively high basal levels of Fos and combined Fos and oxytocin expression which was
unexpected. Perhaps the placing of the rat in a new environment has a greater effect on the stress
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response than previously anticipated. Additionally, the same novel environment (eg. a freshly cleaned
cage) was used for all the rats in the experimental groups so perhaps pheromones still present in the
cage from the previously vacated male were sufficient to stimulate neuronal activation in the
hypothalamus. Finally, in our intromission study, the male rat was placed in the receptive female's
cage, whereas other studies have introduced the female into the male's cage (Dominguez et al, 2001;
Lumley and Cooleen, 1999; Muschamp et al 2007; Olivier et al, 2007). Also, each ovariectomised
receptive female was used 2-3 times for the copulatory tests. Some of these males displayed
exploratory behaviour as opposed to sexual-associated behaviours and they expressed, what seemed to
be, elevated aggressive behaviours (pinning down of the female, increased lengths of time in the
dominant-subordinate position) which may be due to the presence of pheromones in the test cage from
the previously vacated male. Thus, these factors may have contributed to the lower than average
copulatory performance, elevated basal levels of neuronal activation and apparent lack of effect on
neuronal activation of some of the dopamine antagonists.
In these two studies all drugs were given into the left lateral ventricle, so it is not known where each
drug acted or at what concentration. Perhaps by injecting more locally into the MPN, SON or PVN
itself we may have seen a stronger effect of the pharmacological ligands on sexual behaviour, Fos
expression and combined Fos and oxytocin expression. This approach was not used since intra¬
nuclear injection would have damaged the tissue integrity of each nucleus and made accurate analysis
of Fos and oxytocin expression very difficult. Perhaps a unilateral injection into each brain region
may solve this problem and allow analysis of protein expression in the contralateral half of each
nuclei. Although, it is known that such protein expression on one side of the nucleus does not always
clearly reflect that of the other side or brain region as a whole.
Although Fos immunocytochemistry is a widely used technique enabling the tracing of
neuroanatomical pathways involved in sexual behaviour, some researchers remain sceptical about the
functional significance of Fos protein when investigating the direct effects of drugs. It is generically
known as a marker of functional neuronal activation because it is believed to lead to long term
changes in cell structure and function. However, this statement is ambiguous because it is not known
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if Fos expression is indicative of for example, neuropeptide release, an influx of calcium or is indeed a
direct measure of neuronal activation. Regarding sexual behaviour, Fos induction can be associated
with various sensory stimuli and the activation of skeletal motor outputs required for copulation.
Finally, the induction of Fos may serve as a "neuronal predictor" for the activation of certain brain
nuclei known to be involved in the integration of future neuroendocrine-mediated behaviours such as
sexual satiety. So, it seems that whilst Fos immunocytochemistry is an extremely useful investigative
tool, its correlation to behavioural data must be interpreted with caution. Application of dopaminergic
ligands to isolated oxytocin cells (for example using electrophysiology) and examining their effects on
the intracellular calcium signal in oxytocin cells would perhaps provide a better measure of a direct
interaction between dopamine and oxytocin pathways.
Thus, in conclusion, it is apparent that central dopamine D2-like receptors are important in the
expression of penile erection in the male rat. However, the complex neural circuitries which subserve
such dopamine-mediated sexual behaviour remain to be elucidated. The hypothalamic oxytocinergic
system is one potential neuronal candidate that may mediate the excitatory and inhibitory effects of
dopaminergic agonists and antagonists. The involvement of central D4 receptors during in-copula
penile erection seems to be more important than that of D2 receptors which evidently has at most, a
minor role. There is however, growing interest in the role of D3 receptors during erectile function and
its underlying neural pathways. We provide evidence that D4 and D3 but not D2 receptors partly
mediate penile erection via oxytocinergic pathways; but we cannot rule out involvement of non-
oxytocinergic pathways (in the MPN, SON and PVN) as these are almost certainly also recruited.
In our dopamine agonist study, we have shown that during penile erection, the D2/D3 agonist,
Quinelorane acts via medial parvocellular oxytocin neurons which are known to comprise a group of
spinally-projecting fibres. Additionally, in our antagonist study we demonstrated that intromission
and the concomitant activation of oxytocin cells in the SON, were antagonised by the D4A (L-745,
870). Thus, it is clear that dopaminergic ligands can modulate central oxytocinergic transmission;
however, whether endogenous dopamine acts directly via oxytocin cells or indirectly during penile
erection remains unknown. We have shown that dopaminergic ligands can augment oxytocin neuron
119
Chapter 3.4: Dopamine ligands and penile erection - Discussion
activity during penile erection and intromission. Therefore, it is possible to assume the involvement
of a direct mechanism whereby hypothalamic oxytocin cells express D2-like receptors and so mediate
the pro-erectile effects of dopamine. Thus, in the next chapter we set out to investigate the expression
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Chapter 4
4.1 Dopamine D2, D3, D4 receptor and oxytocin expression in the MPN, SON and PVN
The actions of dopamine are modulated by the widespread Dl-like and D2-like receptor subtypes.
D1 -like receptors classically act via positive coupling to adenylate cyclase, conversely, the D2-like
receptors act via negative coupling to adenylate cyclase or through other signalling pathways such as
MAP kinase (Bitner et al, 2004). Both receptor subgroups functionally interact in the brain, whereby
activation of one receptor subclass can affect the function of another, such as seen in the striatum
(Harsing and Zigmond, 1997) and nucleus accumbens (Moine and Bloch, 1996). Dopamine receptor
activation can induce the stimulation of various transduction pathways; however, this is highly
dependent on the nuclear and cellular location as well as the cell-specific G-protein coupled
transduction pathways to which each receptor is associated with.
Dopamine receptor expression and distribution in the rat brain is widely known (Missale et al, 1998;
Sokoloff and Schwartz for review, 1995). D1 receptor expression in the CNS is most abundant
followed by D2 receptor expression (Ariano et al, 1989; Mansour et al 1990; Missale at al, 1998 for
review). D3, D4 and D5 receptor expression is comparatively less abundant and more anatomically
restricted than that of D1 and D2 receptors. However, this does not detract from the overall
importance of both Dl-like and D2-like receptors in many cognitive, neuroendocrine and
behavioural/motor functions.
A growing number of studies have implicated involvement of central D2-like receptors, in particular
in psychiatric diseases such as schizophrenia (Dean et al, 2004; Grace, 1993; Vernaleken et al, 2004)
and Parkinson's disease (Antonelli et al, 2006; Jenner, 2003; Robertson, 1992). In addition to
mediating various cognitive and motor functions, there is now convincing pharmacological evidence
for a role of the D2-like receptors in control of male sexual behaviour, particularly penile erection and
ejaculation (Docherty et al, 1991; Clements et al, 2007; Melis et al, 2005). We have shown (in
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Chapter 3) that during pharmacologically-induced penile erection, D2 and D3 but not D4 receptors
may have some role in mediating penile erection. Furthermore, during physiologically-induced penile
erection, D4 receptors appear to have a more prominent role than D2 and D3 receptors. So the
different contexts in which penile erection is observed have shown there to be some convincing
support for D2-like receptor involvement. Thus, establishing the precise cellular location and
distribution of the D2-like receptor subtypes will help our understanding of dopamine receptor
interactions and the importance of their role in emotionality and neuroendocrine-mediated behaviours.
4.1.1 D2 receptors
As explained in Chapter 1 (section 1.8.2) D2 receptors are widely and abundantly expressed
throughout the rat brain. Cellular location of D2 receptors include the cell bodies (Brok et al, 1992)
and dendritic spines (Levey et al, 1993) and, subcellularly they can be found near the golgi apparatus
and at the plasma membrane (Takeuchi and Fukunaga, 2003). Various neuronal phenotypes are
known to express D2 receptors such as GABA, enkephalin and substance P, (Moine and Bloch, 1996;
Moine and Gaspar, 1998). Additionally, D2 receptor mRNA has been located on cholinergic and
somatostatinergic neurons (MacLennan et al, 1994). However, oxytocin neuron expression of D2
receptors has not yet been established.
4.1.2 D3 receptors
D3 receptor expression is generally restricted to the limbic regions (Levant, 1997 for review) (see
Chapter 1, section 1.8.2). Unlike the D2 and D4 receptors, subcellular location and distribution of D3
receptors within the cells remains unknown. Although substance P-, enkephalin- and neurotensin
containing neurons express D3 receptors (Diaz et al, 1995; Moine and Bloch, 1996), the presence of
D3 receptors on oxytocin neurons remains unknown.
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4.1.3 D4 receptors
D4 receptors are preferentially expressed in cortical and some subcortical regions (see Chapter 1,
section 1.8.2). At the ultrastructural level D4 receptors are often associated with the plasma
membrane, endoplasmic reticulum and the cytoplasm (Mrzljak et al, 1996). Additionally, D4
receptors are highly expressed in GABAergic neurons in the cortex, hippocampus and substania nigra
(Mrzljak et al, 1996; Wedzony et al, 2000) and D4 receptor mRNA is localised on a small population
of Substance P neurons in the neostriatum (Surmeier et al, 1996). However, as with D2 and D3
receptors, the presence of D4 receptors on oxytocin cells has yet to be reported.
4.1.4 D2, D3 and D4 receptor expression in the MPN, SON and P VN
The hypothalamus has been shown to possess the densest population of D2-like receptors in
comparison to other brain areas in the rat (Khan et al, 1998). Also, as previously stated, hypothalamic
nuclei, namely the MPN and PVN, are particularly responsive to the pro-erectile effects of D2-like
dopaminergic ligands (Eaton et al, 1991; Melis et al, 2005; Moreland et al, 2005; Moses et al, 1995).
Because these three nuclei contain moderate to large oxytocinergic populations, which have also been
implicated in male sexual function (Kita et al, 2006; Pattig et al, 2005; Rampin, 2004 for review), it is
of immense interest to investigate whether oxytocin neurons in the MPN, SON and PVN express D2-
like receptors. It certainly seems likely that D2-like receptors are located on oxytocin cells due to the
large number of pharmacological studies implicating central oxytocin pathways in the mediation of
dopaminergic actions (Cameron et al, 1992; Melis et al, 1990; Uvnas-Moberg et al, 1995). Thus, it
seems that oxytocinergic expression of D2-like receptors in the MPN, SON and PVN would provide
direct anatomical evidence for a dopamine-oxytocin link within these nuclei and potentially indicate
dopaminergic control of hypothalamic oxytocin neurons.
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MPN
D2 and D3 receptor mRNA are moderately expressed in the MPN (Bouthenet et al, 1991; Gurevich
and Joyce, 1999). In addition, binding studies have shown there to be a particularly high density of
dopamine D4 receptor binding sites in the rat MPN (Primus et al, 1997).
SON
In the SON, D2 and D4 receptors are moderately expressed on magnocellular neurons (Defagot et al,
1997; Maltais et al, 2000). However, to our knowledge, D3 receptor expression in the SON has not
yet been established.
PVN
The PVN expresses moderately dense populations of both D2 and D3 receptor mRNA (Bouthenet et
al, 1991). Additionally, high levels of D2 receptor protein are also found in this nucleus. There is a
high degree of D4 receptor immunolabelling of the magnocellular PVN, however, D4 receptor
immunolabelling in the parvocellular PVN is comparatively lower (Bitner et al, 2006; Defagot et al,
1997).
While it is apparent that the D2-like receptors are present in relatively dense populations in the MPN,
SON and PVN, the neuronal phenotypes expressing these receptors remain unknown. In the PVN and
SON, the oxytocinergic cell groups comprise approximately 40-50% of the total neuronal population;
therefore, it is tempting to suggest that a proportion of these hypothalamic oxytocin cells must express
D2, D3 and/or D4 receptors.
Thus, our hypothesis was that D2, D3 and D4 receptors are expressed by oxytocin neurons in the
MPN, SON and PVN of sexually-experienced male rats. In order to demonstrate this, double
immunofluorescence for either the D2, D3 or D4 receptor and oxytocin was performed on perfused-
fixed brain sections containing the MPN, SON and PVN. To further investigate the approximate total
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Chapter 4
4.2 Methods
Dopamine D2, D3 and D4 receptor expression in the MPN, SON and PVN
4.2.1 Animals
Male Sprague-Dawley rats (200-250g) were used and housed the normal light cycle on a 12:12h light
dark cycle (lights on 7:00am to 7:00pm). Sexually-experienced male rats were used to remain
consistent with those animals used in the sexual behaviour experiment. Sexual experience was gained
by placing a male with a receptive female over 2-3 nights, copulation through to ejaculation was
confirmed by the presence of a vaginal plug of semen. This was repeated twice to allow 2 runs of
sexual experience. Those males who did not mate after 4 days of being placed with a female were
excluded from the study. Approximately, one week later rats were perfused fixed and brains stored as
explained in the General Methods.
4.2.2 Immunofluorescence
Antibodies
Anti-D2, -D3 and -D4 receptor polyclonal antibodies (rabbit anti-rat, all Calbiochem, UK) have been
used in a previous study demonstrating dopamine receptor expression in the choroid plexus (Mignini
et al, 2000). After establishing an antibody dilution curve for each dopamine receptor expression in
the rat brain, it was decided to use the D2, D3 and D4 receptor antibody at a 1:1000, 1:3000 and
1:1000 dilutions, respectively. We used an anti-oxytocin monoclonal antibody (mouse anti-rat,
Chemicon, UK), which has been used previously (Brailiou et al, 2007) at a dilution of 1:5000 so this
dilution was subsequently used. The secondary fluorescent antibodies, namely, Alexa-fluor 488 (goat
anti-rabbit) and Alexa-fluor 568 (goat anti-mouse) (both (Fab')2 fragments from Invitrogen, UK) have
been applied and published in previous studies (Granneman et al, 2007; Croze et al, 2000; Matsumoto
et al, 2005) at approximate dilutions of 1:1000 which we used for all experiments that followed.
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4.2.3 Cell quantification
A simplisitic and preliminary quantification method was used to establish the percentage of oxytocin
cells in the MPN, SON and PVN expressing D2, D3 or D4 receptors. Using 3D images created by the
confocal microscope and the associated Zeiss computer software, we were able track dopamine
receptor and oxytocin expression throughout the entire tissue (three sections per area per rat, n=3) due
to the combined sequential scanning of thinner specimen slices. The number of cells positive for the
D2, D3, D4 receptor or oxytocin and co-localised dopamine receptor and oxytocin were counted
separately. The incidence of co-localisation was expressed as the percentage of dopamine receptor and
oxytocin cells / the total number of oxytocin cells. Values were calculated per region per rat and then
per group. Statistics could not be performed due to the low "n" number. However, such basic semi¬
quantitative anlaysis should give an indication of the proportion of oxytocin cells expressing
dopamine receptors and thus shed some light on potential dopaminergic and oxytocinergic
interactions in hypothalamic nuclei.
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Chapter 4
4.3 Results
4.3.1 D2, D3 or D4 receptor and oxytocin expression in the MPN
D2 receptor
There was abundant D2 receptor expression in the MPN. D2 receptor labelling was primarily
restricted to the cytoplasm and cell membrane of oxytocin cells but did not appear to be expressed on
oxytocinergic fibres. Interestingly, there was also some intense staining of D2 receptors on non-
oxytocinergic cell bodies and cellular processes in the MPN (Figure 4.1).
D3 receptor
There were moderately high levels of D3 receptor expression in the MPN. Cellular distribution of the
D3 receptor was quite diverse with the cytoplasm, cell bodies and almost all dendritic processes of
oxytocin neurons expressing the D3 receptor in the MPN. Additionally, several non-oxytocinergic
neurons were seen to express D3 receptors (Figure 4.2).
D4 receptor
The D4 receptor signal was comparatively weaker in the MPN when compared to the D2 and D3
receptors, however, it did appear to be expressed in the cytoplasm, on the cell body and dendritic
process of the oxytocin cell shown in the photomicrographs (Figure 4.3). As with the D2 and D3
receptor, D4 receptors were also expressed on cell bodies and processes of cells that were not
oxytocinergic.
Percentage co-localisation in the MPN
Figure 4.10A illustrates the percentage of oxytocin neurons expressing either the D2, D3 or D4
receptor in the MPN of sexually-experienced male rats. It could be seen that MPN oxytocin cells
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The co-expression of the D2 receptor and oxytocin in the MPN. D2 receptor (D2R) and
oxytocin (OXT) labelling are shown in green and red respectively. An overlap of green and
red labelling (yellow in colour) indicates a D2-expressing oxytocin cell. Co-localisation of
the D2 receptor and oxytocin are shown in column A and the areas highlighted in A are
shown at higher magnification in column B. D2 receptors were found to be expressed on the
cell bodies of oxytocin neurons in the MPN. Filled arrows indicate a co-localised cell and
empty arrows show D2 receptor or oxytocin labelling only. Scale bars represent 100pm and
20pm in A and B respectively. 3v=third ventricle





The co-expression of the D3 receptor (D3R) and oxytocin (OXT) in the MPN. D3 receptor
and oxytocin labelling are shown in green and red respectively. An overlap of green and red
labelling (yellow in colour) indicates a D3-expressing oxytocin cell. Co-localisation of the
D3 receptor and oxytocin are shown in column A and the areas highlighted in A are shown
at higher magnification in column B. D3 receptors were found to be expressed on the cell
bodies of oxytocin neurons in the MPN. Filled arrows indicate co-localised cell bodies,
arrowheads illustrate co-localised fibres and empty arrows show D3 receptor or oxytocin
labelling only. Scale bars represent 100pm and 20pm in A and B respectively. 3v=third
ventricle.





The co-expression of the D4 receptor (D4R) and oxytocin (OXT) in the MPN. D4 receptor
and oxytocin labelling are shown in green and red respectively. An overlap of green and red
labelling (yellow in colour) indicates a D4-expressing oxytocin cell. Co-localisation of the
D4 receptor and oxytocin are shown in column A and the areas highlighted in A are shown
at higher magnification in column B. D4 receptors were found to be expressed on the cell
bodies and cellular processes of oxytocin neurons in the MPN. Filled arrows indicate co-
localised cell bodies, arrowheads illustrate co-localised fibres and empty arrows show D4
receptor or oxytocin labelling only. Scale bars represent 100pm and 20pm in A and B
respectively. 3v=third ventricle.
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abundantly expressed the dopamine D3 receptor (68%), whilst the D2 receptor was moderately
expressed (40%) and there was comparatively lower levels of the D4 receptor labelling (15%).
4.3.2 D2, D3 or D4 receptor and oxytocin expression in the SON
D2 receptor
In the SON, punctuate labelling of the D2 receptor was widely expressed. Oxytocin neurons seemed
to express the D2 receptor on the cell bodies but not on the dendritic processes. As seen in the MPN,
not all oxytocin neurons were co-localised with D2 receptors as evidenced by D2 receptor expression
on non-oxytocinerigc cells in the SON (Figure 4.4).
D3 receptor
The D3 receptors were expressed in the SON. Oxytocin neurons seemed to express the D3 receptor
on the cell bodies but not on the dendritic processes; however, D3 receptor staining was less punctuate
than the D2 receptor labelling in the SON. As seen in the MPN, D3 receptors were expressed on non-
oxytocinergic cells in the SON (Figure 4.5).
D4 receptor
The D4 receptor was widely expressed in the SON. Oxytocin neurons seemed to express the D4
receptor in the cytoplasm and on the cell bodies but not on the dendritic processes. As seen in the
MPN, D4 receptors were expressed by cells that were not oxytocinerigc (Figure 4.6).
Percentage co-localisation in the SON
Figure 4.1 OB illustrates the percentage of oxytocin neurons expressing either the D2, D3 or D4
receptor in the SON of sexually-experienced male rats. SON oxytocin cells expressed low to
moderate levels of dopamine D3 receptors (26%), whilst the D2 and D4 receptors were expressed in
relatively low levels on oxytocin neurons (14% and 15% respectively).
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The co-expression of the D2 receptor (D2R) and oxytocin (OXT) in the SON. D2 receptor
and oxytocin labelling are shown in green and red respectively. An overlap of green and red
labelling (yellow in colour) indicates a D2-expressing oxytocin cell. Co-localisation of the
D2 receptor and oxytocin are shown in column A and the areas highlighted in A are shown
at higher magnification in column B. D2 receptors were found to be expressed on the cell
bodies but not the cellular processes of oxytocin neurons in the SON. Filled arrows indicate
co-localised cell bodies and empty arrows show D4 receptor or oxytocin labelling only.





The co-expression of the D3 receptor (D3R) and oxytocin (OXT) in the SON. D3 receptor
and oxytocin labelling are shown in green and red respectively. An overlap of green and red
labelling (yellow in colour) indicates a D3-expressing oxytocin cell. Co-localisation of the
D3 receptor and oxytocin are shown in column A and the areas highlighted in A are shown
at higher magnification in column B. D3 receptors were found to be expressed in the
cytoplasm and on the cell bodies but not the cellular processes of oxytocin neurons in the
SON. Filled arrows indicate co-localised cell bodies and empty arrows show D3 receptor or
oxytocin labelling only. Scale bars represent 100pm and 20pm in A and B respectively.
OX=optic chiasm.
Figure 4.6 : D4 receptor and oxytocin expression in the SON
D4 R +
OXT
The co-expression of the D4 receptor (D4R) and oxytocin (OXT) in the SON. D4 receptor
and oxytocin labelling are shown in green and red respectively. An overlap of green and red
labelling (yellow in colour) indicates a D4-expressing oxytocin cell. Co-localisation of the
D4 receptor and oxytocin are shown in column A and the areas highlighted in A are shown
at higher magnification in column B. D4 receptors were found to be expressed on the cell
bodies but not the cellular processes of oxytocin neurons in the SON. Filled arrows indicate
co-localised cell bodies and empty arrows show D4 receptor or oxytocin labelling only.
Scale bars represent 100pm and 20pm in A and B respectively. OX=optic chiasm.
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D2, D3 or D4 receptor and oxytocin expression in the PVN
D2 receptor
D2 receptors were expressed by a small population of oxytocin neurons in the PVN. Co-expression
was found mainly on magnocellular neurons and to a lesser extent on parvocellular oxytocin neurons.
Oxytocin neurons seemed to express the D2 receptor in the cytoplasm and on the cell bodies but not
on the dendritic processes. As seen in the MPN, D2 receptors were also expressed on non-
oxytocinergic cells in the PVN (Figure 4.7).
D3 receptor
D3 receptors were expressed moderately by oxytocin neurons in the PVN. Co-expression was found
on magnocellular and parvocellular oxytocin neurons in the PVN. Oxytocin neurons seemed to
express the D3 receptor on their cell bodies and dendritic fibres. As seen in the MPN, D3 receptors
were also expressed on non-oxytocinergic cells in the PVN (Figure 4.8).
D4 receptor
D4 receptors were expressed moderately by oxytocin neurons in the PVN. There was clear punctuate
labelling on the oxytocin cell bodies. Co-expression was found exclusively on magnocellular
oxytocin neurons in the PVN. In the sections analysed, parvocellular oxytocin cells did not appear to
express D4 receptors. As seen in the MPN, D4 receptors were also expressed on non-oxytocinerigc
cells in the PVN (Figure 4.9).
Percentage co-localisation in the PVN
Figure 4. IOC illustrates the percentage of oxytocin neurons expressing either the D2, D3 or D4
receptor in the PVN of sexually-experienced male rats. It could be seen that PVN oxytocin cells
expressed consistently low to moderate levels of dopamine D2, D3 and D4 receptors (21%, 21% and
30% respectively).
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Figure 4.7 : D2 receptor and oxytocin expression in the PVN
A B
The co-expression of the D2 receptor (D2R) and oxytocin (OXT) in the PVN. D2 receptor
and oxytocin labelling are shown in green and red respectively. An overlap of green and red
labelling (yellow in colour) indicates a D2-expressing oxytocin cell. Co-localisation of the
D2 receptor and oxytocin are shown in column A and the areas highlighted in A are shown
at higher magnification in column B. D2 receptors were found to be expressed on the cell
bodies of oxytocin neurons in the PVN. Filled arrows indicate co-localisation and empty
arrows show D2 receptor or oxytocin labelling only. Scale bars represent 100pm and 20pm
in A and B respectively. 3v=third venricle; P=parvocellular oxytocin cell; M=magnocellular
oxytocin cell.






The co-expression of the D3 receptor (D3R) and oxytocin (OXT) in the PVN. D3 receptor and
oxytocin labelling are shown in green and red respectively. An overlap of green and red labelling
(yellow in colour) indicates a D3-expressing oxytocin cell. Co-localisation of the D3 receptor
and oxytocin are shown in column A and the areas highlighted in A are shown at higher
magnification in column B. D3 receptors were found to be expressed on the cell bodies and
dendritic fibres of oxytocin neurons in the PVN. Filled arrows indicate co-localised cell bodies,
arrowheads illustrate co-localised dendritic fibres and empty arrows show D3 receptor or oxytocin
labelling only. Scale bars represent 100pm and 20pm in A and B respectively. 3v=third
ventricle; Lp-lateral parvocellular oxytocin cell; M=magnocellular oxytocin cell.












The co-expression of the D4 receptor (D4R) and oxytocin (OXT) in the PVN. D4 receptor
and oxytocin labelling are shown in green and red respectively. An overlap of green and red
labelling (yellow in colour) indicates a D4-expressing oxytocin cell. Co-localisation of the
D4 receptor and oxytocin are shown in column A and the areas highlighted in A are shown
at higher magnification in column B. D4 receptors were found to be expressed on the cell
bodies but not the dendritic fibres of oxytocin neurons in the PVN. Filled arrows indicate
co-localised cell bodies and empty arrows show D4 receptor or oxytocin staining only.
Scale bars represent 100pm and 20pm in A and B respectively. 3v=third venricle;
M=magnocellular oxytocin cell.
















































































Percentage of oxytocin neurons in the MPN (A), SON (B) and PVN (C) expressing either
the D2, D3 or D4 receptor. Similar levels of co-localisation of oxytocin and D2, D3 or D4
receptor were observed in the SON and PVN. Comparatively more D3 receptor and
oxytocin co-localisation was seen in the MPN compared to D2 or D4 receptor co-
localisation with oxytocin.
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Chapter 4
4.4 Discussion
Behavioural studies that we have conducted showing the effects of dopamine agonists and antagonists
on oxytocin neuron activity in the MPN, SON and PVN, provide support for a direct dopaminergic
input to hypothalamic oxytocin neurons. The present study of dopamine D2-like receptor
immunofluorescent labelling in the rat hypothalamus showed distinct cellular co-localisation of D2,
D3 and D4 receptors on oxytocin neurons in the MPN, SON and PVN of sexually-experienced male
rats. There were some subtle differences in regional and cellular distribution of D2-like receptors on
oxytocin neurons in these three brain nuclei suggesting that D2, D3 and/or D4 receptors may
differentially modulate hypothalamic oxytocin cells dependent on their anatomical and cell-specific
location on oxytocin neurons.
4.4.1 Specificity ofantibodies
Brain regions known to express abundant populations of the D2, D3 and D4 receptors were used as
positive controls in this study (Figure 2.6, in General Methods). The caudate putamen (for the D2 and
D4 receptor) and the olfactory tubercle (for the D3 receptor) were analysed after each
immunofluorescence run, to confirm that there was D2-like receptor region-specific labelling. In
those negative controls where the dopamine D2-like receptor antibody was omitted from the
incubation medium, no receptor labelling was observed in any area of the brain including those areas
that served as positive controls. In another group of negative controls, the dopamine D2-like receptor
antibody was substituted with immune serum from which the primary antibody was raised in (in this
case normal rabbit serum). Brain sections immersed in this incubation medium showed relatively low
levels of immuno-labelling. Thus, there is a possibility that these D2-like receptor antibodies display
low levels of cross-reactivity to other unrelated proteins.
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4.4.2 D2-like receptor expression on oxytocin neurons in the MPN, SON and PVN
MPN
The MPN is one of the most crucial brain areas involved in dopamine-mediated copulatory behaviour
(Paredes and Agmo, 2004 for review). It is also highly sensitive to the pro-copulatory effects of
apomorphine (Hull et al, 1986). Thus, it seems likely that D2, D3 and D4 receptors would be
abundantly expressed in this nucleus. However, that the MPN expresses these receptors and on what
cell type has not been established. For the first time, we show that D2, D3 and D4 receptors are
expressed in the MPN. Additionally, a discrete population of oxytocin neurons within this nucleus
express D2, D3 or D4 receptors. At high magnification D2, D3 and D4 receptors were found to be
expressed on the cell bodies and on the cell membrane perimeter of MPN oxytocin neurons.
Interestingly, D3 and D4 but not D2 receptors were located on oxytocinergic dendritic processes
which suggests that D3 and D4 receptors in the MPN may mediate dendritic release of oxytocin
postsynaptically. Additionally, in the MPN, high levels of oxytocin and D3 receptor co-localisation
were observed. Thus, there seems to be a strong neuroanatomical basis for D3-receptor mediated
activation of oxytocin neurons in the MPN.
SON
Only recently has the SON been implicated in male sexual function (Caquineau et al, 2006; Pattij et
al, 2005). However, the responsiveness of the SON to the previously described pro-erectile
dopaminergic ligands remains unkown. Thus, it was important to investigate potential cellular
distribution of D2-like receptors on oxytocin neurons within this nucleus. Dopamine increases the
firing rate of supraoptic oxytocin neurons in vitro (Mason, 1983). Moreover, D2 receptor agonists
have been shown to depolarise supraoptic oxytocin neurons (Yang et al, 1991) and D4 receptors are
known to be expressed in the SON (Defagot et al, 1997). Thus, from such studies it was speculated
that D2 and perhaps D4 receptors were located on magnocellular oxytocin neurons. However, to our
knowledge no such evidence was available for the D3 receptor.
Supraoptic oxytocin neurons were found to express D2, D3 and D4 receptors in similarly moderate
levels. However, such D2-like receptor distribution appeared to be anatomically restricted to the cell
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bodies of oxytocin neurons. D2-like immunolabelling of the dendritic fibres in the SON was not
observed in the limited number of sections analysed. It has been suggested that dopaminergic ligands
can alter oxytocinergic transmission in the SON indirectly via modulating GABAergic and/or
glutamatergic transmission (Azdad et al, 2001; Price and Pittman, 2001). However, here we show that
dopamine could excite oxytocin neurons via a more direct mechanism by acting on D2, D3 and / or
D4 receptors located in the cell membrane of supraoptic oxytocin cells.
PVN
As with the MPN, the PVN is a moderately important nucleus in the control of male sexual behaviour
(Paredes and Agmo, 2004 for review) and it is also highly responsive to dopaminergic agonists
(particularly D4 agonists) (Docherty and Wisler, 1991; Melis et al, 2005, Paredes and Agmo, 2004).
Pharmacological studies have shown that paraventricular dopaminergic and oxytocinergic pathways
interact to facilitate penile erection (Argiolas and Melis, 2005, for review). However, the intricate
signalling pathways subserving dopamine-oxytocin-mediated penile erection are still unclear.
Dopaminergic fibres lie in close apposition to parvocellular and magnocellular neurons in the PVN
(Decavel et al, 1987) thus it was logical to assume that paraventricular oxytocin neurons possessed
D2-like receptors. This study revealed that D2, D3 and D4 receptors were abundantly expressed on
the cell bodies of predominantly magnocellular and a few parvocellular oxytocin neurons in the PVN.
However, only D3 receptors were found to be expressed in the dendritic processes of magnocellular
oxytocin cells. Thus, it seems in the PVN dopamine may act directly on D2, D3 and D4 receptors
located on oxytocin cell bodies. Additionally, dopamine may act via postsynaptic D3 receptors
located on oxytocinergic dendrites.
4.4.3 Expression ofD2-like receptors on non-oxytocinerigc neurons
Whilst hypothalamic oxytocin cells possess D2-like receptors, there appeared to be abundant
expression of D2, D3 and D4 receptors on non-oxytocinergic neurons in the MPN, SON and PVN.
These neurons may represent other cell groups implicated in regulating male sexual behaviour, such
as serotonergic, dopaminergic, melancortinergic, vasopressinergic, galaninergic, GABAergic,
glutamatergic and gonadotrophinergic phenotypes (Benelli et al, 1994; Caquineau et al, 2006;
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Dennison et al 1996; Hull et al, 2004; Melis et al, 2006; 2001; Morris, 2003; Murphy et al, 1987;
Ogier et al, 2006; Paredes and Agmo, 2004). In regard to the SON in particular, we know that this
nucleus is comprised almost exclusively of oxytocin and vaspopressin cells (although oxytocin and
vasopressin can be colocalised with other neuromediators). Since we have shown moderate levels of
D2-like receptor expression on SON cells that are not oxytocin we can be almost certain that these are
vasopressinergic. To our knowledge, there have been no reports as yet of vasopressin cells possessing
dopamine D2-like receptors. This finding suggests that endogenous dopamine may also be able to
modulate the activity of supraoptic vasopressin cells by acting directly on the soma of these cells.
However, whether such a dopamine-vasopressin interaction underlies neural control of masculine
sexual behaviour has yet to be established. Thus, it can be seen dopaminergic inputs to hypothalamic
neurons are not restricted to oxytocin cells but in fact converge on a wide range of peptidergic
neurons.
In this study, there were some technical limitations. In only three rats, three sections per brain region
were analysed, thus it is difficult to suggest that these findings are representative of a group as a
whole. Additionally, we were not able to examine subcellular location and distribution of the D2-like
receptors. Applying electron microscopy would perhaps help in examining the intracellular presence
of D2-like receptors and understanding how dopamine receptors regulate oxytocin release.
In conclusion, we have shown that D2, D3 and D4 receptors are expressed on hypothalamic oxytocin
neurons. Our results provide a strong anatomical basis for a direct dopaminergic activation of
oxytocin neurons in the MPN, SON and PVN. Moreover, D3 receptor expression on oxytocinergic
dendritic processes in the MPN and PVN raises the possibility that dopamine may stimulate oxytocin
release within each nucleus via D3 receptors. Although each receptor is expressed in the MPN, SON
and PVN, it seems that D2 and D4 receptors are primarily expressed on oxytocin cell bodies, whilst
D3 receptors are located somatodendritically. It is not clear if somatic and dendritic dopamine
receptor activation differentially regulate oxytocin release. However, due to the apparent differences
in cellular location, such a finding raises the possibility that D2-like dopamine receptors may in fact
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stimulate hypothalamic oxytocin release via similar and/or alternate mechanistic pathways. The
presence of D2-like receptors on the cell bodies and/or the dendritic processes of oxytocin neurons
introduces the possibility of an additional dopaminergic control of somatodendritic oxytocin release.
Perhaps dopamine and /or oxytocin itself operate in a positive feedback loop whereby dopamine-
and/or oxytocin-induced oxytocin release (via direct activation of dopamine and/or oxytocin receptors
on oxytocin cells), disinhibit GABAergic synaptic transmission and so increase the synchronous firing
activity of oxytocin neurons as seen during lactation (de Kock et al, 2003), although this is highly
speculative.
It is well known that oxytocin receptors are located on hypothalamic oxytocin neurons which
facilitates oxytocin to stimulate its own release in a calcium-dependent manner (Lambert et al, 1994;
Ludwig et al, 2002). During the female reproductive cycle, hypothalamic oxytocin cells become more
excitable and their firing rate changes from low-frequency to high-frequency firing (Leng et al, 1999).
Such an augmentation in the firing rate has been shown to be due to enhanced inhibition of
GABAergic neurotransmission by increased somatodendritic release of oxytocin (de Kock et al,
2003). It seems entirely possible that such a somatodendritic regulatory mechanism of oxytocin
release exists in the male rat during penile erection.
Oxytocinergic pathways in the hypothalamus do appear to be one particular population of target
neurons that partly mediate the actions of dopamine during erectile function. Moreover, we show that
oxytocin neurons within sexually responsive brain nuclei possess D2-like receptors, thus providing
neuroanatomical evidence for a direct dopaminergic input to these oxytocin cells. If the activity of
oxytocin cells is altered during dopamine ligand mediated- penile erection (as we have shown in
chapter 3), then it seems logical to propose that such dopaminergic agents can influence oxytocin
release within the CNS, providing they gain access to the brain. During sexual behaviour, there is
increased oxytocin release within the PVN (Waldherr and Neumann, 2007). However, the
lumbosacral spinal cord (containing pro-erectile centres) is another central candidate believed to
mediate the effects of dopamine due to the presence of oxytocin receptor binding sites and innervating
oxytocinergic fibres originating in the parvocellular PVN (Tang et al, 1998; Veronneau-Longueville et
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al, 1999). Thus dopamine-mediated oxytocin release and action in the lumbosacral spinal cord of the
male rat was next investigated.
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Electrical and pharmacological stimulation of the PVN have been shown to induce robust increases in
intracavenous pressure (ICP) in anaesthetised and conscious male rats (Bernabe et al, 1999; Chen et
al, 1997). As previously explained (in General Methods, section 8.1), using ICP as a physiological
marker of penile erection allows greater sensitivity and objectivity when quantitatively analysing
erectile function. The corpora cavernosa erectile tissues lie alongside each side of the shaft of the
penis and are larger in diameter in comparison to the corpora spongiosum (of which there is only one)
which runs along the ventral surface of the penis. Penile pressure is generally recorded from the
corpora cavernosum because (1) due to its size and shape, it is technically easier to insert a pressure
probe into this region and (2) the majority of blood (90%) enters the corpora cavernosa during
tumescence. Thus, recording from the corpus cavernosum rather than the corpus spongiosum will
give a more accurate measurement of intra-penile pressure during the achievement of penile erection.
The corpora spongiosum forms the glans penis and acts to prevent compression of the urethra during
erection and facilitates movement of the ejaculate. There have been some studies measuring corpora
spongiosum pressure during erection in rats, stallions, dogs and sheep (Beckett et al, 1975a; Beckett et
al, 1975b; Purohit and Beckett, 1976; Schmidt et al, 1995). However, all these studies concomitantly
involve the recording of perinal striated muscle activity. Rises in corpora spongiosum pressure during
penile erection are much lower than those seen in the corpora cavernosum. Additionally, such copora
spongiosum rises are associated with contraction of the bulbospongiosus muscles (Purohit and
Beckett, 1976). So, corpora spongiosum erectile tissue may have a more prominent role in ejaculation
as opposed to penile erection which helps to explain the preference for using the ICP model when
measuring erectile responses.
Apomorphine (Ki=101, 32, 26, 2.6, lOnM for Dl, D2, D3, D4 and D5 receptors, and low affinity for
adrenergic a and serotonergic receptors) injected i.v. (Giuliano et al, 2001) or directly into the PVN
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(Chen et al, 1999) produces transient increases in ICP in the anaesthetised rat. Additionally,
administering compounds into the PVN that act to enhance dopaminergic responses have similar
effects on ICP (Allard et al, 2002). Thus, these findings add to those behavioural studies confirming a
role for dopamine acting in the PVN during the expression of penile erection. The paraventricular
target neurons believed to mediate the effects of dopamine remain unknown. However, oxytocin
neurons in the PVN are believed to be one potential central substrate. As we have previously shown
in Chapter 3, stimulation of D2 and D3 receptors in the brain induces an erectile response in male rats
that seems to partly involve the activation of paraventricular parovcellular oxytocin cells.
Additionally, oxytocin cells within the pPVN were shown to possess D2, D3 and to a lesser extent D4
receptors (Chapter 4). So, our findings provide some more evidence for a role of the paraventricular
oxyocin system in mediating the erectogenic effects of dopamine agonists. Our results also lightly
touch on the possibility of a direct dopaminergic influence on this oxytocin population during sexual
behaviour.
The PVN contains a heterogenous population of cells and possesses a distinct cyto-architecture. As
previously described, paraventricular oxytocin cells can be divided into magnocellular and
parvocellular sub-populations. The magnocellular neurons are larger in diameter and project to the
neurohypophysis where they release oxytocin and vasopressin into the blood to regulate such
functions as milk ejection and parturition (Lin et al 2003; Neumann et al, 2001; Russell et al, 2003).
Parvocellular neurons are smaller in diameter and are known to project to extra-hypothalamic sites in
the CNS such as the brainstem (Petrov et al, 1995), the cervical-thoracic (Hosoya et al, 1991;
Swanson and Kuypers, 1980; Toth et al, 1999) and the lumbo-sacral spinal cord (Veronneau-
Longueville et al, 1999; Tang et al, 1998) where they are believed to regulate autonomic processes
including cardiovascular and erectile function. Recent findings postulate that parvocellular oxytocin
release at these sites contributes to central control of cardiorespiratory activities (Mack et al, 2002;
Mack et al, 2007), penile erection and copulation (Argiolas & Melis, 2004 for review; Melis &
Argiolas, 2003 for review).
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5.1.1 Decscending paraventriculospinal pathway
Since dopaminergic activation of the PVN elicits penile erection (Melis et al, 1987) and the PVN
contributes oxytocin fibres to the lumbosacral spinal cord (Veronneau-Longueville et al, 1999) where
local oxytocin action potently induces erectile function (Giuliano et al, 2001); it has been inferred that
initiation of penile erection is preceded by the activation of a descending paraventriculospinal
oxytocin pathway. Dopamine is thought to act on cell bodies of parvocellular oxytocin neurons via
dopamine receptors to stimulate release of oxytocin at the lumbosacral spinal cord and facilitate penile
erection. However, currently there is no direct evidence to show that dopamine activates this pathway
or can alter oxytocin concentration in the spinal cord of the male rat during penile erection.
An increase in oxytocin concentrations in the CSF of copulating male rats was first demonstrated by
Hughes and colleagues (1987). Since then there have been a growing number of studies implicating
oxytocin action in the lumbosacral spinal cord as an important mediator in the generation of penile
erection. The erection generator network receives oxytocinergic innervation and possesses oxytocin
receptor binding sites (Tang et al, 1998; Veronneau-Longueville et al, 1999). Additionally, local
injection of oxytocin into the lumbosacral spinal cord strongly induces ICP rises (Giuliano et al,
2001). These findings suggest that oxytocin can activate spinal networks and in turn elicit penile
erection. The central stimulus/stimuli which provide supraspinal command and so partly influence the
activation of the spinal cord-projecting oxytocin fibres are far from being elucidated. However,
increased dopaminergic activity in the PVN is emerging as one potential excitatory input to oxytocin
neurons that may contribute to the initiation of penile erection. It has been hypothesised that spinal
oxytocin release may be partly influenced by dopaminergic stimulation at the paraventricular level.
5.1.2. Anatomical evidence
Tracer and immunocytochemical studies have revealed that parvocellular oxytocin neurons,
originating in the PVN, project to many spinal sites such as the superior cervical ganglion
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(Teclemariam-Mesbah et al, 1997), the intermediolateral column and the dorsal vagal complex (
Swanson & Sawchenko, 1980), the dorsal grey commisure (DGC) of the thoracolumbar (sympathetic)
and lumbosacral (parasympathetic) spinal cord (Swanson and McKellar, 1979). More specifically,
parvocellular neurons in the anterior, dorsal and medial pPVN are known to terminate in the L5-L6
area of the spinal cord which contains the sexually dimorphic spinal nucleus of the bulbocavernosus
(Wagner and Clemens, 1991); a motor nucleus which innervates the perineal muscles involved in
penile reflexes. Additionally, in the L4-L6 spinal cord, some oxytocin fibers have been shown to
make direct synaptic contacts with preganglionic neurons in the sacral parasympathetic nucleus
(SPN); a pro-erectile spinal nucleus believed to be an integration site, co-ordinating supraspinal
commands and peripheral output to the penis (Swanson & McKellar, 1979; Tang et al, 1998;
Veronneau-Longueville et al, 1999). It is possible that these oxytocin fibres may also act on
interneurons in the DGC or SPN (Tang et al, 1998). Additionally, oxytocin binding sites have been
located in the dorsal horn, DGC and SPN of the rat lumbosacral spinal cord (Veronneau-Longueville
et al, 1999). Such neuroanatomical evidence suggests that there is a strong overlap between
oxytocinergic paraventriculo-spinal neuronal projections and the distribution of oxytocin binding sites
in the lumbosacral spinal cord. Impinging on these descending paraventricular oxytocin fibres are
incertohypothalamic-derived dopaminergic fibres (Buijs et al, 1984; Lindvall et al, 1984). Therefore,
there is a strong basis for the existence of a descending oxytocinergic parvocellular pathway of
paraventricular origin which terminates in the lumbosacral spinal cord and is innervated by branching
dopaminergic fibres.
J. 1.3. Lesion studies
Lesions which destroy the descending parvocellular fibres to the lumbosacral spinal cord have been
shown to deplete almost all (75%) oxytocin concentrations in the CSF (Hawthorn et al, 1985) and
disrupt oxytocin-like immunoreactivity in the lumbosacral spinal cord (Ackerman et al, 1997;
Monaghan et al, 1993). Damage to the whole PVN (thus disrupting magnocellular and parvocellular
regions) does not cause any apparent deficits in penile erection but can affect some copulatory
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parameters (Liu et al, 1997). In addition, local PVN lesions which selectively destroy spinal cord-
projecting neurons resulted in an increase in the latency and a decrease in the frequency of non-
contact erections suggesting a specific effect on the activation of pathways (presumably parvocellular)
regulating erection. Furthermore, in addition to general parvocellular involvement in erectile
function, it seems that specific parvocellular subregions in the PVN may differentially modulate
certain parameters of sexual behaviour. Local lesioning of the lateral and posterior parvocellular parts
of the PVN completely abolishes the ejaculation-related increase in CSF oxytocin concentration
(Hughes et al, 1987). The particular importance of paraventricular oxytocin neurons in the mediation
of dopamine-induced penile erection was demonstrated in another lesioning study where penile
erection elicited by apomorphine was profoundly inhibited after destruction of the PVN (Argiolas et
al, 1987). This strongly suggests that the descending paraventriculospinal oxytocin pathway is
intergral to the pro-erectile actions of dopamine in particular. Thus, whilst it is not possible to
delineate which oxytocin phenotype in the PVN is excited by apomorphine, there is some convincing
evidence which supports a role for parvocellular oxytocin neurons (projecting to the lumbosacral
spinal cord) in the initiation of penile erection evoked by remote oestrus female cues. Conversely,
magnocellular oxytocin neurons may have more of a modulatory role in reflexive erections and
influence those sexual events occurring after the achievement of penile erection eg. intromission
and/or ejaculation.
5.1.4. Neuronal activation studies
Immunocytochemistry studies using Fos protein as a marker of neuronal activation have similarly
implicated involvement of parvocellular oxytocin cells in the PVN during penile erection. We have
previously shown that oxytocin cells in the medial parvocellular region of the PVN are activated upon
Quinelorane-induced penile erection (Chapter 2, section 2.3.1.3.). In addition, oxytocin-induced
penile erections significantly induce Fos expression in the dorsal, medial and lateral subregions of the
PVN (Kita et al, 2006). Finally, an increase in Fos expression in lateral parvocellular oxytocin cells
was observed during intromission and ejaculation (Witt & Insel, 1997).
141
Chapter 5.1: Lumbosacral oxytocin action and apomorphine-induced penile
erection - Introduction
In conclusion, neuronanatomical, pharmacological and immunocytochemical evidence have revealed
that paraventricular descending oxytocinergic neurons serve as one candidate pathway important for
generating penile erection. However, whether disruptions in this pathway can affect dopamine-
induced penile erection or whether dopamine can stimulate release of oxytocin in the lumbosacral
spinal cord is not yet known. Therefore, in this study, we aimed to test the hypothesis that dopamine-
induced penile erection involves oxytocin release in the lumbosacral spinal cord.
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5.2 Methods
5.2.1. Effects ofan oxytocin receptor antagonist (i.s.) on apomorphine-induced ICP rises
5.2.1.1. Animals
Naive Sprague-Dawley male rats (200-300g) were used and maintained throughout on a normal
12:12h light dark cycle (lights on from 07:00am to 7:00pm). The rats were housed in groups of 4-5
and were allowed access to food and water ad libitum. All experiments conformed to the UK Animals
(Scientific Procedures) Act 1986.
5.2.1.2. Drugs
Apomorphine (Sigma, UK) was dissolved in isotonic saline containing 0.1% ascorbic acid (Sigma,
UK) and then diluted further in isotonic saline prior to injection. Oxytocin (Sigma, UK) or the
oxytocin receptor antagonist, UK-427,843 (developed by Pfizer Labs, Sandwich,UK) were both
dissolved in saline prior to administration.
5.2.1.3. Anaesthesia and vascular cannulae
As described in the General Methods, rats were anaesthetised with 1.2g/kg urethane (i.p. Sigma, UK)
and placed on a homeothermic blanket to maintain body temperature during the experimental test
period. The femoral artery and femoral vein were both cannulated (Portex Ltd., UK) to measure
blood pressure and allow drug delivery.
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5.2.1.4 Recording ofICP and bloodpressure (BP)
For recording of ICP, the penis was denuded of skin and all connective tissue removed. A 25-gauge
needle attached to a catheter and connected to a pressure transducer (EM 750, Elcomatic, Glasgow,
UK) was inserted into one corpus cavernosum.
Blood pressure was recorded simultaneously because changes in blood pressure can markedly affect
blood supply to the penis and so influence ICP responses (Giuliano et la, 1993). As explained in
General Methods (section 8.1.3.), the amplitude of each ICP rise was thus standardised according to
the corresponding mean BP. Recording of BP was performed as described in General Methods
(section 4.1.4.).
5.2.1.5 Intraspinal injections
For intraspinal (i.s.) injections, rats were initially placed in their ventral surface and a small opening
was made between the T13 and LI vertebrae to expose the L4-L6 spinal cord. Using a lOpl Hamilton
syringe (Hamilton, Switzerland) secured in a stereotaxic frame, the needle was lowered into the
lumbosacral spinal cord, lateral to the central vein and approximately 1-1.5mm deep. Drugs were
administered in 3pl over 3 min by hand.
5.2.1.6 Intra-PVN injections
For intra-PVN injections, rats were secured in the stereotaxic frame. Checks were made to ensure
lambda and bregma were level before aiming a 1 Opl Hamilton injection syringe at the PVN
(stereotaxic co-ordinates; 1.8mm caudal, 0.5mm lateral (from bregma and 8.6mm ventral from the
skull surface). Drugs were injected in 2pl over 2 min by hand.
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For all drug injections using the lOpl Hamilton syringe, the injection needle was kept in place for a
further 30 sees to ensure diffusion of the drug from the needle and to prevent backflow of the drug
into the injection needle.
5.2.1.7 Histology and location of injection sites
At completion of the experiment, rats were given an overdose of urethane. The brain or L4-L6 region
of the spinal cord were then dissected out and stored in formalin (with 4% paraformaldehyde) for 24
hours before being cut on a cryostat (30pm). Brain sections containing the PVN or L4-L6 spinal cord
sections were mounted onto gelatinised microscope slides. Sections are then firstly placed in
decreasing ethanol concentrations (100% x2, 90%, 70%. 50%x2 ) followed by methylene blue and
then dehydrated in increasing ethanol concentrations (50% x2, 70%, 90%, 100% x2) and histoclear x2
for 2 min each prior to coverslipping. The site of injection was located using a light microscope at
x20 magnification.
5.2.1.8 Experimental design
Initially, we aimed to establish the erectile response to intra-PVN delivery of apomorphine. Rats were
injected with either vehicle (saline supplemented with 0.1% ascorbic acid) or I pg of apomorphine
(4pl) in the PVN (rationale for injecting such a large volume is explained in section 5.4.1.1) to
confirm that apomorphine delivered intra-PVN can induce increases in ICP in the anesthetised rat.
We then proceeded to establish the erectile dose-response to intravenous (i.v.) delivery of
apomorphine. Seven groups, each of 5 rats were injected with either vehicle (saline supplemented
with 0.1% ascorbic acid) or 0.1, 0.5, 0.15, 0.25, 1 or 5 mg/kg apomorphine i.v. This experiment
allowed the determination of a sub-maximal effective dose of apomorphine to be used in subsequent
experiments.
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Following these, the ICP response to i.s. delivery of oxytocin was assessed. One group of 5 rats was
injected with oxytocin (30ng in 3 pi). This experiment was designed to mimic release of oxytocin in
the lumbosacral spinal cord and show that oxytocin injected at L4-L6 spinal level is effective in
eliciting penile erections. This therefore confirmed the correct injection site for the oxytocin receptor
antagonist.
After the above preliminary studies, the dose-dependent inhibitory effect of the oxytocin antagonist
UK-427,843 on apomorphine-induced penile erections was assessed. Four groups, each of 6-7 rats
were injected with vehicle (saline) or 36, 180 or 900 ng of UK-427843 i.s. (3pl). The injection in the
spinal cord was performed 5 min prior to i.v. administration of apomorphine. This experiment
allowed direct testing of the ability of an oxytocin antagonist delivered at the lumbosacral spinal cord
to inhibit penile erections induced by apomorphine injected i.v.
In all ICP studies, basal ICP conditions were recorded for 10 min prior to apomorphine (or oxytocin
injection) and then observed for a further 30 min after apomorphine (or oxytocin / oxytocin antagonist
injection).
5.2.1.9 Quantification ofICP responses
Only ICP rises with a maximal value greater than the sum of the average + 2 standard deviations of
the ICP recording during 10 min prior to drug injection were included in analyses. The following
parameters were measured:
• Incidence (%) of erectile responses (number of rats showing at least 1 ICP rise)
• Mean number of erectile responses per rat
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• Latency to the first ICP response
• Duration of ICP response
• ICPmax/BP (maximum amplitude of ICP rise normalised according to corresponding BP)
• SUM AUC/BP (overall duration of ICP rise, considering the amplitude and duration of the
ICP rise. As above, values are standardised according to the corresponding BP).
All of the above measured parameters were averaged per group, except the SUM AUC/BP. Those rats
who did not show any ICP responses within the 30 min test period, were assigned a value of zero for
the incidence, mean number of ICP increases and AUC/BP. Additionally, when calculating the
ICPmax/BP, AUC/BP, latency and duration, those rats who did not elicit at least one ICP response in
the 30 min experimental test period were excluded from statistical analysis.
5.2.1.10 Statistics
The different treatments within each experiment were randomised as necessary. Data to be analysed
were the incidence of ICP rises (%) (Chi-squared test), the mean number of erectile responses,
latency, duration, ICPmax/BP and the SUM AUC/BP (all parameters were assessed using One Way
ANOVA followed by Dunn's method). P values <0.05 were considered statistically significant.
5.2.2. Effect ofapomorphine on oxytocin release in the lumbosacral spinal cord
5.2.2.1. Animals
Due to financial and time constraints, nai've Sprague-Dawley male rats (200-250g) were used in this
study and maintained throughout on a normal 12:12h light dark cycle (lights on from 07:00am to
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7:00pm). The rats were housed in groups of 5 and were allowed access to food and water ad libitum.
All experiments conformed to the UK Animals (Scientific Procedures) Act 1986.
5.2.2.2. Drugs
Apomorphine (Sigma, UK) was dissolved in 0.1% ascorbic acid (Sigma, UK) and then diluted in
saline.
5.2.2.3. Surgical preparation
Rats were anaesthetised as before and cannulation of the femoral artery, L4-L6 spinal cord dissection
and histology were performed as previously described in General Methods and section 4.2.1.3.
Because penile erection was not recorded in this study, we did not measure blood pressure in these
animals.
5.2.2.4. Microdialysis
As described in the General Methods, the T13-L1 vertebrae were mounted on the stereotaxic frame to
expose the L4-L6 spinal cord. A microdialysis probe (Brain microdialysis probe, 2mm membrane,
Bioanalytical Systems, Inc, Indiana, USA) was secured in a probe holder in the stereotaxic frame.
The microdialysis probe was connected via teflon tubing (FEP tubing, 50cm in length, 6pl in volume,
Linton Instrumentation, UK) to a lOOpl Hamilton syringe mounted on a "push" perfusion pump (PHD
2000 Infuse/Withdraw pump (Harvard Apparatus, USA) set at a flow rate of approximately 3pl/min.
The probe was perfused with artificial cerebrospinal fluid (ACSF) and positioned in to the
lumbosacral spinal cord as described before. After an initial 30 min ACSF wash, two 30 min baseline
samples were collected. Apomorphine (0.25mg/kg) was then injected at 0 min and a further three 30
min analyte samples were collected at 30, 60 and 90 min after which time the animal was sacrificed
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with an overdose of urethane anaesthesia. All samples were collected in sterile eppendorfs containing
0.2M HC1 (IOjj.1) and placed in dry ice before transferring to -20°C.
4.2.2.5. Push-pullperfusion
The animal was secured in the stereotaxic frame as described above and a microdialysis probe (as
above) lacking the 2mm membrane was used as a push-pull probe. The probe was connected to both a
"push" pump (set at 10-1 lpl/min) and a "pull" pump (Miniplus 3 peristaltic pump, Gilson, France) via
teflon tubing (FEP tubing, 25cm in length, 3pl in volume, Linton Instrumentation, UK), set at 0.55
arbitary units (resulted in the collection of 10-11 pi samples per min). The "push" and "pull" pumps
were calibrated prior to and after insertion of the probe into the lumbosacral spinal tissue to ensure the
sample collection rats were maintained at 10-1 lpl/min. The sample collection protocol for push-pull
perfusion was the same as that for microdialysis.
5.2.2.6. Recording ofbreathingfrequency
Apomorphine can act as a cardiovascular depressant and affect breathing frequency, which can cause
slight movement around the probe injection site. Due to such movement during breathing, local tissue
damage around the probe site may have some effect on oxytocin release in the lumbosacral spinal
cord. Thus, in order to ensure that any observed changes in oxytocin levels were predominantly due
to the effects of apomorphine, the number of inspirations in 60 sees was recorded at the following
intervals for each rat; -30, -5 and 5 min. An inspiration was defined as a single visible expansion of
the thoraco-abdominal cavity in the anaesthetised rat.
5.2.2.7. Oxytocin radioimmunoassay
Oxytocin radioimmunoassay was perfomed by Rainer Landgraf (Max Planck Institute of Psychiatry,
Munich). Details are previously described in Chapter 2 (section 2.11.2).
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5.2.2.8. Experimental design
This experiment was designed to assess the effects of apomorphine (0.25mg/kg) (i.v.) on oxytocin
release in the lumbosacral spinal cord of the anaesthetised rat. For microdialysis, 5 rats were initially
injected with i.v. apomorphine. For push-pull perfusion, rats were injected i.v. with apomorphine
(n=8) or vehicle (saline supplemented with 0.1% ascorbic acid) (n=6).
5.2.2.9. Statistics
Those rats that died during the experimental test period (5/13) due to them encountering breathing
difficulties were excluded from statistical analysis. Differences in oxytocin levels between vehicle
and apomorphine treated rats at -60, -30, 0, 30, 60, 90 min were compared (Two Way ANOVA with
repeated measures). Differences in oxytocin levels in apomorphine treated rats at -60 (basal) and 30
min were also assessed (one way ANOVA for repeated measures). Delta values (oxytocin
concentration at 30 min minus mean basal concentration) were calculated for both vehicle and
apomorphine treated rats and statistical comparisons in the overall oxytocin response were analysed
(Unpaired Student's t-test). Finally, the effects of apomorphine on breathing frequency were also
assessed (Unpaired Student's t-test). P values <0.05 were considered statistically significant.
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5.3.1. Effects ofan oxytocin receptor antagonist on apomorphine-induced ICP rises
5.3.1.1. Erectile dose response curve to apomorphine (intra-PVN)
Because we wanted to selectively activate the PVN and measure erectile responses an injection needle
delivering apomorphine was stereotaxically aimed at the PVN. Figure 5.1A and 5.IB show the
example ICP responses to intra-PVN delivery of vehicle and apomorphine (lpg in 4pl), respectively.
Intra-PVN injection of vehicle (5.1A) elicited only marginal increases in ICP; such small rises are
often termed "spontaneous ICP rises" and have been reported before in studies using the ICP model
(Giuliano et al, 2001). These ICP rises are not necessarily related to intra-PVN injection of vehicle
(saline + 0.1% ascorbic acid) but reflect the innate erectile responses that can occur under any
experimental recording conditions. Indeed in conscious male rats, spontaneous erections (reflected by
spontaneous ICP rises in the anaesthetised rat) are frequently observed in vehicle groups (Melis et al,
2005, 2006).
Intra-PVN injection of apomorphine (5. IB) produced transient increases in ICP. Apomorphine
increased the number of ICP rises and each peak was of higher amplitude and longer duration
compared to those ICP rises elicited in control animals. The photomicrograph in 5.1C illustrates the
injection site histologically. It can be seen that the injection needle reached the very lateral region of
the mPVN. Unfortunately, direct injection in the PVN proved technically very difficult and the
success rate was relatively low, thus the number of rats per group was low. Thus, statistics could not
be performed on this set of data. To minimise the number of animals used and due to time
restrictions, it was decided to administer apomorphine i.v. for all subsequent studies.
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Effects of central injection (which lies very close to the PVN) of apomorphine (Apo, 1 pg)
on ICP. Example traces show blood pressure (top) and ICP responses (bottom) to central
delivery (in close proximity to the PVN) of vehicle (A) and Apo (B). The
photomicrograph in C illustrates the injection site (black arrow). Apo induces transient
increases in ICP compared to vehicle. Scale bars represent 200pm.
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5.3.1.2. Erectile dose response curve to apomorphine (i.v.)
Apomorphine (i.v.) (0.01, 0.05, 0.15, 0.25, 1, 5mg/kg) dose-dependently induced transient increases in
the ICP baseline. Figures 5.2-5.4 show example traces of rats treated with vehicle (Figure 5.2A), 0.05
(Figure 5.2B), 0.25 (Figure 5.3B) or lmg/kg (Figure 5.4B). In each trace, a transient decrease in
blood pressure can be observed after each saline flush and prior to apomorphine injection. This is due
to the presence of urethane in the catheter prior to the saline flush. It is well known that urethane can
have a depressant effect on sympathetic neuronal firing (Sun and Reis, 1995) and thus explains the
momentary fall in systemic blood pressure.
Rats treated with vehicle (i.v.) did not display any spontaneous rises in ICP. As expected, increasing
the dose of apomorphine increased the number, amplitude and duration of ICP rises. Since no rats in
the vehicle group displayed any ICP rises, amplitude and duration of ICP rises could not be compared
statistically. Figure 5.5 shows that apomorphine dose-dependently increased the mean number of ICP
rises per rat (Figure 5.5A) (One Way ANOVA followed by Dunn's method) with the lmg/kg eliciting
the greatest number of ICP rises. Apomorphine also increased the incidence (percentage) of rats
displaying ICP rises (Figure 5.5B) (Chi-squared test) with lmg/kg dose being the most effective.
From these data, a dose of 0.25mg/kg apomorphine was used in all subsequent studies.
Apomorphine (i.v.) at low doses exhibited a slight effect on systemic blood pressure. It can be seen
that the 0.05 and 0.15mg/kg apomorphine significantly decreased blood pressure (Figure 5.6) (One
Way ANOVA followed by Dunn's method). However, no other doses of apomorphine had any
significant depressant effects on blood pressure.
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Effects of i.v. delivery of apomorphine (Apo, 0.05mg/kg) on ICP. Example traces show
ICP responses to i.v. delivery of vehicle (A) and Apo (B). Apo induces transient increases
in ICP compared to vehicle.

























Effects of i.v. delivery of apomorphine (Apo, 0.25mg/kg) on ICP. Example traces show
ICP responses to i.v. delivery of vehicle (A) and 0.25mg/kg Apo (B). Apo induces
transient increases in ICP compared to vehicle.







































Effects of i.v. delivery of apomorphine (Apo) on ICP. Example traces show ICP
responses to i.v. delivery of vehicle (A) and lmg/kg Apo (B). Increasing the dose of Apo
transiently increases ICP.





















vehicle 0.01 0.05 0.15 0.25 1 5
Apo mg/kg (i.v.)
Effect of apomorphine (Apo) on the mean number of ICP rises (A) and the incidence (%)
of penile erection (B). Apo (n=4-5 per group) dose dependently increased the mean
number of ICP rises (One Way ANOVA followed by Dunn's method, *=P<0.05;
**=P<0.01,) and the percentage of rats displaying ICP rises (Chi-squared test, *=P<0.05;
**=P<0.01).



















vehicle 0.01 0.05 0.15 0.25
Apo mg/kg (i.v.)
Effect of apomorphine (Apo) on blood pressure in the anaesthetised rat. In those rats
treated with Apo only (n=4-5 per group), 0.05 and 0.15mg/kg Apo significantly decreased
blood pressure (One Way ANOVA followed by Dunn's method, *P<0.05).
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5.3.1.3. Effects ofoxytocin (i.s.) on 1CP rises
In order to confirm that oxytocin action in the L4-L6 lumbosacral spinal cord elicits rises in ICP,
oxytocin (30ng) (n=5) was injected in the L4-L6 spinal level to mimic the release of oxytocin.
Typical ICP responses after i.s. injection of oxytocin (30ng) are shown in the example trace in Figure
5.7A. Oxytocin (i.s.) induced robust increases in the ICP baseline in all 5 rats examined. The
photomicrograph in Figure 5.7B, histologically shows the injection site. It can seen that the injection
needle lies close to the sacral parasympathetic nucleus (SPN) which is an important nucleus involved
in the generation of penile erection. As stated previously, i.s. injection of oxytocin in the L4-L6 spinal
cord was performed solely to confirm our injection site was in fact the correct spinal level for
oxytocin action to produce increases in ICP (this has been shown previously, Giuliano et al 2001).
Thus, a vehicle treated group was not included in this part of the study and so statistics were not
performed.
5.3.1.4. Effects ofan oxytocin receptor antagonist (i.s.) on apomorphine (i.v.)-induced ICP rises
In order to establish that oxytocin action in the L4-L6 spinal cord mediates apomorphine-induced ICP
rises, 36, 180 or 900ng of an oxytocin receptor antagonist was injected in the L4-L6 spinal cord 5 min
prior to 0.25mg/kg apomorphine (i.v.). Figures 5.8-5.10 show example ICP traces of rats pre-treated
with vehicle (Figure 5.8A), 36 (Figure 5.8B), 180 (Figure 5.9B) or 900ng (Figure 5.10B) followed by
0.25mg/kg apomorphine. After quantification it was observed thatl 80 and 900ng of the oxytocin
receptor antagonist significantly decreased the mean number of ICP rises per rat (Figure 5.11 A) (One
Way ANOVA followed by Dunn's method) and the incidence (percentage) of ICP rises (Figure
5.1 IB) (Chi-squared test) with the dose of 180ng being the most effective in both measured
parameters. No significant differences were detected in the latency (Figure 5.11C), duration (Figure
5.12A) or peak amplitude (Figure 5.12B) (ICPmax/BP) of the apomorphine-induced ICP rises after
36, 180 or 900ng of the oxytocin receptor antagonist. Thel80ng dose of the oxytocin antagonist
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Effect of i.t. delivery of oxytocin (30ng) on ICP. Example trace shown in A
displays ICP responses to i.t. injection of oxytocin (30ng). Oxytocin induces
increased phasic responses in the ICP baseline. Photomicrograph in B illustrates
the injection site (black arrow) in the lumbar spinal cord which lies close to the
SPN (hatched box). Scale bars represent 50pm. SPN=sacral parasympathetic
nucleus.
Figure 5.8: Effects of an oxytocin receptor antagonist (i.t.) on
























Effect of an oxytocin receptor antagonist (OXA) on apomorphine (Apo)-induced ICP rises.
Example traces show ICP responses to i.v. delivery of 0.25mg/kg Apo (as indicated by the
black arrow) after i.t. injection of vehicle (A) and 36ng OXA (B). 36ng OXA marginally
decreases the frequency of Apo-induced ICP rises.
Figure 5.9: Effects of an oxytocin receptor antagonist (i.t.) on


























Effect of an oxytocin receptor antagonist (OXA) on apomorphine (Apo)-induced ICP rises.
Example traces show ICP responses to i.v. delivery of 0.25mg/kg Apo after i.t. injection of
vehicle (A) and 180ng OXA (B). 180ng OXA decreases the frequency of Apo-induced
ICP rises.
Figure 5.10: Effects of an oxytocin receptor antagonist (i.t.) on
























Effect of an oxytocin receptor antagonist (OXA) on apomorphine (Apo)-induced ICP rises.
Example traces show ICP responses to i.v. delivery of 0.25mg/kg Apo after i.t. injection of
vehicle (A) and 900ng OXA (B). 900ng OXA decreases the frequency of Apo-induced
ICP rises.
Figure 5.11: Effects of an oxytocin receptor antagonist (i.t.) on




vehicle 36 180 900
OXA ng (i.t.)
Effect of an oxytocin receptor antagonist (OXA) on apomorphine (Apo)-induced ICP rises.
The OXA (n=6-7 per group) significantly decreased the mean number of ICP rises (A)
(One Way ANOVA followed by Dunn's method, *P<0.05; **P<0.005) and the incidence
(%) of ICP rises (B) (Chi-squared test, *P<0.05; **P<0.01). The OXA did not have any
significant effect on the latency of Apo-induced ICP increases (C).
Figure 5.12: Effects of an oxytocin receptor antagonist (i.t.) on

















Effect of an oxytocin receptor antagonist (OXA) on apomorphine (Apo)-induced ICP rises.
The OXA (n=6-7 per group) did not have significant effect on the duration of ICP rises (A)
or the ICPmax/BP (B). Conversely, the OXA (180ng) significantly decreased the SUM
AUC/BP (C) (One Way ANOVA followed by Dunn's method, *P<0.05).
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(900ng was almost significant P=0.052) significantly reduced the SUM AUC/BP (indicator of overall
erectile function) (Figure 5.12C) (One Way ANOVA followed by Dunn's method).
Injection of an oxytocin receptor antagonist on apomorphine-induced ICP rises had no effect on blood
pressure as shown in Figure 5.13.
5.3.2 Meausring oxytocin release in the lumbosacral spinal cord after apomorphine (i.v.) injection
5.3.2.1 Effects ofapomorphine (i.v.) on oxytocin release in the lumbosacral spinal cord
Because we have shown that lumbosacral oxytocin action partly modulates apomorphine-induced
penile erection, we decided to investigate whether apomorphine increases release of oxytocin in the
lumbosacral spinal cord. Microdialysis was initially used to obtain samples from the L4-L6 spinal
cord. However, as can be seen from Figure 5.14A, the extracted samples contained very low
concentrations of oxytocin, perhaps too low to measure any detectable changes after apomorphine
injection. Push-pull perfusion yielded samples with greater oxytocin concentrations as can be seen in
Figure 5.14B, thus push-pull perfusion was used thereafter.
After apomorphine injection at 0 min, there was a non-significant increase in oxytocin release
compared to vehicle (Figure 5.15A). Such an increase was not evident at 60 or 90 min. No
significant differences were detected when comparing oxytocin levels prior to apomorphine injection
with oxytocin concentrations 30 min after apomorphine injection (time period when the largest rise in
oxytocin release was detected). Additionally, when comparing the delta values (mean baseline values
vs response at 30 min) of vehicle and apomorphine treated rats, those rats receiving 0.25mg/kg
apomorphine showed a higher overall oxytocin response compared to vehicle; however this was not
significant (Figure 5.15B). One to two rats in the control group did exhibit unexpected high
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Figure 5.13: Effects of apomorphine (i.v.) on blood pressure in rats pre-

















Effect of apomorphine (Apo) on blood pressure in the anaesthetised rat. Rats receiving
Apo (0.25mg/kg) after i.t. injection of OXA (n=6-7 per group) did not show any significant
depressant effects on blood pressure.
































Effect of apomorphine (Apo) on oxytocin release in the lumbar spinal cord. Using
microdialysis (A) (n=5), no changes in oxytocin baseline were observed after Apo
(0.25mg/kg) injection (black arrow) at 0 min. Using push-pull perfusion (B) (n=8),
increases in oxytocin release were observed after Apo injection. Additionally, higher
concentrations of oxytocin in the collected samples were seen using push-pull perfusion
which explains the different scales on the y-axis.
























































Effect of apomorphine (Apo) on oxytocin release in the lumbar spinal cord. After Apo
(0.25mg/kg) injection (black arrow) at 0 min, Apo-treated rats (n=8) showed a non¬
significant increase in oxytocin release in the lumbar spinal cord compared to vehicle (n=3)
(A). When comparing the delta values (mean baseline response vs response at 60 min) of
vehicle and Apo, Apo-treated rats produced a greater oxytocin response compared to
vehicle; however, this was not significant.
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concentrations of oxytocin at time 0 min. The reason for this is unclear but minor technical errors
may have been a contributing factor.
5.3.2.2 Effects ofapomorphine (i.v.) on breathingfrequency
Apomorphine injection at 0 min had no significant effect on breathing frequency in the anaesthetised
rat (Figure 5.16). It is interesting to note however, that prior to apomorphine injection, rats placed in
the apomorphine-treated group exhibited significantly more inspirations per 60 sec at -30 min when
compared to rats in the vehicle group (Figure 5.16) (Two way ANOVA using repeated measures,
*P<0.05). This was an unexpected finding but perhaps individual variability within each group may
account for the levels of significance observed.
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Effect of apomorphine (Apo) on breathing frequency in the anaesthetised rat. After Apo
injection (black arrow), the breathing frequency of Apo-treated rats (n=8) did not
significantly differ from vehicle-treated rats (n=6). Prior to Apo injection, those rats placed
in the Apo-treated group displayed significantly more breaths per min at 60 min compared
to rats placed in the vehicle group (Two way ANOVA using repeated measures, *P<0.05).
U Apo




5.4.1 Effects ofoxytocin receptor blockade in the lumbosacral spinal cord during apomorphine-
induced 1CP rises
The present study further substantiates previous findings proving apomorphine to be a powerful
erectogenic agent in both anaesthetised and conscious animals (Bernabe et al, 1999; Giuliano et al,
2001, 2002; Moreland et al, 2005). Here we have shown that ICP responses induced by systemic
injection of apomorphine can be compromised after oxytocin receptor blockade in the lumbar spinal
cord. Accordingly, our preliminary results suggest that apomorphine may increase oxytocin release in
the lumbar spinal cord to facilitate penile erection. Thus, for the first time we demonstrate a role for
spinal oxytocin in the mediation of penile erection upon dopamine stimulation.
5.4.1.1 Effect ofapomorphine (intra-PVN) on ICP rises
The PVN has been shown to be one of the most highly sensitive brain regions to respond to the pro-
erectile effects of apomorphine (Melis et al, 1987). As expected in this study, intra-PVN (1 pig)
delivery of apomorphine produced transient increases in ICP which has previously been shown in
conscious and anaesthetised animals (Chen et al, 1999; Melis et al, 1987, 2005; Succu et al, 2007). It
is noteworthy that the erectogenic doses administered to conscious animals compared to the dose of
apomorphine used in this study were comparatively low (100-200ng vs lpg). A lpg dose of
apomorphine was used because 500ng has previously been known to exert some facilitatory effects on
ICP rises (Allard et al, 2002). Thus we used lpg to almost certainly ensure a pro-erectile response. In
addition, general anaesthesia is believed to have some affect on the responsiveness of some neural
systems in terminally anaesthetised animals. Thus, a higher dose of apomorphine was injected to
compensate for any potential reduction in neuronal excitability due to the anaesthesia. Because it can
be technically very difficult (for an inexperienced experimentor) to consistently place the injection
156
Chapter 5.4: Lumbosacral oxytocin action and apomorphine-induced penile
erection - Discussion
needle in the PVN, apomorphine was given in a 4pl volume (as opposed to 300nl in conscious
studies). This larger volume was injected to account for any small stereotaxic injection site
inaccuracies (for example, those that lay just outside the PVN), thus increasing the likelihood of
diffusion of apomorphine to the PVN. As explained earlier, due to the low success rate of injecting
directly in the PVN (as evidenced by an unexpectedly high number of injection tracts located outside
the PVN), it was soon decided to administer apomorphine (i.v.) thereafter.
5.4.1.2 Effect ofapomorphine (i.v.) on ICP rises
Apomorphine (i.v.) dose-dependently increased the frequency of ICP rises per rat and the percentage
of rats displaying ICP increases which is consistent with previous reports (Giuliano et al, 2001). ICP
increases were initially detected after 0.01 mg/kg and such increases were maximally displayed after
lmg/kg. The higher dose of 5 mg/kg was less effective in eliciting ICP responses than lmg/kg. Since
0.25 and 1 mg/kg dose of apomorphine produced 5 and 6 mean ICP rises per rat, respectively, we
chose the sub-maximal dose of 0.25 mg/kg in all subsequent studies. In contrast to our erectile dose
response data, Giuliano and colleagues (2002) administered doses of apomorphine ranging from
0.002-0.25 mg/kg and subsequently used 0.05 mg/kg i.v. dose of apomorphine because this was the
lowest dose they found to significantly increase the SUM AUC/BP. We too found 0.05 mg/kg
apomorphine to significantly increase ICP responses compared to vehicle; however, we found that
such responses were further enhanced after 0.25 and lmg/kg. Thus, we decided 0.25mg/kg was the
most suitable dose of apomorphine for our study because it consistently produced robust increases in
ICP and so would allow the oxytocin receptor antagonist (injected in experiments that followed) to act
within the efficacious pharmaceutical window. Latency, duration and amplitude of ICP responses
after apomorphine injection could not be statistically analysed due to the lack of ICP response in all
vehicle treated rats.
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Interestingly El-Din and colleagues (2006) found that i.v. injection of apomorphine (0.1-0.2 mg/kg)
alone was not sufficient to induce ICP rises. They only found significant changes when apomorphine
(i.v.) was administered prior to cavernous nerve stimulation. They believed that the erectogenic
effects of apomorphine were only visible when in the presence of some form of sexual stimulation.
However, this finding is not consistent with our data or previous studies in conscious and
anaesthetised rats, where the pro-erectile effect of apomorphine occurred without any apparent
associated sexual stimulation (Giuliano et al, 2001; Hsieh et al, 2004; Martino et al, 2005; Melis et al,
1987, 1989, 2005). So it seems that apomorphine can act as an inducer and facilitator of penile
erection suggesting that dopamine acts at multiple sites or it can perhaps activate more than one pro-
erectile pathway. We are thus convinced that the powerful erectogenic responses observed in our
study are due to the specific inducer actions of apomorphine on central erectile pathways.
El-Din and colleagues (2006) also found 0.1 mg/kg apomorphine was sufficient to potentiate ICP
responses to cavernous stimulation, whilst 0.2 mg/kg had no effect when compared to vehicle. They
claim these effects were due to the biphasic effects of apomorphine (low doses facilitating penile
erection and high doses inhibiting penile erection as reported before (Eaton et al, 1991; Pehek et al,
1988). However, these experimentors only observed the biphasic effects after increasing the dose
five- and tenfold and not twofold. Reasons for such discrepancies between our results and those of El-
Din and colleagues remain unclear but perhaps the strain of rat used and "n" number per group (both
unknown in the study conducted by El-Din and colleagues) were contributing factors. It is likely
however, that such contrasts are due to the differential activation of central pathways upon dopamine
stimulation alone and in conjunction with other components of the erectile framework.
The hypotensive effect of apomorphine in rats has been reported before (El-Din et al, 2006; Velasco
and Luchsinger, 1998 for review). In our study we noticed that lower doses of apomorphine (10 and
150pg/kg) significantly decreased blood pressure, however, the higher doses did not have such a
profound hypotensive effect. Rats treated with these two lower doses displayed clear increases in
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ICP, thus this slight depressant effect of apomorphine on blood pressure did not seem to have any
profound effects on ICP.
5.4.1.3 Effect ofan oxytocin receptor antagonist (i.s.) on apomorphine-induced ICP rises
In agreement with other studies (Giuliano et al, 2001; Martino et al, 2005), 30ng of oxytocin given i.s.
is able to produce powerful increases in phasic ICP responses. The L4-L6 spinal cord contains the
sacral parasympathetic nucleus (SPN) which regulates parasympathetic proerectile outflow. The SPN
is partly innervated by oxytocin fibres and possesses oxyocin receptor binding sites (Veronneau-
Longueville et al, 1999). Thus, it seems logical to assume that oxytocin action in this area of the
lumbar spinal cord is a potent stimulator of spinal proerectile neurons. However, it is important to add
however, that the SPN is not comprised exclusively of pro-erectile preganglionic neurons and the SPN
is under central control from other neuromodulatory pathways such as serotonin and galanin which
have been implicated in erectile function and sexual behaviour (Benelli et al, 1994; Tang et al, 1998).
Thus, it would be naive to presume that oxytocinergic transmission in the SPN is the primary spinal
inducer of erection. Because of the presence of oxytocinergic constituents in this nucleus it is
tempting to hypothesis that expression of penile erection is secondary to local oxytocin effects.
However, it is important not to discount the possibility of an indirect effect of oxytocin in the spinal
cord or involvement of other known pro-erectile neuromodulators.
Because apomorphine acting in the PVN and oxytocin acting in the L4-L6 spinal cord (due to
oxytocin release from the descending paraventriculo-spinal oxytocin pathway) are erectogenic, it
seems plausible to suggest that apomorphine elicits penile erection via activation of this descending
oxytocin pathway. For the first time we have shown that oxytocin receptor blockade in the
lumbosacral spinal cord, reduced the facilitatory effect of apomorphine on ICP rises. This suggests
that lumbosacral oxytocin mediates apomorphine-induced penile erection. Both 180ng and 900ng of
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the oxytocin receptor antagonist (OXA) significantly reduced apomorphine-induced 1CP responses
with the 180ng dose being the most effective. It is unclear as to why the 900ng dose of OXA was less
effective than the 180ng dose. However, one possible reason may be that 900ng was in fact too high
and whilst all the oxytocin receptor binding sites were saturated, the OXA may have acted on other
non-specific sites that may act to facilitate penile erection.
Interestingly, the OXA did not completely abolish ICP responses, indicating that spinal oxytocin is
not the only neuromediator involved in penile erection and suggests oxytocin has a modulatory rather
than a primary role in dopamine-mediated penile erection. The injection site of the OXA lay close to
the dorsal horn (DH), dorsal grey commisure (DGC), SPN and intermediolateral grey matter (IML),
all of which receive oxytocinergic innervation, which contain oxytocin receptor binding sites and are
believed to be involved in sensory and somatic control of erectile pathways (Tang et al, 1998;
Veronneau-Longueville et al, 1999). The precise role of each of the above spinal nuclei and
involvement of oxytocin, it is not clear. Perhaps direct injection in the SPN may have produced a
greater inhibitory effect on apomorphine-induced ICP rises.
In addition to the role of other spinal cord nuclei in the ICP response, the less than profound effect of
the OXA on erectile episodes elicited by apomorphine may be partly due to the dose of apomorphine
administered. The 0.25 mg/kg dose of apomorphine may have been too high for the OXA to
completely attenuate ICP rises. Other studies have used 0.05-0.1 mg/kg as an effective dose to elicit
significant increases in ICP, thus perhaps administering a lower dose of apomorphine after OXA
injection would have revealed its effects via oxytocin more clearly. This is unlikely to be the case
because the lumbosacral spinal cord is the important intergrative site that is believed to generate
penile erection. In OXA treated rats, apomorphine did not affect the amplitude, latency or duration of
the ICP response suggesting that expression of penile erection is threshold-dependent. Thus, by
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increasing the dose of apomorphine, this does not necessarily reflect a concomitant/sequential increase
in spinal oxytocin release.
The most likely explanation for the lack of abolishment of apomorphine-induced ICP rises after OXA
injection is perhaps due to involvement of other excitatory neuromodulatory pathways in the spinal
cord. Descending oxytocin pathways are not the only candidate neurons implicated in spinal control
of erectile function. Injection (i.s.) of dopamine, glutamate and melanocortin have all been shown to
elicit ICP responses (Giuliano et al, 2001; Rampin et al, 2004; Wessells et al, 2003). Furthermore, it
is possible that the paraventricular projection to the lumbosacral spinal cord may not be direct but via
the recruitment of serotonergic cells in the nucleus paragigantocellularis. Fibres originating in the
PVN have been shown to lie in close apposition to serotonergic cells in the nucleus
paragigantocellularis (Bancila et al, 2002). Additionally, intraspinal injection of 5HT 1C and 5HT 2C
agonists produces transient increases in ICP (Stafford et al, 2006; Steers et al, 1992) suggesting the
existence of a descending excitatory serotonergic pathway.
Finally, OXA treated rats receiving apomorphine did not show any significant depressant effects on
blood pressure, thus the reduced facilitatory effect on ICP increases seen in these animals was due to
the OXA and not caused by hemodynamic changes in the penile vasculature.
5.4.2. Effect ofapomorphine (i.v.) on oxytocin release in the lumbosacral spinal cord
Increases in oxytocin levels have been observed in the PVN, CSF, subarachnoid space and systemic
blood during sexual behaviour in rats and humans (Hughes et al, 1987; Kruger et al, 2006; Sansone et
al, 2002; Uckert et al, 2003; Waldherr and Neumann, 2007). Dopamine agonists are also known to
increase plasma and hippocampal oxytocin concentrations (Melis et al, 1989, 1990). Since we have
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shown that blockade of lumbosacral oxytocin receptors reduces the incidence of penile erection
stimulated by apomorphine, we investigated whether apomorphine could also increase oxytocin
release within the lumbosacral spinal cord of the anaesthetised rat.
Our preliminary data show that oxytocin levels appeared to peak at approximately 60 min after
apomorphine (0.25 mg/kg) injection, where we observed a non-significant increase in oxytocin levels
in the lumbosacral spinal cord. There were some initial technical difficulties experienced in the
experimental set up and an unexpectedly high number of animals did not survive the experimental test
period (presumably due to fluid accumulation in the lungs). Thus, the "n" numbers were
comparatively low in the control group (n=8 and 6 for apomorphine and vehicle treated groups,
respectively) and perhaps partly explain the lack of statistical significance. One surprising finding in
this study was that the increase in oxytocin levels was not detected until 60 min after apomorphine
injection. This does not fit well with the quick effect of the oxytocin antagonist on apomorphine-
induced ICP responses. Nor does it bode well for the generation of penile erection in a sexual
behaviour context because the rapid onset of penile erection is required for intromission and
ejaculation (which normally occur within 5-10 min during sexual behaviour studies). Furthermore,
conscious and anaesthetised animals injected with apomorphine display erections within 15 min
(Brioni et al, 2004) and 10 min (see Figure 4.3-4.4), respectively. Thus, one would assume
apomorphine-induced oxytocin increases to occur prior to 10 min to elicit penile erection.
Interestingly, in a similar study in female rats, the investigators used vaginocervical stimulation to
stimulate oxytocin release in the lumbosacral spinal cord. They found an enhancement in oxytocin
release approximately 10-15 min after the vaginocervical stimulation (Sansone et al, 2002). Reasons
for such discrepancies could be due to the different forms of stimulation of oxyocin release, i.e.
mechanical versus pharmacological stimulation and the different pathways recruited by each. It is
known that when placed with a receptive female, the male rat will receive olfactory and social cues
which facilitate sexual arousal and penile erection and allow for rapid and efficient copulation.
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Therefore, it could be said that the increased latency for rises in spinal oxytocin levels in the
anaesthetised rat is due to the absence of female oestrus pheromones. This seems unlikely however,
as those conscious and anaesthetised males receiving apomorphine in the absence of a female or
oestrus cues, achieve penile erection within approximately 10-15 mins. The most likely reason may
be that as mentioned previously, the activity of neural pathways can often be less responsive than
those in freely-moving rats. Although the central pathways recruited by apomorphine to control
penile erection do not seem to be affected by urethane anaesthesia, perhaps those neurons that convey
signals to erectile pathways may be augmented.
One other possibility could be that apomorphine stimulates simultaneous and/or sequential release of
oxytocin at other central sites during penile erection which may diffuse to target sites that regulate
erectile function. We know that apomorphine increases oxytocin levels in the plasma and
hippocampus (Melis et al, 1989, 1990). The SON and PVN are two other potential release sites. The
pro-erectile melanocortin, a-MSH has been shown to enhance dendritic release of oxytocin within the
SON (Sabatier et al, 2003) and copulatory behaviour markedly increases the concentration of oxytocin
in the PVN (Waldherr and Neumann, 2007). Thus, it seems tempting to suggest that apomorphine-
induced penile erection requires release of oxytocin at multiple central sites implicated in sexual
behaviour and not exclusively in the lumbosacral spinal cord.
This latent and marginal increase in spinal oxytocin levels after dopaminergic stimulation further
substantiates our previous findings demonstrating that oxytocin action in the lumbosacral spinal cord
exhibits a the less than pivotal role in the generation of dopamine-mediated erectile function. Thus,
penile erection generated in the conscious male rat in a sexually-exciting environment is more likely
due to the summative effect of the activation of various neurotransmitter and neuropeptide pathways
as opposed to one neural pathway in particular.
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In conclusion, we have shown that the erectogenic ligand, apomorphine, may act centrally to stimulate
penile erection partly via the recruitment of paraventricular descending oxytocin neurons and release
of oxytocin in the lumbosacral spinal cord. Subsequently, the spinal proerectile neurons (perhaps
contained within the SPN) become activated and control peripheral outflow to the penis. It is apparent
that penile erection elicited by apomorphine does not exclusively involve this descending oxytocin
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It is clear that dopamine has a well established role in the expression of male copulatory behaviour
(Hull and Dominguez, 2007 for review). By modulating dopaminergic neurotransmission via the
central application of dopamine receptor ligands, expression of penile erection in male rats can be
augmented. We have shown that such effects on erectile function appear to be at least partly
modulated via the parvocellular and magnocellular oxytocin cells in the hypothalamus of the male rat.
One of the most interesting findings in our studies was the apparent differential involvement of
hypothalamic oxytocin cells during dopamine-mediated penile erection. The activation of these
neurons appeared to be contextually-specific, with parvocellular oxytocin cells in the PVN being
implicated in pharmacologically-induced penile erection and magnocellular oxytocin neurons in the
SON mediating physiologically-induced penile erection during copulation (in-copula penile erection).
6.1 Parvocellular oxytocin cells and the initiation ofpenile erection
In our behavioural study, the dopamine receptor agonists Quinelorane (D2/D3) and PD168077 (D4)
were highly effective in eliciting penile erection in conscious males. However, Quinelorane but not
PD 168077 seemed to activate oxytocin neurons in the parvocellular PVN during the expression of
penile erection. Interestingly, neither agonist had any effect on Fos expression in oxytocin neurons in
the MPN, SON or mPVN.
Currently, the PVN is the only known nucleus to contribute parvocellular oxytocin fibres to the
lumbosacral spinal cord (Tang et al, 1998; Veronneau-Longueville et al, 1999; Wagner and Clemens,
1991). From our ICP study in anaesthetised rats, we attempted to block the action of oxytocin
released from descending parvocellular oxytocin cells in the lumbosacral spinal cord after systemic
delivery of apomorphine. Such disruption of oxytocin action in the lumbosacral spinal cord clearly
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impaired the frequency of ICP rises induced by apomorphine. Thus, from our studies in conscious
and anaesthetised rats, it seems that oxytocin cells in the parvocellular PVN are one potential pathway
recruited by dopamine receptor agonists during the expression of penile erection. The dopamine
receptor(s) believed to subserve the pharmacologically-induced penile erection we observed in our
studies remains unknown. Apomorphine acts on all dopamine receptors, however, Quinelorane
preferentially acts on D2 and D3 receptors and PD168077 is a selective D4 receptor agonist. Since
Quinelorane but not PD 168077 selectively activated the parvocellular PVN during the expression of
penile erection, it is tempting to suggest that activation of the dopamine-oxytocin pathway in eliciting
penile erection relies upon stimulation of D2 and/or D3 receptors. Moreover, this idea is reinforced
by the finding that parvocellular oxytocin cells in the PVN express D2 and D3 receptors. Dopamine
D4 receptor activation was also effective in eliciting penile erection. However, in contrast, the D4
agonist had no effect on hypothalamic oxytocin neurons and we found D4 receptors to be
predominantly expressed by magnocellular but not parvocellular oxytocin neurons. So perhaps D4
receptor-mediated penile erection operates via alternative neural circuitries (such as GABA as
described previously) or an as yet unknown pathway.
Some researchers believe that parvocellular oxytocin cells have at most a minimal role in penile
erection. This is partly due to the fact that these cells exist in lower numbers and release
comparatively lower levels of oxytocin when compared to the robust magnocellular oxytocin system.
As previously mentioned, lesioning of the descending oxytocin pathway selectively impairs penile
erection parameters, particularly oxytocin- and apomorphine-induced erectile events but rats show no
obvious deficits in copulatory function (Ackerman et al, 1997; Argiolas et al, 1987; Liu et al, 1997).
Taken together, the findings from our studies and those of others seem to suggest that parvocellular
oxytocin pathways originating in the PVN serve as important neural substrates in the initiation and
achievement of penile erection. However, a possible role for parvocellular oxytocin cells in those
sexually-associated events occurring after penile erection have yet to be established.
To further understand the exact central mechanism(s) whereby dopamine exerts its pro-erectile
effects, it is important to mention that the spinal generator of erectile events is under tonic supraspinal
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inhibitory control via descending serotonergic fibres located in the nucleus paragigantocellularis
(NPG). Thus, dopamine acting on descending oxytocin fibres alone is probably not sufficient to
stimulate penile erection. We know that the PVN sends direct projections to the NPG (Bancila et al,
2002) and serotonergic fibres in the NPG have been implicated in the inhibition of penile reflexes
(Marson et al, 1992; Marson and Mckenna, 1992). So, it may be that dopamine acts in a dual manner
to disinhibit the inhibitory spinal serotonergic influence whilst activating the descending excitatory
oxytocin pathway. Once parasympathetic neurons in the SPN have been sufficiently depolarised by
oxytocin acting in the lumbosacral spinal, there is subsequent stimulation of pelvic and cavernosal
nerves to elicit penile erection (see Figure 6.1).
6.2 Magnocelhilar oxytocin cells and intromission
We have shown that penile erection elicited by central and systemic delivery of dopamine agonists
partly involves stimulation of parvocellular oxytocin neurons. Conversely, when examining the effect
of D2-like receptor antagonists on physiologically-induced penile erection during sexual activity, no
significant effects on parvocellular oxytocin neurons were observed. We have seen that blockade of
D3 receptors partially inhibits penile erection via a non-oxytocinergic pathway in the MPN, SON and
PVN (as identified by the Fos only data). However, it was surprising to find that by inhibiting the
actions of endogenous dopamine at the D4 receptors, we effectively reduced the expression of penile
erection partly via an oxytocinergic pathway in the SON but not in the MPN or PVN. This suggests a
role for magnocellular but not parvocellular oxytocin cells during in-copula penile erection.
Such differential involvement of parvocellular and magnocellular oxytocin cells in the expression of
penile erection provides some new insight into those neural processes underlying the initiation and
maintenance of penile rigidity. It is apparent that pharmacologically- and physiologically-induced
penile erections seem to recruit different pathways in the generation of penile erection. Both stimuli
appear to operate via distinct neuronal populations, and in some cases sub-populations, within the
MPN, SON and PVN. From these behavioural studies, it is apparent that oxytocin neurons in the
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Role of parovcellular oxytocin cells in the generation of penile erection. Those sexually-
relevant stimuli known to elicit penile erection increase incertohypothalamic-derived
dopamine concentrations (1), dopamine then acts either directly and/or indirectly to
disinhibit descending serotonergic control (2) and to excite descending parovcellular
paraventriculospinal oxytocin cells (3), oxytocin released in the L4-L6 spinal cord
activates preganglionic parasympathetic neurons in the sacral parasympathetic nucleus
(4), which stimulates peripheral output to the penis and elicits penile erection (5).
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paragigantocellularis.
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parvocellular PVN mediate penile erection induced pharmacologically. However, blockade of
dopamine D4 receptors during physiologically-induced penile erection (as experienced during
copulation) appears to affect only the magnocellular oxytocin neurons in the SON (but not in
magnocellular PVN). Could it be that non-contact penile erection induced by dopamine receptor
agonists (or sexual stimuli which promote dopamine release such as exposure to remote female
oestrus cues), involves parvocellular PVN oxytocin neurons; however, in-copula penile erection
selectively activates magnocellular oxytocin neurons? The mechanism by which dopamine excites
magnocellular oxytocin cells has yet to be explored. However, it could be postulated that during
intromission, dopamine levels increase in the SON and such elevated dopaminergic levels coupled
with sensory feedback from the penis act to disinhibit the GABAergic influence on oxytocin cells and
so facilitate oxytocinergic activation. Paraventricular and supraoptic oxytocin cells in particular are
known to be activated upon tactile manipulation of the glans penis and stimulation of the dorsal penile
nerve (Honda et al, 1999; Yanagimoto et al, 1996). This suggests that genito-sensory signals
transmitted by the dorsal penile nerve, selectively activate magnocellular oxytocin cells in the PVN
and SON. Thus, it seems that magnocellular oxytocin activation requires penile erection and genito-
sensory input as experienced during intromission in copulating rats (see Figure 6.2). Furthermore, a
more prominent role for magnocellular oxytocin neurons during the consummatory elements of sexual
behaviour as opposed to non-contact erections was further substantiated when it was shown that
significant disruptions in copulatory function were only observed after lesioning of both the
parvocellular and magnocellular PVN (Ackerman et al, 1997).
It is interesting to point out that while supraoptic magnocellular oxytocin cellular activation has been
implicated in the regulation of in-copula penile erection, no such effect was observed in
magnocellular PVN oxytocin cells. This was an unexpected finding as a similar homogenous
population of magnocellular oxytocin cells are thought to exist in both the SON and PVN and both
have been shown to be activated during intromission (Caquineau et al, 2006). Perhaps by disrupting
normal dopaminergic neurotransmission (as we have by administering dopamine antagonists), this has
more of an impact on the functioning of oxytocin cells in the SON during sexual behaviour as
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Role of supraoptic magnocellular oxytocin cells during intromission in the
copulating rat. During intromission there is an increase in incertohypothalamo-
derived dopamine concentrations (1) as well as peripheral sensory feedback from
the genitals (2) which inturn stimulate magnocellular oxytocin release within the
SON, plasma and at other unknown sites (3) to facilitate intromisssion (4).
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opposed to those in the magnocellular PVN which may have more of a modulatory role. We know
that dopamine agonists and antagonists can act locally in the SON to inhibit or facilitate GABAergic
neurotransmission, respectively and so subsequently enhance or decrease oxytocin release,
respectively (Azdad et al, 2003). However, this is not known for paraventricular magnocellular
oxytocin cells, so it may be that those neural inputs impinging on oxytocin cells in the mPVN may
differentially modulate oxytocinergic transmission compared to those in the SON, although this is
highly speculative.
In addition to the involvement of magnocellular oxytocin neurons in erectile function, it is important
to draw attention to the potential role of magnocellular vasopressin cells in the SON (and perhaps the
PVN) in mediating the pro-erectile effects of dopamine. In our studies, we have shown that blockade
of D3 receptors in the SON and PVN attenuates neuronal activation of non-oxytocinergic cells during
in-copula penile erection (Chapter 3). Because the SON and PVN contain large populations of
oxytocin and vasopressin cells, it is quite possible that the neuronal phenotype expressing Fos may
include vasopressin. Furthermore, we also demonstrated an abundant expression of D2-like receptors
on non-oxytocinergic neuronal populations in the SON and PVN (Chapter 4) which are also likely to
be vasopressin in origin. So, this introduces an exciting prospect whereby a dopamine-vasopressin
link exists in addition to a dopamine-oxytocin pathway in mediating erectile function. Of the very
few studies investigating the role of vasopressin and male sexual behaviour, it has been shown that
microinjection of vasopressin into the PVN or hippocampus stimulates penile erection; however, it
was less erectogenic than oxytocin (Argiolas et al, 1986; Argiolas et al, 1989; Melis et al, 1986). In
addition, paraventriculospinal vasopressin fibres appear to have some excitatory influence over the
activity of penile striated muscles (Ogier et al, 2006) which are important for penile rigidity and
facilitating ejaculation. To date there are no published studies demonstrating an interaction between
dopamine and vasopressin in a sexual context. We know that central or intra-SON injection of
dopamine stimulates vasopressin release in vitro and in vivo (Bridges et al, 1975; Urano and
Kobayashi, 1978). Behavioural studies have also shown an activation of mesolimbic dopamine
pathways and vasopressin systems during conditioned partner preference and pair bonding associated
169
Chapter 6: General discussion
with aggression (Smeltzer et al, 2006; Gobrogge et al, 2007; Lim et al, 2004). However, the
implication of a dopamine-vasopressin relationship subserving aspects of masculine sexual behaviour
makes for an exciting area of neurobiology yet to be explored.
6.3 Summary
Thus, it seems that two functional oxytocinergic groups may exist in the male rat to facilitate penile
erection. Firstly, a group of "low threshold" parvocellular oxytocin cells which can be stimulated
after endogenous release of dopamine in the presence of a sexually-relevant stimulus such as exposure
to female oestrus cues and/or mounting behaviour. Such interactions between dopamine and
parvocellular PVN oxytocin neurons are required for the initiation phase of penile erection but not for
those sexually-associated events occurring after achievement of penile erection (eg. intromission and
pelvic thrusting). As we have shown, penile erection alone is not sufficient to stimulate magnocellular
oxytocin cells. Thus, a second group of "high threshold" magnocellular oxytocin neurons may exist
which are activated by endogenous dopamine during intromission when there is sensory feedback
from the genitals. Perhaps the combined actions of endogenous dopamine and peripheral feedback are
necessary to activate magnocellular oxytocin cells. It would seem then that such magnocellular
oxytocin involvement may serve as an important neural basis regulating those events occurring after
achievement of penile erection, such as intromission, pelvic thrusting and even ejaculation. The
above explanation is hypothetical and does not take into account other potential neural pathways that
can indirectly and directly influence oxytocinergic transmission in the brain or that oxytocin may be
released sequentially or concurrently at multiple release sites in the CNS during penile erection. It is
likely that a delicate and co-ordinated oxytocinergic system exists whereby there is release of oxytocin
within the SON, PVN, plasma and the spinal cord which governs central and peripheral output and
culminates in penile erection.
Finally, it is very apparent that the central regulation of penile erection is not under the control of any
one brain nucleus in particular and so it would be naive to consider the MPN, SON and PVN to be the
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only major brain regions responsible for initiating penile erection. There appears to be reciprocal
connections between the nucleus accumbens, amygdala, striatum, hippocampus and the hypothalamus
to name but a few, all of which have been implicated in co-ordinating male sexual responses (Kippin
et al, 2004; Temel et al, 2006 for review). Thus, we know that a very complex and intricate system
exists which integrates peripheral and olfactory stimulatory cues with brain pathways that modulate
the spinal pro-erectile network. In our studies we have only looked at one particular hypothalamic
pathway (dopamine-oxytocin) and one specific sexual element, penile erection. The role of
dopaminergic-oxytocinergic crosstalk in those events occurring prior to (sexual motivation) and
immediately after penile erection (maintenance of penile rigidity required for intromission) remain
unknown. However, further investigation of the neurochemical correlates responsible for the
appetitive and consummatory aspects of male sexual behaviour would help provide new insight into
our rather blurred current interpretation. Finally, it is necessary to better understand the role of those
nuclei that provide a range of neural inputs into the main pro-erectile brain centres and also the





Chapter 7: General Conclusion
Chapter 7
Chapter 7 General Conclusion
Although some may view impaired erectile function as a natural age-related progressive decline in
sexual functioning, the increasing prevalence of erectile dysfunction among middle-aged men and its
physical and psychological impact on sufferer's lives make this condition an important area of
neurophysiology yet to be fully explored.
Elucidating those central and peripheral pathways responsible for generating penile erection has
proved complex because the exact causes of impaired penile erection remain ambiguous. Vascular,
neurological and hormonal influences are all believed to be causative. However, in addition to this, a
range of underlying vascular diseases such as diabetes, hypertension and atherosclerosis, all of which
can disrupt blood flow to the penile vasculature, can pre-dispose individuals to impaired erectile
function. Additionally, psychogenic factors can also have a marked effect on penile erection as
inferred by studies showing men suffering from depressive-like illnesses exhibit a higher incidence of
erectile dysfunction (Greiner and Weigel, 1996 for review). Thus, successful treatment of this
condition has proved difficult because targeting those central and peripheral processes that are
disrupted during erectile dysfunction may not be sufficient to treat penile erection in some individuals
where perhaps a more holistic approach may be more beneficial. However, it is important to stress
that in most cases of erectile dysfunction the causes are organic. Although a curative therapy is not
available for this form of male sexual dysfunction, there has been some commercial success with a
few select pharmacological agents that are designed to target different stages of the erectile pathway
in men.
7. I Modem treatmentfor erectile dysfunction
Modern pharmacological treatments for erectile dysfunction have included sublingual delivery of
apomorphine and oral administration of phosphodiesterase-5 (PDE5) inhibitors (Dinsmore, 2004).
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Apomorphine as stated earlier is a potent inducer and facilitator of penile erection and has proven to
be relatively effective in men with mild to moderate erectile impairments (Altwein and Keuler, 2001;
Briganti et al, 2004 for review). However, it is generally short-lasting and can produce severe side
effects including nausea and emesis. Due to its strong inducer and facilitatory effects, there have been
some reports of priapism (prolonged painful erections) in men suffering from multiple sclerosis and
Parkinson's disease (Landtblom, 2006; O'Sullivan and Hughes, 1998). Because these side effects can
be too severe to provide any long term treatment, development of alternative pharmacological
therapies are needed that are more efficacious and possess a larger therapeutic window. Interestingly,
very recently intranasal delivery of apomorphine in rats was shown to have improved efficacy with
fewer side effects (Lu et al, 2008). Thus, an intranasal route of administration of apomorphine may be
a potentially effective alternative for treatment in humans and aid in combating the percentage of
patients experiencing adverse side effects associated with dopamine-enhancing drugs.
Phosphodiesterase (PDE) inhibitors, particularly PDE5 inhibitors are another form of pharmacological
treatment for erectile dysfunction which is currently the most popular of oral therapies (Miner and
Seftel, 2007; Sperling et al, 2003). PDE5 inhibitors act peripherally on penile tissue to prevent the
breakdown of NO-stimulated cGMP levels. Due to the high concentration of cGMP in penile tissue,
there is a subsequent decrease in intracellular calcium levels which potentiates the relaxation of penile
smooth muscle and so facilitates penile erection (Corbin et al, 2002). PDE5 inhibitors have provided
safe, effective treatment in some men, causing only minor side effects (Dinsmore, 2004) and there is a
low risk of priapism (Saenz et al, 2001). However, because NO release precedes cGMP formulation,
PDE5 inhibitors are only effective in stimulating penile erection following sexual arousal. Thus,
PDE5 inhibitors aid in maintaining penile rigidity but unlike apomorphine, they have no effect on the
initiation of penile erection. They acts as facilitators and are not inducers of penile erections. Thus
some men may not respond to or display reduced responsiveness to these peripheral agents.
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So, it can be seen that recent advancements in erectile dysfunction therapies have proved to be
relatively successful in some patients; however, due to the relative non-specificity of apomorphine and
the purely facilitatory effect of PDE5 inhibitors, it is essential to develop other therapeutic alternatives
that will be equally efficacious in inducing and maintaining penile erection without severely
impacting on normal physiological functions.
7.2 Central oyxtocin sites as potential therapeutic targets
In this thesis, we have tried to establish a link between central dopamine and oxytocin pathways with
the aim of elucidating one potential neuroanatomical pathway that may mediate erectile function.
From our findings and other published data (Argiolas and Melis, 2004 for review), we are convinced
that endogenous dopamine may act (directly/indirectly) via oxytocin in the CNS to induce penile
erection. Due to their large oxytocinergic populations, the PVN and SON may serve as two potential
integration sites. Such activation of oxytocin neurons in these nuclei can result in widespread
oxytocin release in the CNS and in the plasma resulting in the activation of pro-erectile pathways.
Oxytocin cells are not solely responsive to dopamine agonists but are also believed to respond to a
range of erectogenic agents including excitatory amino acids, oxytocin, NO and hexarelin analogues
(Melis and Argiolas, 2003 for review) suggesting that hypothalamic oxytocin pathways are a key
component of penile erection. Thus, this gives rise to an area of sexual pharmacology yet to be
explored.
Oxytocin has become a key clinical target due to its potent erectogenic effects in pre-clinical studies
(Argiolas and Melis, 2004 for review; Kita et al, 2006; Martino et al, 2005) and seemingly lack of
severe side effects to patients when given in low doses (Smith and Merrill, 2006). However, to date
there are no oxytocin agonists clinically available for the treatment of erectile dysfunction. In modern
obstetrics, oxytocics have a clearly established role (den Hertog et al, 2001). Clinical management of
pre-term labour and post partum haemorrhaging, both of which are influenced by oxytocinergic inputs
and are due to enhanced oxytocinergic neurotransmission; are effectively managed by systemic
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delivery of oxytocin antagonists. Similarly, oxytocin agonists can be administered to increase uterine
activity and so induce labour in women who have reached full-term in their pregnancy (Romero et al,
2000; Shyken and Petrie, 1995a, 1995b; Smith and Merrill, 2006). Other clinical and pre-clinical
studies have revealed that systemic delivery of oxytocin antagonists are able to block uterine
contractions stimulated by oxytocin in women, monkey and rats (Croci et al, 2007; Pettibone et al,
1995; Serradeil-Le Gal et al, 2004) and delay parturition in pregnant rats and monkeys (Croci et al,
2007; Serradeil-Le Gal et al, 2004). Taken together, these findings show that manipulation of
oxytocin levels via the use of oxytocin ligands can be extremely effective in facilitating child birth and
treating post partum bleeding in women. This strongly suggests that pharmacological agonists of
oxytocin may also have some clinical relevance regarding the treatment of erectile impairment in men.
Thus, targeting central oxytocin pathways may serve as one potential way of improving treatment of
sexual dysfunction in men.
It is too premature to speculate on the potential therapeutic value of combination therapy involving
dopaminergic and oxytocingeric stimulants. However, this may be one area of pharmacotherapeutic
development that would benefit from more exploratory and investigative research and aid in the
continued development of safe and effective treatment for erectile dysfunction.
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